data_2kii_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kii _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HG ' ' N ' ' A' ' 21' ' ' VAL . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' ARG . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 77' ' ' LEU . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.72 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.72 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 98' ' ' ILE . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.538 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo . . . . . 0 N--CA 1.492 1.404 0 CA-C-O 120.841 0.267 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.673 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.641 ' H ' ' HG ' ' A' ' 172' ' ' CYS . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.673 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.641 ' HG ' ' H ' ' A' ' 165' ' ' MET . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 175' ' ' ILE . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.4 m120 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 77.4 m80 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.467 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.512 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.6 p . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.727 0.299 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' ARG . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 87' ' ' LYS . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 85' ' ' VAL . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' LEU . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 98' ' ' ILE . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 120.811 0.255 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 128' ' ' ILE . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.545 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 163' ' ' THR . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.496 ' HG ' ' H ' ' A' ' 165' ' ' MET . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 175' ' ' ILE . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.729 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.729 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 98' ' ' ILE . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.531 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 CA-C-O 120.825 0.261 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.826 0.346 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.543 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 175' ' ' ILE . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.565 ' ND2' HH21 ' A' ' 80' ' ' ARG . 49.5 t-20 -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.059 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.464 ' H ' ' H ' ' A' ' 3' ' ' GLY . 23.2 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.663 0.268 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.408 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.432 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' ARG . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.538 ' HG ' HH11 ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.565 HH21 ' ND2' ' A' ' 7' ' ' ASN . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.733 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.733 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 100' ' ' ASP . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' H ' ' CG ' ' A' ' 99' ' ' HIS . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.53 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 N--CA 1.487 1.147 0 CA-C-O 120.893 0.289 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.581 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.493 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.4 t . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.523 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.485 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 175' ' ' ILE . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.675 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.622 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 3.2 m120 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.675 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.7 p . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 98' ' ' ILE . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.527 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.408 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.498 1.776 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.463 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.815 0.34 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.559 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.508 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.424 ' HG ' ' H ' ' A' ' 165' ' ' MET . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 175' ' ' ILE . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.3 p90 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 3' ' ' GLY . 86.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.753 0.311 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 77' ' ' LEU . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD1' ' A' ' 100' ' ' ASP . 5.5 p80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD1' ' CE1' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.533 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.533 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.841 0.267 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.472 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.518 ' CD1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 18.6 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.581 0.229 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.563 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 4.3 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.54 ' NE2' ' O ' ' A' ' 163' ' ' THR . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.472 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 175' ' ' ILE . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.604 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.604 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.543 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.489 1.239 0 CA-C-O 120.839 0.266 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.431 ' CD1' ' C ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.639 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 163' ' ' THR . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.545 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.9 OUTLIER -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.545 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.639 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 175' ' ' ILE . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.69 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.69 ' N ' ' H ' ' A' ' 3' ' ' GLY . 51.4 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HE2' ' A' ' 81' ' ' HIS . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 97' ' ' GLY . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 94' ' ' LEU . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 98' ' ' ILE . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.528 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.528 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.4 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 CA-C-O 120.895 0.29 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.454 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.454 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 19.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.763 0.316 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 153' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.3 p80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.43 ' CD1' ' HD1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 175' ' ' ILE . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.672 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.627 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 61.2 m-70 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.672 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.656 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 98' ' ' ILE . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.534 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.793 0.247 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m . . . . . 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.506 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 18.3 mm-40 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.656 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.524 ' O ' ' SG ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.483 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.499 ' HG ' ' N ' ' A' ' 50' ' ' ILE . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.499 ' N ' ' HG ' ' A' ' 49' ' ' SER . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 98' ' ' ILE . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.772 0.238 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.419 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 20.3 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.799 0.333 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.9 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CG ' HH21 ' A' ' 131' ' ' ARG . 22.5 p80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 175' ' ' ILE . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.52 ' HG ' ' N ' ' A' ' 21' ' ' VAL . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.6 m120 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.734 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 98' ' ' ILE . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo . . . . . 0 N--CA 1.5 1.884 0 CA-C-O 120.949 0.312 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 134' ' ' SER . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 133' ' ' SER . 1.7 m . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.642 0.258 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.631 ' HZ2' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.529 ' NE2' ' O ' ' A' ' 163' ' ' THR . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.527 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.521 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 175' ' ' ILE . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.631 HE22 ' HZ2' ' A' ' 156' ' ' LYS . 42.6 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.602 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.6 m120 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.458 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.602 ' N ' ' H ' ' A' ' 3' ' ' GLY . 31.4 p . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 50' ' ' ILE . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' LEU . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.494 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.54 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 105' ' ' GLU . 26.9 mtmt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.499 1.84 0 CA-C-O 120.801 0.251 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 134' ' ' SER . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.75 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 175' ' ' ILE . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.832 0.349 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.417 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.475 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.543 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.81 0.254 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.47 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.3 p30 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.809 0.337 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.553 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 163' ' ' THR . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.535 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.486 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 175' ' ' ILE . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.634 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.634 ' N ' ' H ' ' A' ' 3' ' ' GLY . 59.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.726 0.298 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 94' ' ' LEU . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 98' ' ' ILE . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.494 1.501 0 CA-C-O 120.827 0.261 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.79 0.328 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.56 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.7 OUTLIER -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 175' ' ' ILE . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.429 HD22 ' CD ' ' A' ' 27' ' ' GLU . 1.3 t30 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' CD ' HD22 ' A' ' 23' ' ' ASN . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.805 0.336 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.664 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.492 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 94' ' ' LEU . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.53 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.842 0.268 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 6.3 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.664 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 175' ' ' ILE . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.3 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.948 0.404 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.729 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.729 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.436 ' H ' ' ND1' ' A' ' 99' ' ' HIS . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.531 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.813 0.274 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 128' ' ' ILE . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 133' ' ' SER . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.646 0.26 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.553 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.7 p80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 175' ' ' ILE . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.663 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.4 ' N ' ' H ' ' A' ' 3' ' ' GLY . 52.0 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.528 ' H ' ' HG1' ' A' ' 82' ' ' THR . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.736 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.736 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 120.861 0.275 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 119' ' ' ASN . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD13 ' A' ' 175' ' ' ILE . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.661 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 HD22 ' CD ' ' A' ' 27' ' ' GLU . 2.5 t30 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.438 ' CD ' HD22 ' A' ' 23' ' ' ASN . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.661 ' N ' ' H ' ' A' ' 3' ' ' GLY . 87.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.714 0.292 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' NH1' ' CG2' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 94' ' ' LEU . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.807 0.253 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.515 ' C ' ' H ' ' A' ' 166' ' ' HIS . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 164' ' ' CYS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.498 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 175' ' ' ILE . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 38' ' ' SER . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.602 ' HH ' ' HE1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.727 ' H ' ' H ' ' A' ' 3' ' ' GLY . 80.7 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.744 0.307 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.442 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.721 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.721 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' LEU . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 98' ' ' ILE . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.869 0.279 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 124' ' ' PRO . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' A' ' 123' ' ' LEU . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 126' ' ' ASN . 6.2 p-10 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' H ' HD21 ' A' ' 125' ' ' ASN . 24.8 m-20 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.525 ' CG ' HD22 ' A' ' 125' ' ' ASN . 30.2 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' OH ' ' OG ' ' A' ' 134' ' ' SER . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' OH ' ' A' ' 132' ' ' TYR . 83.8 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.488 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.488 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 175' ' ' ILE . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.641 ' H ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.641 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.2 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.515 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 8.1 m170 -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.712 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.712 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 98' ' ' ILE . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.524 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.515 ' OE2' ' CE1' ' A' ' 81' ' ' HIS . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.403 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.71 0.213 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.68 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.755 0.312 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.6 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.68 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 175' ' ' ILE . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 3' ' ' GLY . 96.6 mttt -146.55 116.54 7.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.476 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.27 103.24 0.01 OUTLIER Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HG ' ' N ' ' A' ' 21' ' ' VAL . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -99.67 -1.33 38.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -75.38 150.74 85.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.55 -164.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -68.49 -43.52 76.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.91 -45.47 94.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.425 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 65.41 46.29 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.44 143.34 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.811 0.339 . . . . 0.0 110.555 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 -114.43 112.01 22.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.86 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p -82.76 -29.54 29.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.44 63.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.64 -173.78 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 t -143.99 1.52 1.13 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.469 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 75.7 t80 -79.48 163.24 24.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 54.31 18.96 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.491 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.78 -24.3 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m -63.57 -26.55 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 80' ' ' ARG . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 77' ' ' LEU . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.72 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.72 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 98' ' ' ILE . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.538 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.571 HD22 ' CD ' ' A' ' 113' ' ' PRO . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.12 -35.24 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 96.0 mt -74.38 -34.87 63.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.428 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 69.6 m-85 -158.07 176.5 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.7 m80 55.56 -163.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -150.89 153.69 33.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.193 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.571 ' CD ' HD22 ' A' ' 107' ' ' ASN . 85.3 Cg_exo -36.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.541 2.161 . . . . 0.0 112.39 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' GLU . 82.1 p -173.57 25.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.48 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 26.6 mt -75.99 147.79 80.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 93.2 Cg_exo -38.68 164.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.523 2.148 . . . . 0.0 112.376 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.673 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p 172.94 132.42 0.1 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.53 -36.97 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.179 1.919 . . . . 0.0 112.24 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 138' ' ' LEU . 92.3 mtt-85 -49.31 -19.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.772 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 37.03 24.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.7 tp -88.89 31.78 0.84 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p -49.8 -38.87 36.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.646 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.641 ' H ' ' HG ' ' A' ' 172' ' ' CYS . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.673 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.641 ' HG ' ' H ' ' A' ' 165' ' ' MET . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 175' ' ' ILE . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -82.16 137.8 34.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -112.03 11.71 20.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.515 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.0 t0 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.615 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.417 ' C2C' ' CG2' ' A' ' 102' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 20.1 tptp -162.7 61.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.65 99.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.4 m120 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 77.4 m80 -87.8 2.21 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -138.62 154.56 73.33 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' ALA . 83.7 Cg_exo -44.35 179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.421 2.081 . . . . 0.0 112.513 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -45.3 -53.46 8.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.25 75.89 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -90.11 148.45 23.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.75 141.98 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 110.867 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 -95.17 115.96 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.685 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.467 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.512 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.6 p -77.94 -34.89 50.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.8 76.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.526 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 42' ' ' TYR . 18.7 mmmt -73.24 -55.31 6.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t 48.1 12.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 40' ' ' LYS . 64.9 t80 -68.23 -33.09 73.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.47 16.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 42' ' ' TYR . 13.6 tm-20 -50.82 -31.18 16.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p -59.6 -36.39 76.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' ARG . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.435 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 87' ' ' LYS . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 85' ' ' VAL . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' LEU . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.477 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 98' ' ' ILE . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 110' ' ' TYR . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.91 61.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.35 -33.41 72.38 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.518 ' CZ ' ' OE2' ' A' ' 112' ' ' GLU . 30.7 p90 -157.34 149.48 22.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.325 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -77.58 145.65 36.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.933 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' OE2' ' CZ ' ' A' ' 110' ' ' TYR . 4.3 pt-20 -170.88 151.22 3.26 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.261 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -38.11 -72.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.403 2.069 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.0 p -168.5 157.59 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.503 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.5 mt -94.5 148.51 35.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.531 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -40.22 162.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.249 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 128' ' ' ILE . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p -174.32 133.85 0.55 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HG2' ' H ' ' A' ' 136' ' ' ARG . 89.4 Cg_endo -79.65 -56.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.372 2.048 . . . . 0.0 113.359 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 44' ' ' GLU . 67.0 ttp85 -82.29 -46.58 13.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -61.01 152.58 27.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.01 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.2 mt -103.71 130.49 51.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p -68.96 -32.01 71.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.541 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.545 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 163' ' ' THR . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.496 ' HG ' ' H ' ' A' ' 165' ' ' MET . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 175' ' ' ILE . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -84.8 145.48 27.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 53.2 t-20 -41.24 -37.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.833 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.586 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.418 ' C2C' ' CG2' ' A' ' 102' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.51 ' N ' ' OG ' ' A' ' 38' ' ' SER . 69.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 60.2 mttp 54.64 70.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.06 100.05 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -88.31 2.78 51.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -136.88 152.76 74.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' ALA . 86.7 Cg_exo -43.94 178.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.461 2.107 . . . . 0.0 112.55 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -48.77 -53.15 20.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.144 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 51.3 p30 -145.83 74.81 1.4 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.02 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -91.4 149.78 21.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.054 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.61 133.65 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.898 0.38 . . . . 0.0 110.832 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -88.1 118.88 27.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 1' ' ' MET . 85.0 p -84.15 -33.8 24.18 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.02 81.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.236 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -80.16 -171.8 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.98 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -159.96 0.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.823 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -66.67 -33.07 74.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.831 0.348 . . . . 0.0 110.809 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.57 -16.39 63.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' OE2' ' O1D' ' A' ' 182' ' ' HEM . 96.3 mt-10 -46.69 -35.87 6.52 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.465 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -36.1 71.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.542 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.729 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.729 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 98' ' ' ILE . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.531 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' TYR . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -70.42 -25.12 63.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -34.67 20.67 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.093 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.617 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 63.2 t80 -154.77 176.44 12.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.617 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 32.3 m80 -57.75 -154.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.546 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 61.05 63.81 2.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.582 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.51 69.5 5.91 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.623 2.216 . . . . 0.0 112.063 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -168.95 121.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.9 mt -133.12 152.27 79.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 96.2 Cg_exo -37.01 159.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.226 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' OH ' ' O2A' ' A' ' 182' ' ' HEM . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER 167.43 154.09 0.11 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.63 -27.52 32.29 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.32 2.013 . . . . 0.0 111.828 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -72.39 -14.8 61.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 139' ' ' CYS . 48.7 mtp85 55.14 -111.65 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.683 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 55.07 11.14 0.47 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.123 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' A' ' 137' ' ' ARG . 8.0 t -46.23 -32.12 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.543 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 175' ' ' ILE . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -78.04 137.49 38.29 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -110.98 11.65 22.16 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.498 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.586 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.47 ' O2A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' OG ' ' A' ' 38' ' ' SER . 64.9 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 3' ' ' GLY . 34.3 ttpt -84.08 108.69 17.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.26 101.52 0.01 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.565 ' ND2' HH21 ' A' ' 80' ' ' ARG . 49.5 t-20 -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 -89.6 3.02 53.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -143.33 148.78 45.6 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.818 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.29 -159.93 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.572 2.181 . . . . 0.0 111.887 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -57.3 -46.34 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 35' ' ' VAL . 91.9 m-20 -77.81 51.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.418 HH11 ' CD2' ' A' ' 26' ' ' LEU . 36.4 ptt85 -72.33 15.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.04 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 33' ' ' ASP . 2.6 m -84.18 125.32 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.773 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -89.02 121.92 31.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 110' ' ' TYR . 23.2 p -63.88 -31.77 73.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.62 -38.54 80.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.29 -174.37 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.075 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 44' ' ' GLU . 7.3 t -160.98 7.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -66.95 -38.92 87.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.09 19.27 2.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.726 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 41' ' ' SER . 20.2 pt-20 -68.64 -36.96 79.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.687 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -30.93 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 80' ' ' ARG . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.538 ' HG ' HH11 ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.565 HH21 ' ND2' ' A' ' 7' ' ' ASN . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' C ' ' H ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.733 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.733 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 100' ' ' ASP . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' H ' ' CG ' ' A' ' 99' ' ' HIS . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.53 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' TYR . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -72.09 -32.62 67.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -83.39 -13.89 53.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 38' ' ' SER . 12.4 t80 -144.58 123.97 13.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' TYR . 56.4 m80 -57.88 -154.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 57.82 78.43 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.29 -166.9 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.387 2.058 . . . . 0.0 111.945 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 m 62.67 56.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.4 mt -69.49 152.79 96.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.316 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 65.6 Cg_exo -35.18 157.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.581 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 135' ' ' PRO . 1.4 t 171.48 150.72 0.19 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.543 ' N ' ' HG ' ' A' ' 134' ' ' SER . 58.1 Cg_endo -70.93 -50.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.515 2.143 . . . . 0.0 112.041 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -53.03 -22.06 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.429 ' O ' ' OH ' ' A' ' 132' ' ' TYR . 39.1 ttm180 60.26 -103.57 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.7 mt 52.13 15.76 0.47 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.581 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m -46.28 -35.74 5.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.583 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.557 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.523 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.485 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 175' ' ' ILE . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -79.65 136.57 36.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -110.11 11.83 23.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.571 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.435 ' CBC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' N ' ' OG ' ' A' ' 38' ' ' SER . 7.1 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 49.6 mtpt -141.85 63.77 1.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.675 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.12 99.1 0.01 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.622 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 3.2 m120 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -83.89 2.08 40.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.12 147.27 65.13 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.539 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.0 -170.06 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.461 2.107 . . . . 0.0 112.09 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.73 -35.37 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' ARG . 81.2 m-20 -50.95 -55.67 16.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.519 ' HE ' ' CD ' ' A' ' 27' ' ' GLU . 69.0 ttt-85 40.74 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.91 139.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.287 0.565 . . . . 0.0 110.942 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -117.24 91.8 3.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.375 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.675 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.7 p -79.03 -34.8 43.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 42' ' ' TYR . 4.0 mmmm -64.89 -54.56 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 m 57.46 5.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 40' ' ' LYS . 66.1 t80 -70.17 -33.8 72.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.385 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.97 -4.37 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.756 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -46.37 -31.06 2.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.415 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p -58.34 -33.48 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 98' ' ' ILE . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.527 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 110' ' ' TYR . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.92 -31.84 66.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.58 -34.58 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' ASN . 16.2 m-85 -101.17 147.91 25.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.28 88.17 7.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 114' ' ' SER . 7.9 pt-20 -179.19 70.3 0.19 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.21 68.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.949 2.433 . . . . 0.0 112.253 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 112' ' ' GLU . 2.0 t 171.97 122.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -133.42 150.86 76.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 115' ' ' LEU . 57.9 Cg_exo -37.5 169.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 123.081 2.521 . . . . 0.0 112.945 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.463 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.529 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.529 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m -168.53 135.39 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 -54.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.308 2.005 . . . . 0.0 112.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -82.33 -46.64 13.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.879 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.57 ' NH2' ' CGD' ' A' ' 182' ' ' HEM . 72.5 mtt-85 -73.14 149.41 43.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.053 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -102.34 133.99 46.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t -62.83 -24.18 67.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.559 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.508 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.52 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.424 ' HG ' ' H ' ' A' ' 165' ' ' MET . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 175' ' ' ILE . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.31 137.94 35.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -113.65 14.92 18.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.623 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.57 ' CGD' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLY . 35.7 mmtm -79.92 120.26 23.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.381 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.15 97.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -91.16 -3.43 57.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -88.55 150.84 47.19 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.659 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 30' ' ' ALA . 73.5 Cg_exo -47.72 -172.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.335 2.023 . . . . 0.0 112.071 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 13.5 ttmm -54.19 -53.28 55.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.656 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 63.4 m-20 -160.89 77.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -127.64 162.62 26.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 36' ' ' TYR . 69.1 t -122.34 158.08 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.726 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.3 p90 -81.14 136.21 35.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.337 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 3' ' ' GLY . 86.7 p -67.56 -30.73 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.81 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.5 mmmt -77.11 -67.84 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.404 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.428 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 61.5 m 50.24 10.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 40' ' ' LYS . 69.4 t80 -61.28 -34.76 75.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.568 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 43.25 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.1 pm0 -53.56 -25.5 17.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t -54.19 -33.69 58.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 77' ' ' LEU . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD1' ' A' ' 100' ' ' ASP . 5.5 p80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD1' ' CE1' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.533 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 111' ' ' HIS . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.56 -23.03 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -35.04 21.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.085 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 48.0 t80 -160.78 23.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.733 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 107' ' ' ASN . 74.7 m80 52.86 77.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.667 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 79.3 mt-10 -78.54 150.01 75.77 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.419 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 114' ' ' SER . 59.0 Cg_endo -71.71 81.21 1.35 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.416 2.077 . . . . 0.0 112.112 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 113' ' ' PRO . 37.6 p 56.09 159.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.737 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.3 mt -134.57 152.48 77.87 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 115' ' ' LEU . 81.5 Cg_exo -36.89 160.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.582 2.188 . . . . 0.0 112.425 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.472 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.518 ' CD1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.84 154.21 1.77 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 137' ' ' ARG . 60.4 Cg_endo -71.99 -54.95 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.661 2.241 . . . . 0.0 112.124 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.616 HH21 ' CGA' ' A' ' 182' ' ' HEM . 34.0 ttp180 -48.93 -11.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.631 ' NH1' ' HD1' ' A' ' 166' ' ' HIS . 58.8 ttp180 40.23 93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tp -150.18 38.76 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.151 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 18.6 m -58.54 -31.51 68.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.949 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.563 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 4.3 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.54 ' NE2' ' O ' ' A' ' 163' ' ' THR . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.631 ' HD1' ' NH1' ' A' ' 137' ' ' ARG . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.472 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 175' ' ' ILE . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -85.59 144.33 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -115.02 16.77 17.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.557 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.623 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.616 ' CGA' HH21 ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' N ' ' OG ' ' A' ' 38' ' ' SER . 64.6 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLY . 9.1 mtmp? 56.61 65.06 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.534 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.604 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.33 98.49 0.01 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 30' ' ' ALA . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -86.9 3.13 46.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -142.98 156.08 62.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' ALA . 85.0 Cg_exo -42.68 175.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.517 2.145 . . . . 0.0 112.423 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -46.2 -54.36 8.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -147.74 77.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -86.44 149.81 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.981 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.36 136.82 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -97.04 135.32 39.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.604 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.3 p -70.67 -31.3 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.46 -37.55 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.21 -174.34 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.42 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 42' ' ' TYR . 21.6 t -151.51 -137.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.365 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.619 ' H ' ' HG ' ' A' ' 41' ' ' SER . 42.1 t80 61.39 -70.58 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.88 -17.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 42' ' ' TYR . 82.5 tt0 -49.94 -26.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p -59.86 -26.24 65.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.418 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.543 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -67.83 -29.46 68.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 10.7 mp -71.61 -45.57 61.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.263 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 81.7 m-85 -158.26 -161.49 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 65.22 101.54 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.685 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 mt-10 -78.25 -35.85 1.23 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.389 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 91.7 Cg_endo -88.36 174.31 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.504 2.136 . . . . 0.0 112.12 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 p -65.04 150.94 47.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.573 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 13.1 mt -91.08 152.54 44.27 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' CG ' ' O1A' ' A' ' 182' ' ' HEM . 85.1 Cg_exo -36.15 158.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 122.602 2.202 . . . . 0.0 112.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.431 ' CD1' ' C ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' PRO . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.639 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 137' ' ' ARG . 7.8 p -171.87 135.54 0.89 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.0 -58.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.297 1.998 . . . . 0.0 113.153 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.759 HH22 HH21 ' A' ' 137' ' ' ARG . 35.6 ptt-85 -86.85 -37.69 17.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.759 HH21 HH22 ' A' ' 136' ' ' ARG . 32.3 mtt180 -71.68 148.54 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.759 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.272 0.558 . . . . 0.0 111.008 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t -68.95 -30.79 69.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.361 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 163' ' ' THR . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.545 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.9 OUTLIER -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.545 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.639 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD11 ' A' ' 175' ' ' ILE . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 -90.83 150.65 21.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -43.0 -48.28 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.748 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.599 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.467 ' O1D' ' NH1' ' A' ' 137' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.2 pttt -155.27 142.56 19.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.69 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 41.46 101.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 32' ' ' LYS . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -91.19 2.58 56.25 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -138.5 154.23 73.26 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.63 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 30' ' ' ALA . 75.7 Cg_exo -45.49 -176.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.453 2.102 . . . . 0.0 112.564 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 15.5 ttmm -45.52 -51.37 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -155.55 74.5 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.029 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -90.79 147.16 23.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.149 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.71 144.61 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.872 0.368 . . . . 0.0 110.806 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -94.13 114.81 27.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.69 ' N ' ' H ' ' A' ' 3' ' ' GLY . 51.4 p -66.71 -32.57 73.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.48 80.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.906 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -78.96 -174.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.371 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -158.99 79.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' GLU . 98.6 m-85 -150.38 158.28 43.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 48.92 12.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' TYR . 87.1 tt0 -54.78 -31.62 59.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.435 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m -53.65 -23.68 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HE2' ' A' ' 81' ' ' HIS . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 97' ' ' GLY . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 94' ' ' LEU . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 98' ' ' ILE . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.528 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.528 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.4 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt -74.45 -35.24 63.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.57 -44.06 76.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.956 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 111' ' ' HIS . 9.6 p90 -166.38 175.64 8.04 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.623 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 3.5 p80 39.21 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 2.7 mt-10 -170.61 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HD2' ' H ' ' A' ' 112' ' ' GLU . 86.6 Cg_endo -82.65 -161.37 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.327 2.018 . . . . 0.0 112.024 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 113' ' ' PRO . 6.9 p 64.84 18.14 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.99 104.68 41.38 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.12 169.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.453 2.102 . . . . 0.0 112.816 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.454 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.19 156.62 2.45 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -38.88 7.15 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.616 2.211 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' CZ ' ' O2A' ' A' ' 182' ' ' HEM . 54.7 mtm180 -64.09 -23.32 67.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' A' ' 139' ' ' CYS . 67.7 mtm180 50.78 22.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.6 34.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.503 ' H ' ' C ' ' A' ' 137' ' ' ARG . 19.3 m -49.91 -37.12 30.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.559 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' A' ' 153' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.3 p80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.43 ' CD1' ' HD1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 175' ' ' ILE . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.15 138.02 37.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -108.18 14.78 24.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.464 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.589 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.492 ' CBC' ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' GLY . 31.3 mmtm -79.77 140.42 36.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.672 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 34.68 99.58 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.627 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 61.2 m-70 -86.86 1.99 50.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -138.32 154.58 73.87 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.462 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 87.1 Cg_exo -43.95 178.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.42 2.08 . . . . 0.0 112.404 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -42.83 -53.34 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 53.3 p30 -153.19 73.73 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -88.64 147.18 24.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.1 137.39 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.925 0.393 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -90.66 114.92 27.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.672 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.8 p -75.29 -29.96 60.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.92 -38.03 69.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -78.87 -174.92 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.307 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 39.8 m -165.74 89.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 41' ' ' SER . 91.4 m-85 -157.8 -46.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 -5.99 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.522 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.4 -32.99 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t -58.94 -33.51 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.656 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' A' ' 94' ' ' LEU . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 98' ' ' ILE . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.534 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 111' ' ' HIS . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -66.01 -25.95 67.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 11.2 mp -77.34 -18.47 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 32.4 m-85 -142.96 77.32 1.56 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.784 0.326 . . . . 0.0 110.947 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.8 m80 36.85 -121.16 0.17 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.192 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -166.48 66.88 0.98 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.21 33.79 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 112.157 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.0 t 57.69 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -78.82 154.06 78.08 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 160.12 4.26 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.144 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m 161.95 132.63 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.26 -30.61 2.31 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.017 1.812 . . . . 0.0 112.139 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 138' ' ' LEU . 98.4 mtt180 -55.37 -25.22 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.804 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 37.38 25.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -84.99 20.8 1.76 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.943 0.401 . . . . 0.0 109.925 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.506 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m -43.93 -33.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.004 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 18.3 mm-40 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.656 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.524 ' O ' ' SG ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 181' ' ' ASP . 44.5 mt-30 -83.31 145.79 28.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 47.5 p-10 -39.99 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 56.4 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.54 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.416 ' O2A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.6 mtmm -78.74 133.5 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.64 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 51.81 114.4 0.01 OUTLIER Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.537 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -89.85 1.77 55.78 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.95 147.52 45.06 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.29 -158.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.612 2.208 . . . . 0.0 111.683 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 34' ' ' ARG . 4.8 ttpm? -55.76 -29.47 59.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.592 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.02 39.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 32' ' ' LYS . 64.4 mtm180 -47.57 -22.0 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.92 137.14 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -105.43 137.62 42.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p -61.94 -25.73 67.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.82 33.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -79.19 -177.35 5.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -168.21 40.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.349 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -57.92 -40.35 80.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.815 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.9 69.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.731 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -62.81 -24.51 67.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.429 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p -55.64 -21.88 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.734 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.499 ' HG ' ' N ' ' A' ' 50' ' ' ILE . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.499 ' N ' ' HG ' ' A' ' 49' ' ' SER . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.429 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.724 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 98' ' ' ILE . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.65 -33.14 74.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.69 -35.79 81.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.081 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -103.33 -163.77 1.02 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.75 74.8 1.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -177.92 66.84 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.49 101.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.661 2.241 . . . . 0.0 112.121 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 114' ' ' SER . 14.6 t -177.35 38.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.593 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.7 147.32 89.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.274 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.72 155.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.403 2.069 . . . . 0.0 112.327 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.419 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p -172.81 148.38 1.72 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.6 -32.3 15.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.299 1.999 . . . . 0.0 111.856 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.48 -10.67 59.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.591 ' NH1' ' SG ' ' A' ' 164' ' ' CYS . 32.0 ttt85 59.91 -96.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' O ' ' O1A' ' A' ' 182' ' ' HEM . 1.5 mm? 46.56 16.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 110.066 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.511 ' SG ' ' CZ ' ' A' ' 137' ' ' ARG . 20.3 p -50.66 -39.61 51.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.714 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.9 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.591 ' SG ' ' NH1' ' A' ' 137' ' ' ARG . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CG ' HH21 ' A' ' 131' ' ' ARG . 22.5 p80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 175' ' ' ILE . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -85.0 146.36 27.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 40.9 p-10 -41.08 -31.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.744 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 90.8 m-20 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.428 ' CGA' ' CMA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.2 mtmm -79.2 107.32 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 47.38 114.16 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.52 ' HG ' ' N ' ' A' ' 21' ' ' VAL . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.6 m120 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 30' ' ' ALA . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -104.97 -3.42 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -44.37 158.22 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.642 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.96 -177.91 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.802 2.335 . . . . 0.0 111.876 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -65.54 -33.43 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.354 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -65.55 -23.47 66.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.587 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 71.74 0.86 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.988 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.43 162.77 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 0.0 110.756 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -113.27 114.23 26.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.185 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -72.94 -28.42 62.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.43 -36.73 60.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -80.6 -174.68 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.377 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 43' ' ' ALA . 19.9 t -151.09 -144.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.0 t80 60.45 -72.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -55.61 -19.09 9.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.488 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -47.71 -24.53 0.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p -56.95 -28.37 62.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.615 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.734 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.734 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 98' ' ' ILE . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 115' ' ' LEU . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 110' ' ' TYR . 9.4 t-20 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -69.39 -25.66 64.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 10.3 mp -75.41 -15.98 60.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.488 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 13.0 m-85 -137.85 -176.37 4.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.457 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 75.6 m80 -160.83 -29.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -79.27 -36.21 1.09 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.612 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 90.2 Cg_endo -88.96 131.07 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -86.03 156.43 20.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.29 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.2 mt -102.83 119.83 54.44 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.75 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' LEU . 91.2 Cg_exo -43.42 178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.591 2.194 . . . . 0.0 112.8 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 134' ' ' SER . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 133' ' ' SER . 1.7 m 169.11 154.32 0.16 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.52 -30.19 12.54 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.488 2.126 . . . . 0.0 111.986 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' LEU . 7.9 tpp85 -53.46 -17.78 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.377 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 40.97 21.26 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -86.58 22.91 1.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 0.0 110.185 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p -48.32 -27.64 2.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.631 ' HZ2' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.529 ' NE2' ' O ' ' A' ' 163' ' ' THR . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.527 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.521 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 175' ' ' ILE . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.631 HE22 ' HZ2' ' A' ' 156' ' ' LYS . 42.6 mt-30 -79.5 138.44 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -113.17 18.5 17.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.534 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.448 ' CBC' ' CD2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' N ' ' OG ' ' A' ' 38' ' ' SER . 11.4 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLY . 80.2 tttt 60.3 60.11 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.602 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 37.27 100.96 0.01 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 23' ' ' ASN . 2.6 m120 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -97.94 -5.21 34.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -87.89 146.64 39.19 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.6 -164.8 0.26 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.454 2.103 . . . . 0.0 111.971 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -62.86 -30.61 71.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' VAL . 54.3 t0 -45.9 -38.2 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 61.95 -69.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.03 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' ASP . 1.8 m -70.9 152.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.04 0.448 . . . . 0.0 110.912 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.16 113.98 26.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.538 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.602 ' N ' ' H ' ' A' ' 3' ' ' GLY . 31.4 p -78.57 -34.44 46.93 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.34 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -65.48 -39.41 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.35 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' OG ' ' OE2' ' A' ' 44' ' ' GLU . 14.8 t 53.11 34.17 16.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.607 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 68.6 t80 -99.32 173.01 6.98 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 55.18 5.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 42' ' ' TYR . 83.0 mt-10 -47.7 -25.68 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.793 0.33 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p -60.11 -30.42 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.706 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 50' ' ' ILE . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' LEU . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.494 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.54 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 110' ' ' TYR . 26.9 mtmt -73.12 -33.41 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.35 -13.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.562 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 60.0 t80 -147.14 174.05 11.94 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.325 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.562 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 23.2 m-70 -44.09 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.755 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -155.44 77.9 4.71 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.29 138.83 8.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.707 2.271 . . . . 0.0 111.998 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -65.62 149.84 49.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.88 152.76 80.86 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.131 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.38 160.18 49.44 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.527 2.151 . . . . 0.0 112.094 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 134' ' ' SER . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m -178.37 151.78 0.77 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.49 -33.92 6.33 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.522 2.148 . . . . 0.0 112.028 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -63.99 -14.92 57.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mtm105 51.86 30.73 7.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.929 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.0 mt -82.62 14.19 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.385 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t -44.43 -35.01 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 175' ' ' ILE . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -83.79 142.58 30.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -111.36 14.86 21.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 50.5 p30 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.556 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 3' ' ' GLY . 52.2 mttm -80.22 111.47 16.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 39.23 106.22 0.01 OUTLIER Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 -89.36 1.79 55.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.73 144.76 36.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.01 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.87 -157.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.627 2.218 . . . . 0.0 111.658 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -57.29 -42.86 82.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 110.294 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.44 79.92 9.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -81.92 12.04 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.75 139.52 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.95 116.11 28.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.472 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.465 ' HG ' ' N ' ' A' ' 39' ' ' ALA . 36.0 p -80.26 -28.59 38.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.465 ' N ' ' HG ' ' A' ' 38' ' ' SER . . . -74.73 -34.04 62.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.15 -174.17 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.653 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.6 t -156.96 -142.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.408 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 61.23 -71.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -53.68 -15.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.359 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -47.4 -25.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m -54.72 -31.26 57.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.417 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' C ' ' HD1' ' A' ' 81' ' ' HIS . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HD1' ' C ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.725 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.543 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 110' ' ' TYR . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -70.2 -31.46 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.48 -39.4 81.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.472 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' ASN . 77.9 m-85 -135.07 140.2 45.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.613 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -56.32 137.43 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -164.14 129.69 2.11 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.9 -59.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.995 1.797 . . . . 0.0 112.189 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.2 t -146.22 122.76 11.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.97 152.85 63.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 91.8 Cg_exo -35.8 157.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.66 2.24 . . . . 0.0 112.448 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.47 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.699 HD21 HD22 ' A' ' 180' ' ' ASN . 12.3 p30 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p 173.1 152.59 0.24 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.33 -28.58 18.1 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.535 2.157 . . . . 0.0 112.191 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -61.42 -16.3 45.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.474 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 45.08 27.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tp -83.93 16.56 2.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.548 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.74 -41.82 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.672 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.553 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.534 ' NE2' ' O ' ' A' ' 163' ' ' THR . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.535 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.535 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.486 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 175' ' ' ILE . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -80.09 136.44 36.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.699 HD22 HD21 ' A' ' 126' ' ' ASN . 82.4 m-20 -104.86 8.75 34.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.453 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 56.0 t0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.593 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.436 ' O2A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.631 ' H3 ' ' HG ' ' A' ' 38' ' ' SER . 71.9 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' GLY . 92.2 mttt 55.09 70.85 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.596 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.634 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 39.4 98.62 0.01 OUTLIER Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.476 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -87.74 -4.78 58.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.87 147.97 35.01 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.621 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.47 -169.84 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.517 2.144 . . . . 0.0 111.958 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -62.26 -40.36 95.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.618 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' ARG . 90.6 m-20 -61.32 -46.25 91.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.574 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 33' ' ' ASP . 56.4 ttp180 43.29 94.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.84 140.6 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.118 0.485 . . . . 0.0 110.946 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -116.04 91.61 3.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.553 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.634 ' N ' ' H ' ' A' ' 3' ' ' GLY . 59.5 p -70.75 -28.57 64.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -72.61 -41.21 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 42' ' ' TYR . 18.1 mmmt -77.96 -69.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.42 ' O ' ' OE2' ' A' ' 44' ' ' GLU . 19.7 m 45.65 15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 40' ' ' LYS . 67.9 t80 -67.43 -19.44 65.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.53 48.52 1.39 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.758 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 47.0 mp0 -56.73 -28.83 61.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 110.276 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t -57.22 -34.62 68.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.474 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 94' ' ' LEU . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 98' ' ' ILE . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -68.04 -30.01 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.74 -32.9 71.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 39' ' ' ALA . 83.8 t80 -128.12 123.57 34.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -62.97 -172.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 62.18 69.56 0.93 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.3 120.93 9.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 114' ' ' SER . 10.8 t -179.68 52.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 116' ' ' PRO . 25.4 mt -82.47 148.38 58.65 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 115' ' ' LEU . 84.7 Cg_exo -40.64 169.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.403 2.069 . . . . 0.0 112.235 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m -168.63 133.5 1.4 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.65 -52.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.231 1.954 . . . . 0.0 112.806 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -86.12 -38.36 17.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.17 160.27 28.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.13 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.1 138.86 49.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t -65.72 -25.02 67.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.616 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CA ' ' O1A' ' A' ' 182' ' ' HEM . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.56 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.7 OUTLIER -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 175' ' ' ILE . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -85.25 147.37 26.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -43.7 -39.44 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.805 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.411 ' OD1' ' OXT' ' A' ' 181' ' ' ASP . 51.8 p30 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.666 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.512 ' CGA' ' CMA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' GLY . 54.3 mtpt -68.74 -67.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.43 100.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.429 HD22 ' CD ' ' A' ' 27' ' ' GLU . 1.3 t30 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' CD ' HD22 ' A' ' 23' ' ' ASN . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -88.54 2.23 53.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . -148.55 149.37 31.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.775 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.61 -162.39 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.599 2.199 . . . . 0.0 112.022 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.32 -38.94 81.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 35' ' ' VAL . 94.6 m-20 -79.44 55.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' C ' ' NE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -74.44 17.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.007 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 33' ' ' ASP . 2.4 m -80.26 125.93 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -97.98 129.51 44.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -65.57 -32.81 74.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 111' ' ' HIS . . . -69.02 -50.26 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.8 mmmt -66.4 -53.77 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.32 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m 61.77 1.19 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.623 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 40' ' ' LYS . 72.6 t80 -63.23 -37.48 87.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.545 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.71 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.772 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -46.37 -30.91 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.523 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p -57.78 -35.1 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.499 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.664 ' ND2' ' HE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.492 ' H ' ' HG1' ' A' ' 82' ' ' THR . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 94' ' ' LEU . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.53 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.642 HD22 ' CB ' ' A' ' 113' ' ' PRO . 6.7 t-20 -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -66.69 -31.98 72.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.7 -30.92 64.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.77 171.07 9.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.376 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.677 ' ND1' ' H ' ' A' ' 112' ' ' GLU . 6.0 p80 -68.63 -108.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.566 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.677 ' H ' ' ND1' ' A' ' 111' ' ' HIS . 82.0 mt-10 -69.44 150.35 97.03 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.642 ' CB ' HD22 ' A' ' 107' ' ' ASN . 73.7 Cg_endo -73.88 -97.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.414 2.076 . . . . 0.0 111.857 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.8 p 39.14 47.16 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.186 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.14 153.19 84.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.29 158.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.416 2.077 . . . . 0.0 112.053 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.579 ' ND2' HD22 ' A' ' 180' ' ' ASN . 0.7 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.436 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 6.3 p -177.66 150.33 0.79 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 137' ' ' ARG . 59.2 Cg_endo -71.64 -50.28 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.404 2.069 . . . . 0.0 112.108 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 137' ' ' ARG . 20.6 ptp180 -49.22 -11.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.59 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 135' ' ' PRO . 55.1 ttp180 41.11 95.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tp -154.55 29.12 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.466 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t -50.85 -33.24 22.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.732 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' N ' ' O1A' ' A' ' 182' ' ' HEM . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.664 ' HE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.521 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 175' ' ' ILE . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.34 135.69 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.579 HD22 ' ND2' ' A' ' 126' ' ' ASN . 86.2 m-20 -104.52 7.71 35.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 180' ' ' ASN . 64.2 t0 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.531 ' O1A' ' N ' ' A' ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' H3 ' ' C ' ' A' ' 36' ' ' TYR . 12.6 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLY . 93.0 mttt -78.8 -65.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 37.11 104.04 0.01 OUTLIER Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.83 -2.95 24.08 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -47.86 157.1 0.64 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.56 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.53 179.06 6.68 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.743 2.295 . . . . 0.0 111.965 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -64.87 -33.31 75.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.162 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' VAL . 52.1 t0 -72.23 -11.86 60.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 62.4 -69.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 33' ' ' ASP . 2.0 m -64.62 151.28 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.078 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.512 ' C ' ' H3 ' ' A' ' 1' ' ' MET . 1.3 p90 -107.11 113.79 27.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.885 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.6 p -74.85 -27.53 60.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.15 -36.99 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -80.24 -174.07 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.556 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 52.5 p -156.03 -136.27 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' N ' ' OG ' ' A' ' 41' ' ' SER . 35.3 m-85 59.96 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.601 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -57.55 -13.12 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.484 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -47.25 -21.33 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m -58.24 -26.69 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.515 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.591 ' CD2' ' CBC' ' A' ' 182' ' ' HEM . 63.8 m-70 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.729 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.729 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.436 ' H ' ' ND1' ' A' ' 99' ' ' HIS . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.531 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.69 -25.34 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.15 -45.93 31.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 107' ' ' ASN . 26.0 m-85 -102.21 154.02 19.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.35 -30.81 71.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.492 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER -46.11 108.45 0.82 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.9 -61.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.115 1.877 . . . . 0.0 112.208 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m -79.34 145.45 33.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.483 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.8 mt -132.72 153.37 81.06 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 88.0 Cg_exo -36.25 162.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.896 2.398 . . . . 0.0 112.813 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 128' ' ' ILE . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.559 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t 178.89 150.37 0.45 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.46 -40.13 1.7 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.549 2.166 . . . . 0.0 112.149 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 137' ' ' ARG . 83.7 mtp180 -54.39 -13.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.62 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' ARG . 93.1 mtt180 35.17 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -153.75 24.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 110.571 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m -41.52 -35.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.553 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.7 p80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 175' ' ' ILE . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -76.29 145.62 39.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -37.46 -35.2 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.588 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.591 ' CBC' ' CD2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' N ' ' OG ' ' A' ' 38' ' ' SER . 72.3 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 3' ' ' GLY . 25.9 mtmm 56.3 49.72 14.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 37.24 103.05 0.01 OUTLIER Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' ALA . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -89.18 3.71 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 27' ' ' GLU . . . -142.19 147.87 45.73 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.503 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 169.65 17.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.483 2.122 . . . . 0.0 111.923 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -56.91 -42.59 80.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.6 39.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -81.13 138.77 35.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.39 144.82 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.911 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 -110.36 107.46 17.19 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 1' ' ' MET . 52.0 p -81.26 -26.2 35.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.95 -30.51 50.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -86.39 -174.48 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.619 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.2 t -153.46 -129.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' C ' ' N ' ' A' ' 44' ' ' GLU . 96.7 m-85 51.72 -84.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.52 -16.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.524 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 42' ' ' TYR . 83.4 tt0 -47.25 -26.5 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -55.27 -31.11 61.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.546 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.528 ' H ' ' HG1' ' A' ' 82' ' ' THR . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.736 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.736 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.45 -30.72 70.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 110' ' ' TYR . 6.8 mt -64.46 -8.93 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.017 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 2.4 t80 87.91 109.97 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.661 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 111' ' ' HIS . 2.9 t-80 -166.12 39.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.294 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 111' ' ' HIS . 73.5 mt-10 57.15 150.51 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.579 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.43 -163.39 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.492 2.128 . . . . 0.0 112.084 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 m 60.75 59.27 2.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.36 128.78 85.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -36.89 153.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 119' ' ' ASN . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t 166.17 151.61 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 137' ' ' ARG . 60.2 Cg_endo -72.17 -30.52 13.12 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.442 2.095 . . . . 0.0 112.063 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 138' ' ' LEU . 61.4 mtp180 -49.4 -15.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.661 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 135' ' ' PRO . 34.2 ptt180 37.33 24.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.0 tp -84.89 21.7 1.53 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.124 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p -45.38 -39.48 6.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.527 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.436 HG23 HD13 ' A' ' 175' ' ' ILE . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -82.75 138.43 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -112.14 13.95 20.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.627 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.454 ' O1D' ' NH1' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 3' ' ' GLY . 57.0 mmtt -79.66 141.01 36.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.456 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.661 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 35.06 99.94 0.01 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 HD22 ' CD ' ' A' ' 27' ' ' GLU . 2.5 t30 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.438 ' CD ' HD22 ' A' ' 23' ' ' ASN . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -89.69 0.57 56.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -153.76 151.74 25.64 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.521 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' ALA . 74.6 Cg_exo -43.65 173.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.26 1.973 . . . . 0.0 112.122 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -75.64 -37.79 59.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -106.91 38.39 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.937 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -80.15 128.69 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.416 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 2.5 m -125.49 127.34 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -86.3 113.88 22.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.818 179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.661 ' N ' ' H ' ' A' ' 3' ' ' GLY . 87.0 p -68.62 -31.74 71.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.76 -38.73 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -80.54 -175.61 5.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.0 t -156.76 -141.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' C ' ' H ' ' A' ' 44' ' ' GLU . 18.6 m-85 62.02 -70.62 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -49.12 -14.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 42' ' ' TYR . 14.4 tm-20 -46.74 -27.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -53.3 -31.9 46.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.664 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' NH1' ' CG2' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 94' ' ' LEU . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.75 -31.44 72.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.17 -32.83 65.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.146 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -85.35 170.54 12.64 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.243 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -76.82 -29.22 55.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.63 153.12 29.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.432 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.86 -91.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.51 2.14 . . . . 0.0 112.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m 43.92 30.1 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.692 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.86 147.29 88.67 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -39.53 160.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.452 2.101 . . . . 0.0 112.305 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 166.35 153.78 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.89 -23.07 26.07 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.512 2.141 . . . . 0.0 111.897 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 138' ' ' LEU . 87.1 mtt180 -59.47 -20.66 56.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.435 ' HE ' ' CE ' ' A' ' 165' ' ' MET . 94.7 mtt180 43.09 17.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.4 mt -79.64 20.8 0.55 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p -45.01 -41.36 7.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.515 ' C ' ' H ' ' A' ' 166' ' ' HIS . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 164' ' ' CYS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.498 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 175' ' ' ILE . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -76.08 139.83 41.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.94 17.48 19.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.551 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' O1D' ' NH1' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 68.5 mttm -80.52 138.05 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.592 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.727 ' H ' ' H ' ' A' ' 38' ' ' SER . . . 41.19 100.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HE1' ' HH ' ' A' ' 36' ' ' TYR . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.76 -0.27 57.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.74 148.47 68.68 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.796 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.4 -159.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.562 2.175 . . . . 0.0 112.019 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.47 -25.28 62.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 35' ' ' VAL . 57.5 t0 -45.49 -49.32 13.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.407 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 56.03 -75.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.421 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.2 m -62.81 136.08 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 111.473 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.602 ' HH ' ' HE1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -97.98 125.76 43.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.331 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.422 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.727 ' H ' ' H ' ' A' ' 3' ' ' GLY . 80.7 p -59.72 -26.95 66.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.92 -41.68 28.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -78.72 -178.07 5.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.956 0.407 . . . . 0.0 110.706 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.2 t -164.74 54.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.301 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -53.05 -40.72 64.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.704 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.84 90.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.602 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.16 -24.84 65.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m -56.35 -27.7 56.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.624 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.442 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.721 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.721 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' LEU . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 98' ' ' ILE . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.542 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 112' ' ' GLU . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -72.85 -29.79 63.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.96 -12.92 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' ASN . 71.0 m-85 -147.97 -157.22 0.79 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.511 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -90.81 -103.63 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.565 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 31.2 mm-40 54.8 72.95 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.744 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.95 -30.08 23.08 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.767 2.311 . . . . 0.0 112.071 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -153.33 110.84 3.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -82.97 152.02 64.84 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.376 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.9 Cg_exo -38.25 164.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.619 2.213 . . . . 0.0 112.41 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.516 ' O ' ' O ' ' A' ' 124' ' ' PRO . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' A' ' 123' ' ' LEU . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 126' ' ' ASN . 6.2 p-10 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.659 ' ND2' HD22 ' A' ' 180' ' ' ASN . 24.8 m-20 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.525 ' CG ' HD22 ' A' ' 125' ' ' ASN . 30.2 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' OH ' ' OG ' ' A' ' 134' ' ' SER . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' OH ' ' A' ' 132' ' ' TYR . 83.8 p -169.14 132.55 1.2 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.61 -57.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.287 1.991 . . . . 0.0 113.0 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 137' ' ' ARG . 35.3 ptt-85 -80.89 -43.65 19.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.828 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 136' ' ' ARG . 6.8 tpt180 -71.24 154.51 41.6 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.946 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.1 mt -108.83 135.83 49.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.904 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p -64.42 -31.72 73.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.488 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.488 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 175' ' ' ILE . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -78.76 137.44 37.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.659 HD22 ' ND2' ' A' ' 126' ' ' ASN . 80.0 m-20 -110.72 8.03 22.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.481 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.4 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.518 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.511 ' CGA' ' C3A' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' H3 ' ' H ' ' A' ' 38' ' ' SER . 74.3 mmm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -174.53 51.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.641 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 36.32 99.5 0.01 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' N ' ' CG2' ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -92.73 -0.77 57.23 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' PRO . . . -93.69 150.94 39.56 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 55.4 Cg_exo -48.38 -171.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.274 1.983 . . . . 0.0 112.212 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -57.02 -53.64 55.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -161.6 77.93 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.672 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -127.38 169.33 13.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.439 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.14 162.37 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -95.35 115.53 27.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.641 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.2 p -65.79 -33.58 76.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -70.71 -49.11 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -69.56 -169.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.19 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 43' ' ' ALA . 44.1 t -52.17 138.23 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.11 12.14 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 41' ' ' SER . . . 40.15 44.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' ' NH2' ' A' ' 136' ' ' ARG . 79.9 tt0 -58.12 -28.66 64.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m -63.13 -37.5 87.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.515 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 8.1 m170 -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.712 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.712 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 98' ' ' ILE . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.524 ' N ' ' CG2' ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.515 ' OE2' ' CE1' ' A' ' 81' ' ' HIS . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.521 HD22 ' CD ' ' A' ' 112' ' ' GLU . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -66.83 -25.1 66.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -52.31 45.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 54.4 t80 -96.33 -106.6 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.566 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.568 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 73.3 m80 -159.54 57.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.655 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.521 ' CD ' HD22 ' A' ' 107' ' ' ASN . 13.2 tp10 58.91 65.53 2.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.692 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.73 -91.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.676 2.25 . . . . 0.0 112.078 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 t -143.11 108.13 4.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.71 101.11 54.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.202 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.34 175.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.33 2.02 . . . . 0.0 112.216 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.68 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' OH ' ' O1A' ' A' ' 182' ' ' HEM . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER 167.47 152.98 0.11 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.42 -31.8 16.97 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.533 2.155 . . . . 0.0 111.986 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 138' ' ' LEU . 34.3 mtp180 -52.13 -18.03 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 42.97 17.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 136' ' ' ARG . 4.7 tp -80.36 16.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.562 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p -44.34 -30.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.6 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.53 ' NE2' ' O ' ' A' ' 163' ' ' THR . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.68 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 175' ' ' ILE . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -79.58 134.87 36.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -108.72 9.05 27.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HEM . . . . . 0.422 ' O1A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.016 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 25' ' ' LEU . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.596 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 66' ' ' VAL . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.7 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.7 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 128' ' ' ILE . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.603 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo . . . . . 0 N--CA 1.492 1.404 0 CA-C-O 120.841 0.267 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.463 HG21 HG11 ' A' ' 95' ' ' VAL . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.687 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.5 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.3 tp-100 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.687 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.023 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.023 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 25' ' ' LEU . 75.0 m-70 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.727 0.299 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.492 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 54' ' ' VAL . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.484 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 77' ' ' LEU . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.454 HG11 HG21 ' A' ' 128' ' ' ILE . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.509 ' SD ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 98' ' ' ILE . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 120.811 0.255 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 95' ' ' VAL . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.496 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.575 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.575 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 10' ' ' GLU . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG12 HD21 ' A' ' 25' ' ' LEU . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 47' ' ' LEU . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.71 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.71 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 128' ' ' ILE . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 102' ' ' ILE . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 CA-C-O 120.825 0.261 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.415 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.506 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.826 0.346 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.529 HD21 ' C ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.524 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.448 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.036 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.036 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.059 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.663 0.268 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 25' ' ' LEU . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 47' ' ' LEU . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.711 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.711 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG1' HG21 ' A' ' 128' ' ' ILE . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.419 ' N ' HG23 ' A' ' 106' ' ' VAL . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 N--CA 1.487 1.147 0 CA-C-O 120.893 0.289 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.41 HG21 ' CG1' ' A' ' 95' ' ' VAL . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.493 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.4 t . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.456 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.3 tp-100 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.481 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.548 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.656 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 47.4 m-20 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.024 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.024 ' N ' HD13 ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' N ' ' N ' ' A' ' 3' ' ' GLY . 78.7 p . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG12 HD21 ' A' ' 25' ' ' LEU . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.656 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 128' ' ' ILE . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.555 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 106' ' ' VAL . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.498 1.776 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 95' ' ' VAL . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.815 0.34 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.533 ' CG ' HH21 ' A' ' 131' ' ' ARG . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.682 HD11 ' HD3' ' A' ' 80' ' ' ARG . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.3 p90 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.753 0.311 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG12 HD21 ' A' ' 25' ' ' LEU . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LEU . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG21 ' CB ' ' A' ' 55' ' ' ALA . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.682 ' HD3' HD11 ' A' ' 4' ' ' ILE . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.707 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.707 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 128' ' ' ILE . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.51 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.5 p-80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.841 0.267 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 118' ' ' ILE . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.419 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 18.6 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.581 0.229 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 142' ' ' ALA . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 27.2 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.507 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.2 tp-100 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' A' ' 174' ' ' LEU . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' ILE . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.017 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.017 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 25' ' ' LEU . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.706 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.432 ' N ' HD23 ' A' ' 94' ' ' LEU . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.489 1.239 0 CA-C-O 120.839 0.266 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.888 HD12 ' N ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.888 ' N ' HD12 ' A' ' 118' ' ' ILE . 66.1 t30 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.505 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.659 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.596 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.705 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 1.4 p-80 -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.405 ' N ' ' CD2' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.659 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.406 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.463 ' H ' ' N ' ' A' ' 3' ' ' GLY . 51.4 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 25' ' ' LEU . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 94' ' ' LEU . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.509 ' CG1' HG21 ' A' ' 128' ' ' ILE . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 CA-C-O 120.895 0.29 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.763 0.316 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 7.2 tp60 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 ' ND1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 157' ' ' ILE . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 73' ' ' LEU . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.625 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 61.2 m-70 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.49 ' N ' ' N ' ' A' ' 3' ' ' GLY . 78.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.481 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' N ' HG23 ' A' ' 62' ' ' ILE . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.489 ' CG1' HG21 ' A' ' 128' ' ' ILE . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.616 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 107' ' ' ASN . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 106' ' ' VAL . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.793 0.247 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CG1' ' A' ' 95' ' ' VAL . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m . . . . . 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 142' ' ' ALA . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 14.7 mm100 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.9 tp60 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.524 ' O ' ' SG ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' A' ' 169' ' ' ALA . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 165' ' ' MET . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.441 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG12 HD21 ' A' ' 25' ' ' LEU . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 128' ' ' ILE . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 98' ' ' ILE . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.617 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.772 0.238 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 118' ' ' ILE . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.498 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 95' ' ' VAL . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 20.3 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.799 0.333 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 42.3 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.443 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.4 tp-100 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.438 ' CG ' HH21 ' A' ' 131' ' ' ARG . 34.9 p-80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.543 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 73' ' ' LEU . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.015 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.015 ' N ' HD13 ' A' ' 25' ' ' LEU . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.504 HG12 HD21 ' A' ' 25' ' ' LEU . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG1' HG21 ' A' ' 128' ' ' ILE . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 102' ' ' ILE . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo . . . . . 0 N--CA 1.5 1.884 0 CA-C-O 120.949 0.312 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.481 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.424 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.642 0.258 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 142' ' ' ALA . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.562 ' HZ1' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.572 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.737 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.562 HE22 ' HZ1' ' A' ' 156' ' ' LYS . 42.6 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.022 ' N ' HD13 ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.418 ' N ' ' N ' ' A' ' 3' ' ' GLY . 31.4 p . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 25' ' ' LEU . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 55' ' ' ALA . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 128' ' ' ILE . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.494 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.406 ' N ' HG22 ' A' ' 98' ' ' ILE . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.606 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 105' ' ' GLU . 26.9 mtmt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.499 1.84 0 CA-C-O 120.801 0.251 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 95' ' ' VAL . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.75 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 10' ' ' GLU . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.832 0.349 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG21 ' CB ' ' A' ' 55' ' ' ALA . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 67' ' ' LYS . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 66' ' ' VAL . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.708 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.708 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 128' ' ' ILE . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.628 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.435 ' ND1' HD11 ' A' ' 118' ' ' ILE . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 107' ' ' ASN . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 106' ' ' VAL . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.81 0.254 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.435 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.3 p30 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.478 HG21 HG11 ' A' ' 95' ' ' VAL . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.809 0.337 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.481 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 176' ' ' ILE . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.557 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 157' ' ' ILE . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.412 ' N ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' LEU . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.028 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.412 ' N ' ' N ' ' A' ' 3' ' ' GLY . 59.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.726 0.298 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 25' ' ' LEU . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.458 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HG23 ' A' ' 62' ' ' ILE . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 66' ' ' VAL . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 128' ' ' ILE . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.412 ' N ' HG22 ' A' ' 98' ' ' ILE . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.494 1.501 0 CA-C-O 120.827 0.261 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 ' CG1' ' A' ' 95' ' ' VAL . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.79 0.328 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.2 tp-100 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.718 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 1.3 p-80 -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.499 ' N ' ' CD2' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 73' ' ' LEU . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.805 0.336 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 25' ' ' LEU . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.444 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 77' ' ' LEU . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.491 ' CG1' HG21 ' A' ' 128' ' ' ILE . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 122' ' ' LEU . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.589 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 107' ' ' ASN . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 106' ' ' VAL . 6.7 t-20 -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.842 0.268 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' ILE . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.491 HG21 ' CG1' ' A' ' 95' ' ' VAL . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 142' ' ' ALA . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.3 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.948 0.404 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.502 HG12 HD21 ' A' ' 25' ' ' LEU . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 118' ' ' ILE . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.566 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 106' ' ' VAL . 45.5 t-20 -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.813 0.274 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.476 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HG11 ' A' ' 95' ' ' VAL . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.488 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 133' ' ' SER . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.646 0.26 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.472 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 14' ' ' VAL . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 14' ' ' VAL . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.031 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.031 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.663 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG12 HD21 ' A' ' 25' ' ' LEU . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.427 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 128' ' ' ILE . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 118' ' ' ILE . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 102' ' ' ILE . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 120.861 0.275 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 HG11 ' A' ' 95' ' ' VAL . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.47 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.468 ' N ' ' N ' ' A' ' 3' ' ' GLY . 87.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.714 0.292 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.444 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 147' ' ' PHE . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' A' ' 128' ' ' ILE . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.599 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 107' ' ' ASN . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 106' ' ' VAL . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.807 0.253 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.473 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 71' ' ' GLN . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.543 ' HG ' ' HG1' ' A' ' 167' ' ' THR . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.543 ' HG1' ' HG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 157' ' ' ILE . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 73' ' ' LEU . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.52 ' H ' ' N ' ' A' ' 3' ' ' GLY . 80.7 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.744 0.307 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.449 HG12 HD21 ' A' ' 25' ' ' LEU . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 55' ' ' ALA . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.688 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.688 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG1' HG21 ' A' ' 128' ' ' ILE . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' HG23 ' A' ' 106' ' ' VAL . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.869 0.279 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 129' ' ' ALA . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.523 ' C ' ' ND2' ' A' ' 125' ' ' ASN . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.523 ' ND2' ' C ' ' A' ' 124' ' ' PRO . 2.5 p30 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 125' ' ' ASN . 24.8 m-20 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.452 ' NE2' ' OD1' ' A' ' 125' ' ' ASN . 41.9 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.493 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 171' ' ' HIS . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.407 ' CG ' HH21 ' A' ' 131' ' ' ARG . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.441 ' N ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 14' ' ' VAL . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLU . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.441 ' N ' ' N ' ' A' ' 3' ' ' GLY . 60.2 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.48 HG12 HD21 ' A' ' 25' ' ' LEU . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.48 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 128' ' ' ILE . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 102' ' ' ILE . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.71 0.213 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 95' ' ' VAL . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.436 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.755 0.312 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 142' ' ' ALA . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 40.2 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.504 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.1 tp-100 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' CYS . . . . . 0.427 ' C ' ' N ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 3' ' ' GLY . 96.6 mttt -146.55 116.54 7.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.476 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.27 103.24 0.01 OUTLIER Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.016 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -99.67 -1.33 38.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -75.38 150.74 85.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.55 -164.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -68.49 -43.52 76.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.91 -45.47 94.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.425 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 65.41 46.29 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.44 143.34 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.811 0.339 . . . . 0.0 110.555 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 -114.43 112.01 22.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.86 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p -82.76 -29.54 29.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.44 63.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.64 -173.78 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 t -143.99 1.52 1.13 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.469 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 75.7 t80 -79.48 163.24 24.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 54.31 18.96 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.491 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.78 -24.3 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m -63.57 -26.55 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 25' ' ' LEU . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.596 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 66' ' ' VAL . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.7 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.7 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 128' ' ' ILE . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.603 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.606 HD21 ' CD ' ' A' ' 113' ' ' PRO . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.12 -35.24 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 96.0 mt -74.38 -34.87 63.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.428 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 69.6 m-85 -158.07 176.5 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.7 m80 55.56 -163.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -150.89 153.69 33.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.193 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' CD ' HD21 ' A' ' 107' ' ' ASN . 85.3 Cg_exo -36.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.541 2.161 . . . . 0.0 112.39 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' GLU . 82.1 p -173.57 25.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.48 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 26.6 mt -75.99 147.79 80.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 93.2 Cg_exo -38.68 164.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.523 2.148 . . . . 0.0 112.376 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.463 HG21 HG11 ' A' ' 95' ' ' VAL . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.687 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p 172.94 132.42 0.1 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.53 -36.97 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.179 1.919 . . . . 0.0 112.24 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 138' ' ' LEU . 92.3 mtt-85 -49.31 -19.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.772 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 37.03 24.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.7 tp -88.89 31.78 0.84 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p -49.8 -38.87 36.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.646 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.5 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.3 tp-100 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.687 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.16 137.8 34.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -112.03 11.71 20.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.515 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.0 t0 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.615 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 20.1 tptp -162.7 61.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 36.65 99.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.023 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.023 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 25' ' ' LEU . 75.0 m-70 -87.8 2.21 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.62 154.56 73.33 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' ALA . 83.7 Cg_exo -44.35 179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.421 2.081 . . . . 0.0 112.513 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -45.3 -53.46 8.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.25 75.89 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -90.11 148.45 23.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.75 141.98 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 110.867 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 -95.17 115.96 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.685 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' GLY . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.565 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.6 p -77.94 -34.89 50.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -68.97 -42.8 76.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.526 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 42' ' ' TYR . 18.7 mmmt -73.24 -55.31 6.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t 48.1 12.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 40' ' ' LYS . 64.9 t80 -68.23 -33.09 73.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.47 16.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CD ' HH12 ' A' ' 136' ' ' ARG . 13.6 tm-20 -50.82 -31.18 16.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p -59.6 -36.39 76.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.492 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 54' ' ' VAL . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.484 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 77' ' ' LEU . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG11 HG21 ' A' ' 128' ' ' ILE . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.509 ' SD ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 98' ' ' ILE . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.91 61.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.35 -33.41 72.38 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.518 ' CZ ' ' OE2' ' A' ' 112' ' ' GLU . 30.7 p90 -157.34 149.48 22.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.325 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -77.58 145.65 36.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.933 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' OE2' ' CZ ' ' A' ' 110' ' ' TYR . 4.3 pt-20 -170.88 151.22 3.26 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.261 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -38.11 -72.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.403 2.069 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.0 p -168.5 157.59 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.503 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD21 ' OE2' ' A' ' 112' ' ' GLU . 89.5 mt -94.5 148.51 35.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.531 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -40.22 162.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.249 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 95' ' ' VAL . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.496 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p -174.32 133.85 0.55 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.65 -56.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.372 2.048 . . . . 0.0 113.359 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.478 HH12 ' CD ' ' A' ' 44' ' ' GLU . 67.0 ttp85 -82.29 -46.58 13.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -61.01 152.58 27.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.01 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.2 mt -103.71 130.49 51.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p -68.96 -32.01 71.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.541 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.575 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.575 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.8 145.48 27.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 53.2 t-20 -41.24 -37.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.833 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.586 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.426 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' H2 ' ' HG ' ' A' ' 38' ' ' SER . 69.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 60.2 mttp 54.64 70.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.06 100.05 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 10' ' ' GLU . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -88.31 2.78 51.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -136.88 152.76 74.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' ALA . 86.7 Cg_exo -43.94 178.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.461 2.107 . . . . 0.0 112.55 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -48.77 -53.15 20.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.144 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 51.3 p30 -145.83 74.81 1.4 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.02 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -91.4 149.78 21.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.054 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.3 m -113.61 133.65 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.898 0.38 . . . . 0.0 110.832 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -88.1 118.88 27.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HG ' ' H2 ' ' A' ' 1' ' ' MET . 85.0 p -84.15 -33.8 24.18 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.02 81.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.236 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -80.16 -171.8 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.98 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -159.96 0.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.823 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -66.67 -33.07 74.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.831 0.348 . . . . 0.0 110.809 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.57 -16.39 63.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' OE2' ' O1D' ' A' ' 182' ' ' HEM . 96.3 mt-10 -46.69 -35.87 6.52 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.465 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -36.1 71.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.542 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG12 HD21 ' A' ' 25' ' ' LEU . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 47' ' ' LEU . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.422 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.71 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.71 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 128' ' ' ILE . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' O ' HD23 ' A' ' 109' ' ' LEU . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 102' ' ' ILE . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' TYR . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -70.42 -25.12 63.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -49.85 -34.67 20.67 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.093 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.617 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 63.2 t80 -154.77 176.44 12.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.617 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 32.3 m80 -57.75 -154.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.546 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 61.05 63.81 2.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.582 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.51 69.5 5.91 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.623 2.216 . . . . 0.0 112.063 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -168.95 121.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.9 mt -133.12 152.27 79.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 96.2 Cg_exo -37.01 159.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.226 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.415 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.506 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER 167.43 154.09 0.11 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.63 -27.52 32.29 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.32 2.013 . . . . 0.0 111.828 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -72.39 -14.8 61.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 48.7 mtp85 55.14 -111.65 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 55.07 11.14 0.47 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.123 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -46.23 -32.12 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -78.04 137.49 38.29 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -110.98 11.65 22.16 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.498 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.586 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.47 ' O2A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 3' ' ' GLY . 34.3 ttpt -84.08 108.69 17.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.26 101.52 0.01 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.529 HD21 ' C ' ' A' ' 7' ' ' ASN . 0.5 OUTLIER -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.524 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.448 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.036 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.036 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 -89.6 3.02 53.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -143.33 148.78 45.6 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.29 -159.93 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.572 2.181 . . . . 0.0 111.887 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -57.3 -46.34 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' VAL . 91.9 m-20 -77.81 51.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.496 ' NH1' HD23 ' A' ' 26' ' ' LEU . 36.4 ptt85 -72.33 15.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.04 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 m -84.18 125.32 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.773 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -89.02 121.92 31.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 110' ' ' TYR . 23.2 p -63.88 -31.77 73.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.62 -38.54 80.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.29 -174.37 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.075 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 44' ' ' GLU . 7.3 t -160.98 7.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -66.95 -38.92 87.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.09 19.27 2.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.726 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 41' ' ' SER . 20.2 pt-20 -68.64 -36.96 79.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.687 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -30.93 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 25' ' ' LEU . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 47' ' ' LEU . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.711 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.711 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG1' HG21 ' A' ' 128' ' ' ILE . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' TYR . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -72.09 -32.62 67.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -83.39 -13.89 53.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 38' ' ' SER . 12.4 t80 -144.58 123.97 13.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' TYR . 56.4 m80 -57.88 -154.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 57.82 78.43 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.29 -166.9 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.387 2.058 . . . . 0.0 111.945 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 m 62.67 56.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.4 mt -69.49 152.79 96.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.316 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 65.6 Cg_exo -35.18 157.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.41 HG21 ' CG1' ' A' ' 95' ' ' VAL . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.493 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.4 t 171.48 150.72 0.19 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.93 -50.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.515 2.143 . . . . 0.0 112.041 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -53.03 -22.06 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 60.26 -103.57 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 138' ' ' LEU . 87.7 mt 52.13 15.76 0.47 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m -46.28 -35.74 5.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.583 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.456 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.3 tp-100 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.481 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.548 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -79.65 136.57 36.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -110.11 11.83 23.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.571 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.481 ' CAC' HG11 ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' H ' ' A' ' 39' ' ' ALA . 7.1 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 49.6 mtpt -141.85 63.77 1.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.741 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.12 99.1 0.01 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.656 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 47.4 m-20 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.024 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.024 ' N ' HD13 ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HE ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -83.89 2.08 40.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -132.12 147.27 65.13 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.539 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.0 -170.06 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.461 2.107 . . . . 0.0 112.09 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.73 -35.37 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' ARG . 81.2 m-20 -50.95 -55.67 16.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' HE ' ' CD ' ' A' ' 27' ' ' GLU . 69.0 ttt-85 40.74 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 37' ' ' VAL . 7.3 p -149.91 139.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.287 0.565 . . . . 0.0 110.942 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -117.24 91.8 3.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.375 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.741 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.7 p -79.03 -34.8 43.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.43 ' H ' ' N ' ' A' ' 1' ' ' MET . . . -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 42' ' ' TYR . 4.0 mmmm -64.89 -54.56 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 m 57.46 5.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 40' ' ' LYS . 66.1 t80 -70.17 -33.8 72.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.385 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.97 -4.37 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.756 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -46.37 -31.06 2.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.415 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p -58.34 -33.48 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG12 HD21 ' A' ' 25' ' ' LEU . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.656 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.534 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 128' ' ' ILE . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.555 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 106' ' ' VAL . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.92 -31.84 66.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.58 -34.58 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' ASN . 16.2 m-85 -101.17 147.91 25.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.28 88.17 7.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 114' ' ' SER . 7.9 pt-20 -179.19 70.3 0.19 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 107' ' ' ASN . 31.5 Cg_exo -57.21 68.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.949 2.433 . . . . 0.0 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 112' ' ' GLU . 2.0 t 171.97 122.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -133.42 150.86 76.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 115' ' ' LEU . 57.9 Cg_exo -37.5 169.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 123.081 2.521 . . . . 0.0 112.945 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.472 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 95' ' ' VAL . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.552 ' CE1' HMA3 ' A' ' 182' ' ' HEM . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m -168.53 135.39 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 -54.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.308 2.005 . . . . 0.0 112.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -82.33 -46.64 13.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.879 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.57 ' NH2' ' CGD' ' A' ' 182' ' ' HEM . 72.5 mtt-85 -73.14 149.41 43.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.053 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -102.34 133.99 46.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t -62.83 -24.18 67.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HB2' ' CMA' ' A' ' 182' ' ' HEM . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.533 ' CG ' HH21 ' A' ' 131' ' ' ARG . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -81.31 137.94 35.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -113.65 14.92 18.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.623 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.57 ' CGD' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLY . 35.7 mmtm -79.92 120.26 23.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.381 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.655 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.15 97.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.682 HD11 ' HD3' ' A' ' 80' ' ' ARG . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -91.16 -3.43 57.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -88.55 150.84 47.19 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.659 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 30' ' ' ALA . 73.5 Cg_exo -47.72 -172.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.335 2.023 . . . . 0.0 112.071 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 13.5 ttmm -54.19 -53.28 55.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.656 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 63.4 m-20 -160.89 77.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -127.64 162.62 26.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 36' ' ' TYR . 69.1 t -122.34 158.08 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.726 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' N ' HG12 ' A' ' 35' ' ' VAL . 3.3 p90 -81.14 136.21 35.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.337 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.655 ' N ' ' H ' ' A' ' 3' ' ' GLY . 86.7 p -67.56 -30.73 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.81 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.5 mmmt -77.11 -67.84 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.404 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.428 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 61.5 m 50.24 10.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 40' ' ' LYS . 69.4 t80 -61.28 -34.76 75.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.568 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 43.25 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.1 pm0 -53.56 -25.5 17.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t -54.19 -33.69 58.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG12 HD21 ' A' ' 25' ' ' LEU . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LEU . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG21 ' CB ' ' A' ' 55' ' ' ALA . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.682 ' HD3' HD11 ' A' ' 4' ' ' ILE . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.707 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.707 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 128' ' ' ILE . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.51 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.5 p-80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 109' ' ' LEU . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 111' ' ' HIS . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.56 -23.03 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -49.85 -35.04 21.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.085 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 110' ' ' TYR . 48.0 t80 -160.78 23.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.733 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 107' ' ' ASN . 74.7 m80 52.86 77.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.667 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 79.3 mt-10 -78.54 150.01 75.77 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.419 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 114' ' ' SER . 59.0 Cg_endo -71.71 81.21 1.35 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.416 2.077 . . . . 0.0 112.112 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 113' ' ' PRO . 37.6 p 56.09 159.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.737 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.3 mt -134.57 152.48 77.87 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 115' ' ' LEU . 81.5 Cg_exo -36.89 160.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.582 2.188 . . . . 0.0 112.425 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 118' ' ' ILE . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.84 154.21 1.77 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 137' ' ' ARG . 60.4 Cg_endo -71.99 -54.95 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.661 2.241 . . . . 0.0 112.124 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.628 HH21 ' CGA' ' A' ' 182' ' ' HEM . 34.0 ttp180 -48.93 -11.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.491 ' H ' ' C ' ' A' ' 135' ' ' PRO . 58.8 ttp180 40.23 93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tp -150.18 38.76 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.151 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.419 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 18.6 m -58.54 -31.51 68.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.949 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 142' ' ' ALA . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 27.2 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.507 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.2 tp-100 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' A' ' 174' ' ' LEU . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -85.59 144.33 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -115.02 16.77 17.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.557 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.623 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.628 ' CGA' HH21 ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' N ' ' OG ' ' A' ' 38' ' ' SER . 64.6 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLY . 9.1 mtmp? 56.61 65.06 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.534 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.666 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.33 98.49 0.01 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' ILE . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.017 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.017 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 30' ' ' ALA . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -86.9 3.13 46.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -142.98 156.08 62.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' ALA . 85.0 Cg_exo -42.68 175.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.517 2.145 . . . . 0.0 112.423 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -46.2 -54.36 8.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -147.74 77.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -86.44 149.81 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.981 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.36 136.82 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -97.04 135.32 39.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.666 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.3 p -70.67 -31.3 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -72.46 -37.55 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.21 -174.34 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.42 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 43' ' ' ALA . 21.6 t -151.51 -137.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.365 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' C ' ' N ' ' A' ' 44' ' ' GLU . 42.1 t80 61.39 -70.58 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.88 -17.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 42' ' ' TYR . 82.5 tt0 -49.94 -26.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p -59.86 -26.24 65.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 25' ' ' LEU . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.706 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' N ' HD23 ' A' ' 94' ' ' LEU . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -67.83 -29.46 68.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 10.7 mp -71.61 -45.57 61.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.263 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 81.7 m-85 -158.26 -161.49 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.591 ' NE2' HMD3 ' A' ' 182' ' ' HEM . 15.2 m-70 65.22 101.54 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.685 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 mt-10 -78.25 -35.85 1.23 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.389 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 91.7 Cg_endo -88.36 174.31 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.504 2.136 . . . . 0.0 112.12 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 p -65.04 150.94 47.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.573 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 13.1 mt -91.08 152.54 44.27 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' CG ' ' O1A' ' A' ' 182' ' ' HEM . 85.1 Cg_exo -36.15 158.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 122.602 2.202 . . . . 0.0 112.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.888 HD12 ' N ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.888 ' N ' HD12 ' A' ' 118' ' ' ILE . 66.1 t30 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.505 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.659 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 137' ' ' ARG . 7.8 p -171.87 135.54 0.89 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.0 -58.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.297 1.998 . . . . 0.0 113.153 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.784 HH22 HH21 ' A' ' 137' ' ' ARG . 35.6 ptt-85 -86.85 -37.69 17.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.784 HH21 HH22 ' A' ' 136' ' ' ARG . 32.3 mtt180 -71.68 148.54 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.759 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.272 0.558 . . . . 0.0 111.008 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t -68.95 -30.79 69.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.361 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.596 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.705 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 1.4 p-80 -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.405 ' N ' ' CD2' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.659 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.406 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 -90.83 150.65 21.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -43.0 -48.28 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.748 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.599 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.591 HMD3 ' NE2' ' A' ' 111' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.2 pttt -155.27 142.56 19.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.745 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 41.46 101.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 32' ' ' LYS . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -91.19 2.58 56.25 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.5 154.23 73.26 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.63 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 30' ' ' ALA . 75.7 Cg_exo -45.49 -176.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.453 2.102 . . . . 0.0 112.564 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 15.5 ttmm -45.52 -51.37 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -155.55 74.5 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.029 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -90.79 147.16 23.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.149 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.71 144.61 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.872 0.368 . . . . 0.0 110.806 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -94.13 114.81 27.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.745 ' N ' ' H ' ' A' ' 3' ' ' GLY . 51.4 p -66.71 -32.57 73.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.48 80.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.906 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -78.96 -174.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.371 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -158.99 79.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' C ' ' N ' ' A' ' 44' ' ' GLU . 98.6 m-85 -150.38 158.28 43.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 48.92 12.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 42' ' ' TYR . 87.1 tt0 -54.78 -31.62 59.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.435 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m -53.65 -23.68 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 25' ' ' LEU . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 94' ' ' LEU . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.509 ' CG1' HG21 ' A' ' 128' ' ' ILE . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt -74.45 -35.24 63.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 109' ' ' LEU . 4.6 mm? -55.57 -44.06 76.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.956 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 111' ' ' HIS . 9.6 p90 -166.38 175.64 8.04 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.623 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 3.5 p80 39.21 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 2.7 mt-10 -170.61 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 112' ' ' GLU . 86.6 Cg_endo -82.65 -161.37 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.327 2.018 . . . . 0.0 112.024 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p 64.84 18.14 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.99 104.68 41.38 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.12 169.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.453 2.102 . . . . 0.0 112.816 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.19 156.62 2.45 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -38.88 7.15 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.616 2.211 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' CZ ' ' O2A' ' A' ' 182' ' ' HEM . 54.7 mtm180 -64.09 -23.32 67.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 139' ' ' CYS . 67.7 mtm180 50.78 22.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.6 34.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.465 ' H ' ' C ' ' A' ' 137' ' ' ARG . 19.3 m -49.91 -37.12 30.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.559 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 7.2 tp60 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 ' ND1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 157' ' ' ILE . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.15 138.02 37.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -108.18 14.78 24.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.464 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.589 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.492 ' CBC' ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' GLY . 31.3 mmtm -79.77 140.42 36.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.719 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 34.68 99.58 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 73' ' ' LEU . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.625 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 61.2 m-70 -86.86 1.99 50.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.32 154.58 73.87 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.462 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 87.1 Cg_exo -43.95 178.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.42 2.08 . . . . 0.0 112.404 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -42.83 -53.34 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 53.3 p30 -153.19 73.73 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -88.64 147.18 24.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.1 137.39 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.925 0.393 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -90.66 114.92 27.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.719 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.8 p -75.29 -29.96 60.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.92 -38.03 69.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -78.87 -174.92 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.307 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 39.8 m -165.74 89.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 41' ' ' SER . 91.4 m-85 -157.8 -46.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 -5.99 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.522 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.4 -32.99 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t -58.94 -33.51 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.481 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' N ' HG23 ' A' ' 62' ' ' ILE . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.489 ' CG1' HG21 ' A' ' 128' ' ' ILE . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.616 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 107' ' ' ASN . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 106' ' ' VAL . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -66.01 -25.95 67.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 11.2 mp -77.34 -18.47 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 32.4 m-85 -142.96 77.32 1.56 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.784 0.326 . . . . 0.0 110.947 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.8 m80 36.85 -121.16 0.17 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.192 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' CG ' HD21 ' A' ' 107' ' ' ASN . 30.2 tt0 -166.48 66.88 0.98 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.21 33.79 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 112.157 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.0 t 57.69 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -78.82 154.06 78.08 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 160.12 4.26 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.144 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CG1' ' A' ' 95' ' ' VAL . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m 161.95 132.63 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.26 -30.61 2.31 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.017 1.812 . . . . 0.0 112.139 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 138' ' ' LEU . 98.4 mtt180 -55.37 -25.22 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.804 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 37.38 25.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -84.99 20.8 1.76 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.943 0.401 . . . . 0.0 109.925 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m -43.93 -33.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.004 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 142' ' ' ALA . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 14.7 mm100 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.2 tp-100 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.524 ' O ' ' SG ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' A' ' 169' ' ' ALA . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 165' ' ' MET . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 181' ' ' ASP . 44.5 mt-30 -83.31 145.79 28.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 47.5 p-10 -39.99 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 56.4 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.54 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.416 ' O2A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.6 mtmm -78.74 133.5 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.64 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 51.81 114.4 0.01 OUTLIER Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.441 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -89.85 1.77 55.78 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -141.95 147.52 45.06 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.29 -158.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.612 2.208 . . . . 0.0 111.683 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 34' ' ' ARG . 4.8 ttpm? -55.76 -29.47 59.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.592 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.02 39.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 32' ' ' LYS . 64.4 mtm180 -47.57 -22.0 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.92 137.14 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -105.43 137.62 42.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p -61.94 -25.73 67.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.82 33.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -79.19 -177.35 5.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -168.21 40.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.349 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -57.92 -40.35 80.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.815 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.9 69.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.731 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -62.81 -24.51 67.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.429 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p -55.64 -21.88 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.734 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG12 HD21 ' A' ' 25' ' ' LEU . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 128' ' ' ILE . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 98' ' ' ILE . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.617 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.65 -33.14 74.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.69 -35.79 81.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.081 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -103.33 -163.77 1.02 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.75 74.8 1.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -177.92 66.84 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.49 101.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.661 2.241 . . . . 0.0 112.121 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.6 t -177.35 38.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.7 147.32 89.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.274 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.72 155.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.403 2.069 . . . . 0.0 112.327 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 118' ' ' ILE . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.498 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 95' ' ' VAL . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p -172.81 148.38 1.72 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.6 -32.3 15.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.299 1.999 . . . . 0.0 111.856 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.48 -10.67 59.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.591 ' NH1' ' SG ' ' A' ' 164' ' ' CYS . 32.0 ttt85 59.91 -96.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' O ' ' O1A' ' A' ' 182' ' ' HEM . 1.5 mm? 46.56 16.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 110.066 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.511 ' SG ' ' CZ ' ' A' ' 137' ' ' ARG . 20.3 p -50.66 -39.61 51.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.714 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 42.3 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.443 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.0 tp60 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.591 ' SG ' ' NH1' ' A' ' 137' ' ' ARG . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.438 ' CG ' HH21 ' A' ' 131' ' ' ARG . 34.9 p-80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -85.0 146.36 27.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 40.9 p-10 -41.08 -31.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.744 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 90.8 m-20 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.482 HMA1 ' CGA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.2 mtmm -79.2 107.32 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 47.38 114.16 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 73' ' ' LEU . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.015 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.015 ' N ' HD13 ' A' ' 25' ' ' LEU . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -104.97 -3.42 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -44.37 158.22 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.642 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.96 -177.91 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.802 2.335 . . . . 0.0 111.876 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -65.54 -33.43 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.354 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -65.55 -23.47 66.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.587 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 71.74 0.86 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.988 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.43 162.77 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 0.0 110.756 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -113.27 114.23 26.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.185 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 39' ' ' ALA . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -72.94 -28.42 62.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -75.43 -36.73 60.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -80.6 -174.68 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.377 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 43' ' ' ALA . 19.9 t -151.09 -144.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.0 t80 60.45 -72.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -55.61 -19.09 9.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.488 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -47.71 -24.53 0.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p -56.95 -28.37 62.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.615 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.504 HG12 HD21 ' A' ' 25' ' ' LEU . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG1' HG21 ' A' ' 128' ' ' ILE . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 115' ' ' LEU . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG11 ' CAC' ' A' ' 182' ' ' HEM . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 110' ' ' TYR . 15.0 t30 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -69.39 -25.66 64.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 10.3 mp -75.41 -15.98 60.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.488 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 13.0 m-85 -137.85 -176.37 4.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.457 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 75.6 m80 -160.83 -29.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -79.27 -36.21 1.09 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.612 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 90.2 Cg_endo -88.96 131.07 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -86.03 156.43 20.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.29 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.2 mt -102.83 119.83 54.44 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.75 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' LEU . 91.2 Cg_exo -43.42 178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.591 2.194 . . . . 0.0 112.8 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.481 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.424 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m 169.11 154.32 0.16 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.52 -30.19 12.54 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.488 2.126 . . . . 0.0 111.986 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' LEU . 7.9 tpp85 -53.46 -17.78 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.377 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 40.97 21.26 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -86.58 22.91 1.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 0.0 110.185 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p -48.32 -27.64 2.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.504 ' HB2' HMA1 ' A' ' 182' ' ' HEM . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 142' ' ' ALA . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.562 ' HZ1' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.572 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.737 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.562 HE22 ' HZ1' ' A' ' 156' ' ' LYS . 42.6 mt-30 -79.5 138.44 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -113.17 18.5 17.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.534 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.51 ' CAC' HG11 ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OG ' ' A' ' 38' ' ' SER . 11.4 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLY . 80.2 tttt 60.3 60.11 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.657 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 37.27 100.96 0.01 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.022 ' N ' HD13 ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -97.94 -5.21 34.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -87.89 146.64 39.19 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.6 -164.8 0.26 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.454 2.103 . . . . 0.0 111.971 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -62.86 -30.61 71.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' VAL . 54.3 t0 -45.9 -38.2 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 61.95 -69.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.03 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' ASP . 1.8 m -70.9 152.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.04 0.448 . . . . 0.0 110.912 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.16 113.98 26.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.538 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.657 ' N ' ' H ' ' A' ' 3' ' ' GLY . 31.4 p -78.57 -34.44 46.93 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.34 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -65.48 -39.41 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.35 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.419 ' OG ' ' OE2' ' A' ' 44' ' ' GLU . 14.8 t 53.11 34.17 16.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.607 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 68.6 t80 -99.32 173.01 6.98 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 55.18 5.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 42' ' ' TYR . 83.0 mt-10 -47.7 -25.68 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.793 0.33 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p -60.11 -30.42 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.706 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 25' ' ' LEU . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 55' ' ' ALA . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 128' ' ' ILE . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.494 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' N ' HG22 ' A' ' 98' ' ' ILE . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.606 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.475 ' C ' ' N ' ' A' ' 110' ' ' TYR . 26.9 mtmt -73.12 -33.41 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.35 -13.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.562 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 60.0 t80 -147.14 174.05 11.94 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.325 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.562 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 23.2 m-70 -44.09 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.755 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -155.44 77.9 4.71 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.29 138.83 8.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.707 2.271 . . . . 0.0 111.998 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -65.62 149.84 49.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.88 152.76 80.86 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.131 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.38 160.18 49.44 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.527 2.151 . . . . 0.0 112.094 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 95' ' ' VAL . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m -178.37 151.78 0.77 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.49 -33.92 6.33 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.522 2.148 . . . . 0.0 112.028 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -63.99 -14.92 57.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mtm105 51.86 30.73 7.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.929 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.0 mt -82.62 14.19 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.385 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t -44.43 -35.01 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB2' HMA1 ' A' ' 182' ' ' HEM . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -83.79 142.58 30.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -111.36 14.86 21.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 50.5 p30 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.556 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.586 ' O1A' HMA2 ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 3' ' ' GLY . 52.2 mttm -80.22 111.47 16.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 39.23 106.22 0.01 OUTLIER Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 10' ' ' GLU . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 -89.36 1.79 55.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -118.73 144.76 36.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.01 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.87 -157.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.627 2.218 . . . . 0.0 111.658 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -57.29 -42.86 82.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 110.294 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.44 79.92 9.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -81.92 12.04 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -76.75 139.52 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 110.6 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.95 116.11 28.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.472 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.0 p -80.26 -28.59 38.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.73 -34.04 62.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.15 -174.17 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.653 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.6 t -156.96 -142.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.408 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 61.23 -71.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -53.68 -15.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.359 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -47.4 -25.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m -54.72 -31.26 57.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG21 ' CB ' ' A' ' 55' ' ' ALA . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 67' ' ' LYS . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 66' ' ' VAL . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.488 ' HE2' HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.708 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.708 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 128' ' ' ILE . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.628 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.435 ' ND1' HD11 ' A' ' 118' ' ' ILE . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' CG1' ' HAC' ' A' ' 182' ' ' HEM . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 106' ' ' VAL . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -70.2 -31.46 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.488 HD22 ' HE2' ' A' ' 81' ' ' HIS . 10.7 mp -68.48 -39.4 81.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.472 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' ASN . 77.9 m-85 -135.07 140.2 45.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.613 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -56.32 137.43 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -164.14 129.69 2.11 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.9 -59.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.995 1.797 . . . . 0.0 112.189 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.2 t -146.22 122.76 11.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.97 152.85 63.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 91.8 Cg_exo -35.8 157.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.66 2.24 . . . . 0.0 112.448 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.435 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.839 ' C ' HD21 ' A' ' 126' ' ' ASN . 0.1 OUTLIER 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.478 HG21 HG11 ' A' ' 95' ' ' VAL . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p 173.1 152.59 0.24 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.33 -28.58 18.1 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.535 2.157 . . . . 0.0 112.191 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -61.42 -16.3 45.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.474 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 45.08 27.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tp -83.93 16.56 2.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.548 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.74 -41.82 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.672 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.481 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.513 ' H ' ' CD ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 176' ' ' ILE . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.557 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 157' ' ' ILE . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -80.09 136.44 36.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -104.86 8.75 34.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.453 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 56.0 t0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.593 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.516 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' H2 ' ' CB ' ' A' ' 38' ' ' SER . 71.9 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' GLY . 92.2 mttt 55.09 70.85 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.596 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.698 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 39.4 98.62 0.01 OUTLIER Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' LEU . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.028 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -87.74 -4.78 58.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -92.87 147.97 35.01 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.47 -169.84 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.517 2.144 . . . . 0.0 111.958 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -62.26 -40.36 95.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.618 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' ARG . 90.6 m-20 -61.32 -46.25 91.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.574 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 33' ' ' ASP . 56.4 ttp180 43.29 94.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 37' ' ' VAL . 7.9 p -160.84 140.6 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.118 0.485 . . . . 0.0 110.946 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -116.04 91.61 3.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.553 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 35' ' ' VAL . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.698 ' N ' ' H ' ' A' ' 3' ' ' GLY . 59.5 p -70.75 -28.57 64.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -72.61 -41.21 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' TYR . 18.1 mmmt -77.96 -69.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.42 ' O ' ' OE2' ' A' ' 44' ' ' GLU . 19.7 m 45.65 15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 40' ' ' LYS . 67.9 t80 -67.43 -19.44 65.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.53 48.52 1.39 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.758 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 47.0 mp0 -56.73 -28.83 61.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 110.276 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t -57.22 -34.62 68.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 25' ' ' LEU . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.458 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HG23 ' A' ' 62' ' ' ILE . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 66' ' ' VAL . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 128' ' ' ILE . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.496 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.412 ' N ' HG22 ' A' ' 98' ' ' ILE . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.407 ' HD1' ' HA ' ' A' ' 99' ' ' HIS . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -68.04 -30.01 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.74 -32.9 71.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 39' ' ' ALA . 83.8 t80 -128.12 123.57 34.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -62.97 -172.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 62.18 69.56 0.93 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.3 120.93 9.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.8 t -179.68 52.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.602 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 116' ' ' PRO . 25.4 mt -82.47 148.38 58.65 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 115' ' ' LEU . 84.7 Cg_exo -40.64 169.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.403 2.069 . . . . 0.0 112.235 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 ' CG1' ' A' ' 95' ' ' VAL . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m -168.63 133.5 1.4 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.65 -52.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.231 1.954 . . . . 0.0 112.806 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -86.12 -38.36 17.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.17 160.27 28.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.13 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.1 138.86 49.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t -65.72 -25.02 67.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.616 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.424 ' HB2' HMA3 ' A' ' 182' ' ' HEM . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.2 tp-100 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.718 ' CD2' ' C ' ' A' ' 166' ' ' HIS . 1.3 p-80 -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.499 ' N ' ' CD2' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -85.25 147.37 26.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -43.7 -39.44 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.805 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.411 ' OD1' ' OXT' ' A' ' 181' ' ' ASP . 51.8 p30 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.666 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.512 ' CGA' ' CMA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' GLY . 54.3 mtpt -68.74 -67.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.43 100.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 73' ' ' LEU . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 30' ' ' ALA . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -88.54 2.23 53.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -148.55 149.37 31.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.775 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.61 -162.39 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.599 2.199 . . . . 0.0 112.022 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.32 -38.94 81.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' VAL . 94.6 m-20 -79.44 55.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' C ' ' NE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -74.44 17.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.007 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.4 m -80.26 125.93 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -97.98 129.51 44.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -65.57 -32.81 74.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 111' ' ' HIS . . . -69.02 -50.26 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.8 mmmt -66.4 -53.77 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.32 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m 61.77 1.19 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.623 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' LYS . 72.6 t80 -63.23 -37.48 87.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.545 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.71 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.772 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -46.37 -30.91 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.523 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p -57.78 -35.1 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.499 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 25' ' ' LEU . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.444 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 77' ' ' LEU . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.491 ' CG1' HG21 ' A' ' 128' ' ' ILE . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 122' ' ' LEU . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.589 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 107' ' ' ASN . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.54 HD22 ' HB3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -66.69 -31.98 72.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 109' ' ' LEU . 11.0 mp -72.7 -30.92 64.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.77 171.07 9.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.376 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.677 ' H ' ' CD2' ' A' ' 111' ' ' HIS . 6.0 p80 -68.63 -108.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.566 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 82.0 mt-10 -69.44 150.35 97.03 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.54 ' HB3' HD22 ' A' ' 107' ' ' ASN . 73.7 Cg_endo -73.88 -97.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.414 2.076 . . . . 0.0 111.857 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.8 p 39.14 47.16 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.186 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.14 153.19 84.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.29 158.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.416 2.077 . . . . 0.0 112.053 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' ILE . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.757 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.3 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.491 HG21 ' CG1' ' A' ' 95' ' ' VAL . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.597 ' CE1' HMA1 ' A' ' 182' ' ' HEM . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.3 p -177.66 150.33 0.79 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 137' ' ' ARG . 59.2 Cg_endo -71.64 -50.28 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.404 2.069 . . . . 0.0 112.108 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 137' ' ' ARG . 20.6 ptp180 -49.22 -11.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.59 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 135' ' ' PRO . 55.1 ttp180 41.11 95.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tp -154.55 29.12 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.466 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t -50.85 -33.24 22.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.732 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' N ' ' O1A' ' A' ' 182' ' ' HEM . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 142' ' ' ALA . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.34 135.69 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 181' ' ' ASP . 86.2 m-20 -104.52 7.71 35.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 180' ' ' ASN . 64.2 t0 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.597 HMA1 ' CE1' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLY . 93.0 mttt -78.8 -65.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 37.11 104.04 0.01 OUTLIER Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.83 -2.95 24.08 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -47.86 157.1 0.64 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.56 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.53 179.06 6.68 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.743 2.295 . . . . 0.0 111.965 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -64.87 -33.31 75.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.162 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' VAL . 52.1 t0 -72.23 -11.86 60.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 62.4 -69.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' ASP . 2.0 m -64.62 151.28 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.078 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 2' ' ' LYS . 1.3 p90 -107.11 113.79 27.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.885 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 39' ' ' ALA . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.6 p -74.85 -27.53 60.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -75.15 -36.99 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -80.24 -174.07 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.556 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 52.5 p -156.03 -136.27 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' N ' ' OG ' ' A' ' 41' ' ' SER . 35.3 m-85 59.96 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.601 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -57.55 -13.12 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.484 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -47.25 -21.33 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m -58.24 -26.69 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.515 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.502 HG12 HD21 ' A' ' 25' ' ' LEU . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.592 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 32.3 m80 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 118' ' ' ILE . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.566 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 110' ' ' TYR . 45.5 t-20 -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.69 -25.34 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.15 -45.93 31.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 107' ' ' ASN . 26.0 m-85 -102.21 154.02 19.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.35 -30.81 71.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.492 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER -46.11 108.45 0.82 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.9 -61.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.115 1.877 . . . . 0.0 112.208 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m -79.34 145.45 33.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.483 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.8 mt -132.72 153.37 81.06 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 88.0 Cg_exo -36.25 162.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.896 2.398 . . . . 0.0 112.813 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.476 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HG11 ' A' ' 95' ' ' VAL . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.488 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.563 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t 178.89 150.37 0.45 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.46 -40.13 1.7 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.549 2.166 . . . . 0.0 112.149 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 137' ' ' ARG . 83.7 mtp180 -54.39 -13.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.62 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' ARG . 93.1 mtt180 35.17 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -153.75 24.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 110.571 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m -41.52 -35.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.472 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -76.29 145.62 39.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -37.46 -35.2 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.588 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.592 HBC1 ' CG ' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' N ' ' OG ' ' A' ' 38' ' ' SER . 72.3 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 3' ' ' GLY . 25.9 mtmm 56.3 49.72 14.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 37.24 103.05 0.01 OUTLIER Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 14' ' ' VAL . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 14' ' ' VAL . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.031 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.031 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' ALA . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -89.18 3.71 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -142.19 147.87 45.73 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.503 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 169.65 17.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.483 2.122 . . . . 0.0 111.923 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -56.91 -42.59 80.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.6 39.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' CB ' ' HB1' ' A' ' 30' ' ' ALA . 3.3 ppt_? -81.13 138.77 35.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.39 144.82 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.911 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 -110.36 107.46 17.19 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 1' ' ' MET . 52.0 p -81.26 -26.2 35.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.95 -30.51 50.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -86.39 -174.48 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.619 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.2 t -153.46 -129.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' C ' ' N ' ' A' ' 44' ' ' GLU . 96.7 m-85 51.72 -84.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.52 -16.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.524 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 42' ' ' TYR . 83.4 tt0 -47.25 -26.5 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -55.27 -31.11 61.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.546 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' HD13 ' A' ' 138' ' ' LEU . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG12 HD21 ' A' ' 25' ' ' LEU . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.427 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 128' ' ' ILE . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 118' ' ' ILE . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 102' ' ' ILE . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.45 -30.72 70.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 110' ' ' TYR . 6.8 mt -64.46 -8.93 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.017 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 2.4 t80 87.91 109.97 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.661 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 111' ' ' HIS . 2.9 t-80 -166.12 39.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.294 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 111' ' ' HIS . 73.5 mt-10 57.15 150.51 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.579 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.43 -163.39 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.492 2.128 . . . . 0.0 112.084 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 m 60.75 59.27 2.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.36 128.78 85.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -36.89 153.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 HG11 ' A' ' 95' ' ' VAL . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.47 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t 166.17 151.61 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 137' ' ' ARG . 60.2 Cg_endo -72.17 -30.52 13.12 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.442 2.095 . . . . 0.0 112.063 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 138' ' ' LEU . 61.4 mtp180 -49.4 -15.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.661 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 135' ' ' PRO . 34.2 ptt180 37.33 24.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.0 tp -84.89 21.7 1.53 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.124 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p -45.38 -39.48 6.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.502 ' HB2' ' CMA' ' A' ' 182' ' ' HEM . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -82.75 138.43 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -112.14 13.95 20.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.627 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.548 HMC3 ' NE2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 3' ' ' GLY . 57.0 mmtt -79.66 141.01 36.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.456 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.713 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 35.06 99.94 0.01 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' ALA . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -89.69 0.57 56.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -153.76 151.74 25.64 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.521 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' ALA . 74.6 Cg_exo -43.65 173.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.26 1.973 . . . . 0.0 112.122 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -75.64 -37.79 59.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -106.91 38.39 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.937 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -80.15 128.69 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.416 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 2.5 m -125.49 127.34 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -86.3 113.88 22.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.818 179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 3' ' ' GLY . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.713 ' N ' ' H ' ' A' ' 3' ' ' GLY . 87.0 p -68.62 -31.74 71.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -72.76 -38.73 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -80.54 -175.61 5.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.0 t -156.76 -141.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' C ' ' N ' ' A' ' 44' ' ' GLU . 18.6 m-85 62.02 -70.62 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -49.12 -14.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 42' ' ' TYR . 14.4 tm-20 -46.74 -27.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -53.3 -31.9 46.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.664 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.444 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 147' ' ' PHE . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' A' ' 128' ' ' ILE . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.599 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 107' ' ' ASN . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 106' ' ' VAL . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.75 -31.44 72.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 109' ' ' LEU . 11.0 mp -73.17 -32.83 65.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.146 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -85.35 170.54 12.64 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.243 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -76.82 -29.22 55.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.63 153.12 29.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.432 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.86 -91.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.51 2.14 . . . . 0.0 112.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m 43.92 30.1 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.692 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.86 147.29 88.67 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -39.53 160.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.452 2.101 . . . . 0.0 112.305 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.473 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 166.35 153.78 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.89 -23.07 26.07 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.512 2.141 . . . . 0.0 111.897 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 138' ' ' LEU . 87.1 mtt180 -59.47 -20.66 56.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HE ' ' CE ' ' A' ' 165' ' ' MET . 94.7 mtt180 43.09 17.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.4 mt -79.64 20.8 0.55 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p -45.01 -41.36 7.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 71' ' ' GLN . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.543 ' HG ' ' HG1' ' A' ' 167' ' ' THR . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.543 ' HG1' ' HG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 157' ' ' ILE . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.08 139.83 41.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.94 17.48 19.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.551 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' O1D' ' NH1' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 68.5 mttm -80.52 138.05 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.592 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.726 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 41.19 100.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 73' ' ' LEU . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.76 -0.27 57.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -128.74 148.47 68.68 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.796 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.4 -159.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.562 2.175 . . . . 0.0 112.019 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.47 -25.28 62.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 35' ' ' VAL . 57.5 t0 -45.49 -49.32 13.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.407 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 56.03 -75.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.421 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.2 m -62.81 136.08 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 111.473 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -97.98 125.76 43.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.436 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.726 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.7 p -59.72 -26.95 66.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -78.92 -41.68 28.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -78.72 -178.07 5.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.956 0.407 . . . . 0.0 110.706 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.2 t -164.74 54.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.301 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -53.05 -40.72 64.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.704 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.84 90.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.602 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.16 -24.84 65.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m -56.35 -27.7 56.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.624 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.449 HG12 HD21 ' A' ' 25' ' ' LEU . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 55' ' ' ALA . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.688 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.688 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG1' HG21 ' A' ' 128' ' ' ILE . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' HG23 ' A' ' 106' ' ' VAL . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -72.85 -29.79 63.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.96 -12.92 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' ASN . 71.0 m-85 -147.97 -157.22 0.79 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.511 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -90.81 -103.63 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.565 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 31.2 mm-40 54.8 72.95 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.744 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.95 -30.08 23.08 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.767 2.311 . . . . 0.0 112.071 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -153.33 110.84 3.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -82.97 152.02 64.84 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.376 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.9 Cg_exo -38.25 164.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.619 2.213 . . . . 0.0 112.41 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 129' ' ' ALA . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.523 ' C ' ' ND2' ' A' ' 125' ' ' ASN . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.576 ' C ' HD21 ' A' ' 126' ' ' ASN . 2.5 p30 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.576 HD21 ' C ' ' A' ' 125' ' ' ASN . 5.7 m120 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.452 ' NE2' ' OD1' ' A' ' 125' ' ' ASN . 41.9 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.493 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 171' ' ' HIS . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.8 p -169.14 132.55 1.2 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.61 -57.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.287 1.991 . . . . 0.0 113.0 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 137' ' ' ARG . 35.3 ptt-85 -80.89 -43.65 19.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.828 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 136' ' ' ARG . 6.8 tpt180 -71.24 154.51 41.6 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.946 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.1 mt -108.83 135.83 49.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.904 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p -64.42 -31.72 73.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.407 ' CG ' HH21 ' A' ' 131' ' ' ARG . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -78.76 137.44 37.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -110.72 8.03 22.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.4 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.518 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.515 HMA3 ' CGA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' N ' ' OG ' ' A' ' 38' ' ' SER . 74.3 mmm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -174.53 51.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.699 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 36.32 99.5 0.01 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 14' ' ' VAL . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLU . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -92.73 -0.77 57.23 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -93.69 150.94 39.56 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 55.4 Cg_exo -48.38 -171.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.274 1.983 . . . . 0.0 112.212 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -57.02 -53.64 55.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -161.6 77.93 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.672 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -127.38 169.33 13.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.439 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.14 162.37 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -95.35 115.53 27.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 3' ' ' GLY . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.699 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.2 p -65.79 -33.58 76.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -70.71 -49.11 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -69.56 -169.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.19 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 43' ' ' ALA . 44.1 t -52.17 138.23 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.11 12.14 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 41' ' ' SER . . . 40.15 44.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' ' NH2' ' A' ' 136' ' ' ARG . 79.9 tt0 -58.12 -28.66 64.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m -63.13 -37.5 87.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.48 HG12 HD21 ' A' ' 25' ' ' LEU . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.48 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.555 ' CD2' HBC1 ' A' ' 182' ' ' HEM . 0.3 OUTLIER -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 128' ' ' ILE . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.511 ' HB3' HD12 ' A' ' 115' ' ' LEU . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG1' ' HAC' ' A' ' 182' ' ' HEM . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.553 HD21 ' CD ' ' A' ' 112' ' ' GLU . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -66.83 -25.1 66.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -52.31 45.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 54.4 t80 -96.33 -106.6 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.566 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.568 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 73.3 m80 -159.54 57.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.655 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 107' ' ' ASN . 13.2 tp10 58.91 65.53 2.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.692 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.73 -91.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.676 2.25 . . . . 0.0 112.078 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.48 ' C ' HD22 ' A' ' 115' ' ' LEU . 33.8 t -143.11 108.13 4.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' HIS . 4.3 mm? -114.71 101.11 54.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.202 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.34 175.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.33 2.02 . . . . 0.0 112.216 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 95' ' ' VAL . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.436 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER 167.47 152.98 0.11 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.42 -31.8 16.97 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.533 2.155 . . . . 0.0 111.986 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 138' ' ' LEU . 34.3 mtp180 -52.13 -18.03 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 42.97 17.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 136' ' ' ARG . 4.7 tp -80.36 16.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.562 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p -44.34 -30.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 142' ' ' ALA . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 40.2 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.504 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 7.1 tp-100 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' CYS . . . . . 0.427 ' C ' ' N ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -79.58 134.87 36.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -108.72 9.05 27.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HEM . . . . . 0.555 HBC1 ' CD2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.522 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.016 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 25' ' ' LEU . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.596 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 66' ' ' VAL . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.7 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.7 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 128' ' ' ILE . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.603 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo . . . . . 0 N--CA 1.492 1.404 0 CA-C-O 120.841 0.267 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.463 HG21 HG11 ' A' ' 95' ' ' VAL . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.687 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p . . . . . 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.5 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.687 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.4 m120 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.023 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.023 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.54 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 77.4 m80 . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 . . . . . 0 N--CA 1.462 0.153 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.727 0.299 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.492 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 54' ' ' VAL . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.484 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 77' ' ' LEU . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.454 HG11 HG21 ' A' ' 128' ' ' ILE . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.509 ' SD ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 98' ' ' ILE . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 CA-C-O 120.811 0.255 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 95' ' ' VAL . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.496 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.808 0.337 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.575 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.575 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 10' ' ' GLU . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG12 HD21 ' A' ' 25' ' ' LEU . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 47' ' ' LEU . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.71 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.71 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 128' ' ' ILE . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 102' ' ' ILE . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo . . . . . 0 N--CA 1.488 1.195 0 CA-C-O 120.825 0.261 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.415 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.506 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.826 0.346 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.585 ' ND2' HH21 ' A' ' 80' ' ' ARG . 49.5 t-20 -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.524 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.448 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.036 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.036 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.059 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.663 0.268 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 25' ' ' LEU . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 47' ' ' LEU . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.585 HH21 ' ND2' ' A' ' 7' ' ' ASN . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.711 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.711 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG1' HG21 ' A' ' 128' ' ' ILE . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.419 ' N ' HG23 ' A' ' 106' ' ' VAL . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 N--CA 1.487 1.147 0 CA-C-O 120.893 0.289 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.41 HG21 ' CG1' ' A' ' 95' ' ' VAL . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.493 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.4 t . . . . . 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.456 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.9 tp60 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.481 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.548 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.656 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 3.2 m120 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.024 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.024 ' N ' HD13 ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.465 0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' N ' ' N ' ' A' ' 3' ' ' GLY . 78.7 p . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.467 HG12 HD21 ' A' ' 25' ' ' LEU . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.656 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 128' ' ' ILE . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.555 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 106' ' ' VAL . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.498 1.776 0 N-CA-C 112.945 0.325 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 95' ' ' VAL . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m . . . . . 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.815 0.34 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.533 ' CG ' HH21 ' A' ' 131' ' ' ARG . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.682 HD11 ' HD3' ' A' ' 80' ' ' ARG . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.432 ' HE2' ' OE2' ' A' ' 10' ' ' GLU . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.3 p90 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.753 0.311 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG12 HD21 ' A' ' 25' ' ' LEU . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LEU . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.602 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG21 ' CB ' ' A' ' 55' ' ' ALA . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.682 ' HD3' HD11 ' A' ' 4' ' ' ILE . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.707 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.707 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 128' ' ' ILE . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD1' ' A' ' 100' ' ' ASP . 5.5 p80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD1' ' CE1' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.841 0.267 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 118' ' ' ILE . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 119' ' ' ASN . 0.4 OUTLIER -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.419 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 18.6 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.581 0.229 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 142' ' ' ALA . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 4.3 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.507 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.2 tp60 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' A' ' 174' ' ' LEU . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 . . . . . 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' ILE . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.9 m120 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.017 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.017 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.865 0.364 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 25' ' ' LEU . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.584 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.706 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.432 ' N ' HD23 ' A' ' 94' ' ' LEU . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.489 1.239 0 CA-C-O 120.839 0.266 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.888 HD12 ' N ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.888 ' N ' HD12 ' A' ' 118' ' ' ILE . 5.3 t-20 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.505 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.659 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.596 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.545 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.9 OUTLIER -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.545 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.659 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.406 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.463 ' H ' ' N ' ' A' ' 3' ' ' GLY . 51.4 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.754 0.311 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 25' ' ' LEU . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 94' ' ' LEU . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.509 ' CG1' HG21 ' A' ' 128' ' ' ILE . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo . . . . . 0 N--CA 1.498 1.787 0 CA-C-O 120.895 0.29 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.763 0.316 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.3 p80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 ' ND1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 157' ' ' ILE . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 73' ' ' LEU . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.625 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 61.2 m-70 . . . . . 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.13 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.49 ' N ' ' N ' ' A' ' 3' ' ' GLY . 78.8 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.481 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' N ' HG23 ' A' ' 62' ' ' ILE . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.489 ' CG1' HG21 ' A' ' 128' ' ' ILE . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.616 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 107' ' ' ASN . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 106' ' ' VAL . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.497 1.731 0 CA-C-O 120.793 0.247 . . . . 0.0 112.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CG1' ' A' ' 95' ' ' VAL . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m . . . . . 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 142' ' ' ALA . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 18.3 mm-40 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.9 tp60 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' A' ' 169' ' ' ALA . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 165' ' ' MET . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.441 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG12 HD21 ' A' ' 25' ' ' LEU . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 128' ' ' ILE . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 98' ' ' ILE . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.617 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.772 0.238 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 118' ' ' ILE . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.498 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 95' ' ' VAL . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 20.3 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.799 0.333 . . . . 0.0 110.714 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.9 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.443 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.0 tp60 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.438 ' CG ' HH21 ' A' ' 131' ' ' ARG . 22.5 p80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.543 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 73' ' ' LEU . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.6 m120 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.015 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.015 ' N ' HD13 ' A' ' 25' ' ' LEU . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.504 HG12 HD21 ' A' ' 25' ' ' LEU . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.409 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.3 OUTLIER 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG1' HG21 ' A' ' 128' ' ' ILE . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 102' ' ' ILE . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo . . . . . 0 N--CA 1.5 1.884 0 CA-C-O 120.949 0.312 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.481 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.424 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.642 0.258 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 142' ' ' ALA . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.562 ' HZ1' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.572 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.527 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.521 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.562 HE22 ' HZ1' ' A' ' 156' ' ' LYS . 42.6 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.6 m120 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.022 ' N ' HD13 ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.418 ' N ' ' N ' ' A' ' 3' ' ' GLY . 31.4 p . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.787 0.327 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 25' ' ' LEU . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 55' ' ' ALA . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 128' ' ' ILE . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.406 ' N ' HG22 ' A' ' 98' ' ' ILE . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.606 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 105' ' ' GLU . 26.9 mtmt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.499 1.84 0 CA-C-O 120.801 0.251 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 95' ' ' VAL . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.75 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 10' ' ' GLU . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.832 0.349 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.594 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.594 HG21 ' CB ' ' A' ' 55' ' ' ALA . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 67' ' ' LYS . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 66' ' ' VAL . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.708 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.708 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 128' ' ' ILE . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.628 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.435 ' ND1' HD11 ' A' ' 118' ' ' ILE . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 107' ' ' ASN . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 106' ' ' VAL . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt . . . . . 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 120.81 0.254 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.435 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.3 p30 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.478 HG21 HG11 ' A' ' 95' ' ' VAL . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.809 0.337 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.481 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.513 ' CD ' ' H ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 176' ' ' ILE . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.557 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 157' ' ' ILE . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.412 ' N ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.581 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' LEU . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.028 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.412 ' N ' ' N ' ' A' ' 3' ' ' GLY . 59.5 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.726 0.298 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 25' ' ' LEU . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.458 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HG23 ' A' ' 62' ' ' ILE . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 66' ' ' VAL . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 128' ' ' ILE . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.412 ' N ' HG22 ' A' ' 98' ' ' ILE . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo . . . . . 0 N--CA 1.494 1.501 0 CA-C-O 120.827 0.261 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 ' CG1' ' A' ' 95' ' ' VAL . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.79 0.328 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.56 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.7 OUTLIER -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 73' ' ' LEU . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.457 HD21 ' CD ' ' A' ' 27' ' ' GLU . 1.3 t30 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CD ' HD21 ' A' ' 23' ' ' ASN . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.134 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.805 0.336 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 25' ' ' LEU . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.444 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 77' ' ' LEU . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.491 ' CG1' HG21 ' A' ' 128' ' ' ILE . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 122' ' ' LEU . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.589 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 107' ' ' ASN . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 106' ' ' VAL . 6.7 t-20 -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.842 0.268 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' ILE . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.491 HG21 ' CG1' ' A' ' 95' ' ' VAL . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 142' ' ' ALA . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.3 p90 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.948 0.404 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.502 HG12 HD21 ' A' ' 25' ' ' LEU . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 118' ' ' ILE . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.566 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo . . . . . 0 N--CA 1.491 1.366 0 N-CA-C 112.813 0.274 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.476 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HG11 ' A' ' 95' ' ' VAL . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.488 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 133' ' ' SER . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.646 0.26 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.7 p80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.472 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 14' ' ' VAL . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 14' ' ' VAL . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.7 m120 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.031 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.031 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.663 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.813 0.339 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG12 HD21 ' A' ' 25' ' ' LEU . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.427 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 128' ' ' ILE . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 118' ' ' ILE . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 102' ' ' ILE . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 120.861 0.275 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 119' ' ' ASN . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 HG11 ' A' ' 95' ' ' VAL . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.47 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 HD21 ' CD ' ' A' ' 27' ' ' GLU . 2.5 t30 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.461 ' CD ' HD21 ' A' ' 23' ' ' ASN . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.468 ' N ' ' N ' ' A' ' 3' ' ' GLY . 87.0 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.714 0.292 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' HH11 ' A' ' 57' ' ' ARG . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.444 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 147' ' ' PHE . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' A' ' 128' ' ' ILE . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.599 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 107' ' ' ASN . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 106' ' ' VAL . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo . . . . . 0 N--CA 1.491 1.372 0 CA-C-O 120.807 0.253 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.473 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.799 0.333 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 71' ' ' GLN . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.543 ' HG ' ' HG1' ' A' ' 167' ' ' THR . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.543 ' HG1' ' HG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 157' ' ' ILE . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 73' ' ' LEU . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.227 -0.119 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.52 ' H ' ' N ' ' A' ' 3' ' ' GLY . 80.7 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.744 0.307 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.449 HG12 HD21 ' A' ' 25' ' ' LEU . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 55' ' ' ALA . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.688 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.688 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG1' HG21 ' A' ' 128' ' ' ILE . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' HG23 ' A' ' 106' ' ' VAL . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.869 0.279 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 129' ' ' ALA . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' A' ' 123' ' ' LEU . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.711 HD22 ' H ' ' A' ' 126' ' ' ASN . 6.2 p-10 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.711 ' H ' HD22 ' A' ' 125' ' ' ASN . 24.8 m-20 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.552 ' CG ' HD21 ' A' ' 125' ' ' ASN . 30.2 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.493 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 171' ' ' HIS . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.407 ' CG ' HH21 ' A' ' 131' ' ' ARG . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.441 ' N ' ' N ' ' A' ' 38' ' ' SER . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 14' ' ' VAL . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLU . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.441 ' N ' ' N ' ' A' ' 3' ' ' GLY . 60.2 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.48 HG12 HD21 ' A' ' 25' ' ' LEU . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.48 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.515 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 8.1 m170 -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 128' ' ' ILE . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.515 ' OE2' ' CE1' ' A' ' 81' ' ' HIS . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 102' ' ' ILE . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 N--CA 1.498 1.742 0 CA-C-O 120.71 0.213 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 95' ' ' VAL . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.436 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.755 0.312 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 142' ' ' ALA . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.6 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.504 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 28.8 tp60 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' CYS . . . . . 0.427 ' C ' ' N ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.515 ' O ' ' O ' ' A' ' 3' ' ' GLY . 96.6 mttt -146.55 116.54 7.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.476 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.27 103.24 0.01 OUTLIER Glycine 0 N--CA 1.469 0.85 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -70.7 -41.84 77.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.252 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.5 mm -62.54 -45.53 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.172 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -67.75 -29.57 68.83 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -64.07 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.149 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.1 t -70.82 -31.41 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.409 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -68.81 -53.68 20.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.23 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.23 -32.63 1.32 Allowed 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.41 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -72.17 -29.46 64.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.169 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.581 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -54.23 7.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.012 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -57.91 -44.14 85.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.523 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.522 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.9 t -53.37 -28.07 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.797 0.332 . . . . 0.0 110.645 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.67 40.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.256 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -96.64 -50.63 4.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.51 4.76 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.79 -178.72 18.11 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -23.81 42.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.55 0.214 . . . . 0.0 111.187 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -62.83 -36.63 83.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.191 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.28 -39.03 78.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.092 0.472 . . . . 0.0 110.217 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.8 t-105 -65.94 -41.36 91.42 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.384 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -75.9 -26.53 57.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.098 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.13 -63.17 1.16 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.016 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -22.56 64.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.992 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.016 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.3 tp -70.77 -42.71 70.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.694 0.283 . . . . 0.0 110.333 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -29.13 66.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.6 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -76.94 -39.4 50.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.426 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -99.67 -1.33 38.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -75.38 150.74 85.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.763 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.55 -164.85 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -68.49 -43.52 76.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.513 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.91 -45.47 94.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.425 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 65.41 46.29 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.44 143.34 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.811 0.339 . . . . 0.0 110.555 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 p90 -114.43 112.01 22.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.86 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.7 t -105.4 138.45 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.88 0.371 . . . . 0.0 110.895 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.5 p -82.76 -29.54 29.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.594 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.44 63.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.64 -173.78 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.482 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 t -143.99 1.52 1.13 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.336 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.469 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 75.7 t80 -79.48 163.24 24.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.513 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 54.31 18.96 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.491 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.78 -24.3 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 m -63.57 -26.55 68.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 7.5 mp0 -54.79 -31.17 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.62 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.6 tp -58.69 -42.13 87.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -65.84 -45.64 81.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.9 p -61.04 -33.12 72.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.206 0.527 . . . . 0.0 110.096 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 25' ' ' LEU . 56.6 mt -74.92 -35.68 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.12 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.8 t -69.5 -38.49 76.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.244 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.03 -38.14 61.53 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.18 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.0 t70 -72.42 -56.44 5.43 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.676 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.72 -31.34 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.596 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.85 -33.52 72.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.612 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.9 mm-40 -66.61 -50.99 61.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.032 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.39 -42.15 79.49 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.293 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.8 mt -68.5 -10.08 53.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.721 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t30 60.76 60.2 1.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.392 0.615 . . . . 0.0 110.315 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 mtt -144.08 151.29 51.79 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.151 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.53 133.96 16.42 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.916 1.744 . . . . 0.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.1 tt -46.57 -35.68 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.276 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.24 -31.83 73.18 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.74 -34.84 24.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.61 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.2 t -66.82 -45.05 88.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.761 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.91 -38.27 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.853 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' N ' HG13 ' A' ' 66' ' ' VAL . 10.4 ttmm -64.62 -61.12 2.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.351 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.37 -38.31 52.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.624 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.88 -41.3 77.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.609 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.61 -54.97 19.75 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -43.05 -45.52 5.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.731 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.581 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.45 -40.25 57.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.188 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.9 tp -52.41 -41.38 63.14 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.594 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.0 t80 -63.76 -43.33 96.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.662 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -57.24 -54.17 49.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.22 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.06 95.33 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.717 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.5 mt -56.05 -54.19 47.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.799 0.333 . . . . 0.0 110.373 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.73 -39.37 8.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.735 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 p -65.52 -23.95 67.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.6 mmt-85 -94.24 -30.22 14.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.818 0.342 . . . . 0.0 110.674 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.4 27.88 8.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.539 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -45.41 -30.19 1.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -66.25 -46.08 78.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.164 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.22 -49.26 56.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.069 0.461 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.49 -51.93 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.681 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -50.06 -13.66 0.12 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.94 -12.35 59.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.055 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.7 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.39 -26.66 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.178 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 90.2 m-20 51.59 -14.91 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.7 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.9 p30 -162.03 139.11 8.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.988 0.423 . . . . 0.0 110.822 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -41.3 -37.22 0.93 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.62 -42.67 98.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.5 m -69.7 -28.39 65.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.6 tt -75.94 -57.59 3.79 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.757 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 128' ' ' ILE . 81.5 t -39.86 -48.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.286 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -76.04 -16.01 60.02 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.712 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.6 -1.06 55.4 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.282 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.2 mt -45.45 -89.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.913 0.356 . . . . 0.0 111.183 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 100' ' ' ASP . 11.4 p80 -42.69 -50.07 5.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.304 0.573 . . . . 0.0 110.796 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.4 ' N ' ' ND1' ' A' ' 99' ' ' HIS . 59.4 t0 -40.67 -100.19 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.5 m -77.33 -48.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.603 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.7 -42.53 61.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -92.09 -10.83 37.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.616 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 tt -85.11 -30.33 24.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.152 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -78.59 -43.94 25.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 102' ' ' ILE . 15.1 m -60.36 -32.78 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.879 0.371 . . . . 0.0 110.392 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.606 HD21 ' CD ' ' A' ' 113' ' ' PRO . 42.4 t30 -60.74 -45.59 93.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.929 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -73.12 -35.24 66.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.488 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 96.0 mt -74.38 -34.87 63.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.428 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 69.6 m-85 -158.07 176.5 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.57 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.7 m80 55.56 -163.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -150.89 153.69 33.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.193 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.606 ' CD ' HD21 ' A' ' 107' ' ' ASN . 85.3 Cg_exo -36.19 87.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.541 2.161 . . . . 0.0 112.39 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' GLU . 82.1 p -173.57 25.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.48 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 116' ' ' PRO . 26.6 mt -75.99 147.79 80.85 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.469 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 115' ' ' LEU . 93.2 Cg_exo -38.68 164.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.523 2.148 . . . . 0.0 112.376 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.97 113.69 25.25 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.4 mt -132.25 125.46 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.527 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.41 102.99 6.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.43 126.71 8.46 Favored Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -125.92 131.58 52.29 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.96 134.59 35.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.263 0.554 . . . . 0.0 111.268 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.68 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.987 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 61.8 Cg_endo -89.78 168.29 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.383 2.055 . . . . 0.0 112.18 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 68.38 25.08 7.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.149 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.98 46.02 2.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.379 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -121.91 148.28 44.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.463 HG21 HG11 ' A' ' 95' ' ' VAL . 48.0 mt -130.43 127.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.794 0.33 . . . . 0.0 110.803 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.89 111.25 23.53 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.37 113.86 26.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.897 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.687 HH21 ' CG ' ' A' ' 171' ' ' HIS . 60.0 ttt-85 -90.46 143.66 26.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.067 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 24.0 t80 -139.33 141.97 37.66 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.853 0.359 . . . . 0.0 110.782 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 p -162.75 136.56 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 2.2 p 172.94 132.42 0.1 Allowed Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.479 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.53 -36.97 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.179 1.919 . . . . 0.0 112.24 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 138' ' ' LEU . 92.3 mtt-85 -49.31 -19.57 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.772 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 37.03 24.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.138 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.7 tp -88.89 31.78 0.84 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 21.8 p -49.8 -38.87 36.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.646 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.458 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.94 -31.96 2.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.452 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.9 t -73.44 -41.65 62.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.66 -38.51 69.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.016 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.31 -51.54 68.44 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.103 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.31 -43.05 84.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.8 mt -57.84 -44.45 86.5 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.735 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.53 -39.62 88.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.315 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -72.68 -34.43 67.18 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.048 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.14 -44.48 97.68 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.27 -34.19 70.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.713 0.292 . . . . 0.0 110.768 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.75 -51.05 64.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.806 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 154' ' ' GLN . 24.8 tt0 -60.11 -50.11 74.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.081 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -41.23 -28.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.871 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.567 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.1 33.62 5.43 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.907 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.5 OUTLIER 38.2 44.38 0.67 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.065 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.5 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -118.32 111.49 18.81 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -83.67 139.84 32.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.061 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.4 pt -148.45 168.01 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -130.51 141.84 50.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.609 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.5 mt -122.17 127.96 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.188 0.518 . . . . 0.0 111.407 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.7 t -110.74 110.52 21.2 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.644 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -112.47 93.99 4.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.7 0.762 . . . . 0.0 110.821 -179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -95.92 -28.95 14.44 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.1 m -104.37 122.31 45.2 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 16.4 t -140.45 125.22 18.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 ttp -53.43 -18.43 2.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -73.23 -19.39 61.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.139 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.9 m -99.67 30.08 3.8 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.748 0.309 . . . . 0.0 111.093 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.24 -13.17 60.52 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.46 159.06 16.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.025 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.525 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 51.5 p30 -88.22 -13.18 41.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 110.281 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.687 ' CG ' HH21 ' A' ' 131' ' ' ARG . 70.6 m-70 -151.13 -159.98 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.298 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.7 m -144.35 157.3 44.33 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.525 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.2 ttp -134.65 111.09 9.73 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.494 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.28 114.99 25.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.24 119.35 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.41 106.21 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.783 0.325 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.03 131.01 34.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.829 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.48 129.82 42.52 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.437 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -82.16 137.8 34.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.788 0.328 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -112.03 11.71 20.55 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.515 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 59.0 t0 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.615 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 20.1 tptp -162.7 61.53 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.491 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.565 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 36.65 99.83 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -72.34 -39.45 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.982 0.42 . . . . 0.0 109.871 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -65.1 -43.81 95.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.209 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -68.8 -30.28 68.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.786 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -63.57 -44.06 95.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.81 -31.89 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -68.25 -53.76 22.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.308 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.517 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.0 tt0 -44.45 -32.92 1.52 Allowed 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.333 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -71.97 -29.25 64.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.113 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.2 -54.07 7.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 -179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.8 m -58.22 -44.23 87.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.47 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.5 t -53.53 -27.94 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.572 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.73 -16.81 40.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.331 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -96.65 -50.47 4.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.65 -16.32 4.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.55 -178.45 18.07 Favored Glycine 0 N--CA 1.473 1.153 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -26.53 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.544 0.211 . . . . 0.0 111.198 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.1 m -60.35 -36.59 78.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.173 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.508 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.11 -39.47 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.045 0.45 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.433 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.9 t-105 -65.78 -42.33 90.9 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.129 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.4 m120 -74.31 -28.25 61.09 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.839 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.04 -63.17 1.11 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.987 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.023 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.45 -20.65 64.64 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.844 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.023 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.5 tp -72.92 -39.1 66.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -76.17 -32.87 59.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.41 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' NZ ' ' CE1' ' A' ' 29' ' ' HIS . 26.1 ttpp -74.18 -43.9 55.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.54 ' CE1' ' NZ ' ' A' ' 28' ' ' LYS . 77.4 m80 -87.8 2.21 51.92 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.591 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.62 154.56 73.33 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' ALA . 83.7 Cg_exo -44.35 179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.421 2.081 . . . . 0.0 112.513 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -45.3 -53.46 8.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.25 75.89 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.046 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -90.11 148.45 23.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.021 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.75 141.98 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.912 0.387 . . . . 0.0 110.867 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.1 p90 -95.17 115.96 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.685 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' GLY . 10.5 t -102.11 142.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.995 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.565 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.6 p -77.94 -34.89 50.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.622 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -68.97 -42.8 76.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.526 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 42' ' ' TYR . 18.7 mmmt -73.24 -55.31 6.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.196 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.1 t 48.1 12.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.84 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' H ' ' C ' ' A' ' 40' ' ' LYS . 64.9 t80 -68.23 -33.09 73.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.585 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.47 16.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.478 ' CD ' HH12 ' A' ' 136' ' ' ARG . 13.6 tm-20 -50.82 -31.18 16.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.0 p -59.6 -36.39 76.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.746 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.88 -30.15 71.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.31 -42.75 82.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.408 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -65.05 -50.24 66.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.525 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.1 m -55.55 -34.17 64.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.15 0.5 . . . . 0.0 109.942 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.492 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -74.94 -35.17 34.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.227 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.28 -38.89 75.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.265 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -74.31 -38.09 63.44 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.23 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.7 t70 -72.15 -56.93 4.74 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.02 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.858 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.96 -33.83 72.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.583 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.7 mt-30 -66.33 -50.14 64.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.086 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -69.45 -41.22 76.54 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.31 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' CD1' HG22 ' A' ' 54' ' ' VAL . 80.8 mt -69.39 -10.04 56.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.0 t30 61.68 55.6 2.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.484 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 11.0 mtm -139.86 150.79 63.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.025 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.37 133.77 18.06 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.864 1.709 . . . . 0.0 111.104 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -45.49 -36.02 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.218 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -65.15 -31.61 72.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.924 -0.311 . . . . 0.0 111.795 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.0 t0 -83.17 -35.53 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.639 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -66.74 -44.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -62.03 -37.99 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.838 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.0 ttmt -64.78 -60.93 2.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.402 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.1 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.729 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.71 -42.67 79.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.48 -54.03 28.69 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -43.62 -48.15 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 0.0 110.944 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.4 t80 -73.31 -41.0 64.05 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.32 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.1 tp -50.77 -40.52 55.15 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.463 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -63.79 -44.08 94.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.683 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -57.11 -52.86 63.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.357 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.83 -43.81 93.23 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.777 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 77' ' ' LEU . 22.9 mt -56.22 -53.71 53.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.828 0.346 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.66 -39.16 7.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 t -66.5 -24.01 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -93.99 -30.79 14.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.717 0.294 . . . . 0.0 110.633 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.37 29.71 7.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -45.99 -39.26 8.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 56.3 t0 -58.93 -39.26 81.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.408 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.77 -46.55 41.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.087 0.47 . . . . 0.0 110.357 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.06 -50.62 78.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.584 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -47.91 -12.46 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -71.85 -10.98 60.56 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.528 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -93.75 -26.24 17.07 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 89.8 m-20 51.06 -14.25 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.2 m-20 -162.36 138.57 7.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.928 0.394 . . . . 0.0 110.832 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -40.94 -35.6 0.54 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.477 ' O ' ' CE ' ' A' ' 96' ' ' MET . 58.9 m -64.92 -46.05 83.27 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.889 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -65.28 -29.52 70.3 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.2 tt -76.64 -55.93 5.07 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.737 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG11 HG21 ' A' ' 128' ' ' ILE . 38.8 t -36.66 -53.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.503 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.509 ' SD ' HD13 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -78.99 -12.32 60.03 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.519 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -94.64 -5.79 61.29 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.444 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.8 mt -45.38 -87.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.003 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.401 ' N ' HG22 ' A' ' 98' ' ' ILE . 81.6 t60 -42.82 -51.55 5.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.434 0.635 . . . . 0.0 110.741 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -41.08 -100.96 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -75.72 -47.85 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.582 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -55.73 -48.41 77.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -86.02 -7.1 58.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.56 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.93 -31.05 19.63 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.242 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -79.31 -27.53 42.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.5 m -79.05 -26.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.175 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.6 t-20 -66.55 -47.69 72.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.496 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -24.91 61.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.884 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.35 -33.41 72.38 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.518 ' CZ ' ' OE2' ' A' ' 112' ' ' GLU . 30.7 p90 -157.34 149.48 22.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.325 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -77.58 145.65 36.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.933 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' OE2' ' CZ ' ' A' ' 110' ' ' TYR . 4.3 pt-20 -170.88 151.22 3.26 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.261 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -38.11 -72.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.403 2.069 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 77.0 p -168.5 157.59 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.503 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD21 ' OE2' ' A' ' 112' ' ' GLU . 89.5 mt -94.5 148.51 35.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.531 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -40.22 162.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.249 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -98.38 124.07 42.85 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.2 mt -145.23 128.31 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.767 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -129.97 106.54 8.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.13 126.57 8.38 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -126.13 131.34 52.08 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -82.5 133.95 35.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.148 0.499 . . . . 0.0 111.341 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -112.28 154.4 44.45 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.252 179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.79 167.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.818 1.679 . . . . 0.0 111.198 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 63.47 -128.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.19 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -131.55 54.55 1.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.665 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -126.06 146.62 49.83 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.814 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 95' ' ' VAL . 32.2 mt -128.7 127.86 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.721 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.496 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.34 108.63 21.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -107.01 111.75 24.38 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.54 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -88.99 143.7 26.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.248 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 133' ' ' SER . 34.4 t80 -140.08 153.28 46.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.584 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 6.2 p -160.21 134.98 7.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 p -174.32 133.85 0.55 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.486 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.65 -56.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 122.372 2.048 . . . . 0.0 113.359 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.478 HH12 ' CD ' ' A' ' 44' ' ' GLU . 67.0 ttp85 -82.29 -46.58 13.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -61.01 152.58 27.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.909 0.385 . . . . 0.0 111.01 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.2 mt -103.71 130.49 51.21 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 164' ' ' CYS . 2.6 p -68.96 -32.01 71.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.541 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -33.39 5.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.365 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.4 t -74.61 -43.26 56.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.303 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.95 -40.69 70.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.403 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -59.53 -48.2 82.58 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.392 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.15 -45.99 56.87 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.3 mt -55.48 -43.58 75.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 110.934 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -73.4 -35.15 65.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.088 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.29 -40.72 94.38 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.46 -26.92 55.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 110.617 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.41 -53.49 35.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -62.79 -46.54 87.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.225 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.98 -29.56 0.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.962 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -119.5 29.72 7.47 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.087 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 39.15 42.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.234 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -114.0 87.7 2.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.026 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -61.0 139.21 58.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.204 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.5 pt -149.37 168.63 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.741 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -130.96 140.15 50.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.718 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.58 128.24 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.1 0.476 . . . . 0.0 111.367 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 m -108.6 102.23 11.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.715 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.575 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.8 t-160 -105.44 84.4 2.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.963 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.25 -34.49 14.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.536 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.4 m -98.79 122.61 42.25 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 139' ' ' CYS . 11.5 t -144.25 135.98 25.97 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 111.148 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.2 tpt -55.09 -23.46 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.217 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -66.19 -19.03 65.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -101.14 22.28 12.59 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.761 0.315 . . . . 0.0 111.05 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.41 -17.55 47.65 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -53.84 150.89 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -83.42 -0.39 49.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.848 0.356 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -163.94 -170.65 2.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.264 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.0 m -136.11 158.3 44.74 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -135.28 110.76 9.13 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.743 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.575 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.4 mp -115.77 114.5 24.87 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.2 mm -103.21 118.22 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 104.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 120.867 0.365 . . . . 0.0 110.85 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -85.21 129.59 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.821 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.3 mt -94.02 126.04 39.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.378 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -84.8 145.48 27.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.415 . . . . 0.0 110.728 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 180' ' ' ASN . 53.2 t-20 -41.24 -37.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.833 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.586 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.426 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' H2 ' ' HG ' ' A' ' 38' ' ' SER . 69.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 60.2 mttp 54.64 70.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 36.06 100.05 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -73.42 -41.86 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.875 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.7 mm -60.66 -47.89 91.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.141 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -65.56 -29.82 70.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.53 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -64.49 -47.37 79.19 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.9 t -68.82 -29.47 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.249 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.8 tp -69.48 -53.38 19.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.192 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.1 tt0 -44.37 -28.28 0.53 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.048 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -73.06 -34.18 66.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.544 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.0 mtt -71.3 -53.72 13.28 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.9 m -57.91 -45.46 87.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 10' ' ' GLU . 36.4 t -52.15 -27.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.86 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.8 -16.51 38.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.328 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -95.03 -50.74 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.37 -14.65 4.74 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.88 -177.22 17.71 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -25.74 39.52 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.489 0.185 . . . . 0.0 111.218 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -61.48 -35.3 77.27 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.163 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.8 p -69.71 -40.23 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 0.0 110.267 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.3 t-105 -65.38 -42.88 92.24 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.107 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -28.28 61.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.82 -63.11 1.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.988 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.92 -20.07 64.21 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.784 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 35.3 tp -73.11 -39.92 65.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.89 0.376 . . . . 0.0 110.033 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -76.22 -32.56 59.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.405 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -73.4 -43.49 60.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.13 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -88.31 2.78 51.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.658 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -136.88 152.76 74.74 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.588 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' ALA . 86.7 Cg_exo -43.94 178.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.461 2.107 . . . . 0.0 112.55 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -48.77 -53.15 20.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.144 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 51.3 p30 -145.83 74.81 1.4 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.02 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -91.4 149.78 21.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.054 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.3 m -113.61 133.65 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.898 0.38 . . . . 0.0 110.832 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -88.1 118.88 27.97 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -102.62 143.6 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.331 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HG ' ' H2 ' ' A' ' 1' ' ' MET . 85.0 p -84.15 -33.8 24.18 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.22 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.02 81.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.236 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -80.16 -171.8 3.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.98 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -159.96 0.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.823 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -66.67 -33.07 74.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.831 0.348 . . . . 0.0 110.809 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.57 -16.39 63.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' OE2' ' O1D' ' A' ' 182' ' ' HEM . 96.3 mt-10 -46.69 -35.87 6.52 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.465 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.9 m -57.6 -36.1 71.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.542 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.84 -27.6 63.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.738 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.1 tp -57.43 -47.25 82.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.587 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -61.61 -47.15 86.74 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.477 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.3 p -58.05 -34.38 70.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.13 0.49 . . . . 0.0 109.997 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG12 HD21 ' A' ' 25' ' ' LEU . 57.5 mt -74.78 -33.64 31.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.123 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 47' ' ' LEU . 53.2 t -71.38 -38.71 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.276 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -74.43 -38.01 63.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.1 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.6 t70 -72.14 -56.98 4.64 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.738 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.58 -31.91 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.052 0.453 . . . . 0.0 109.841 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.33 -33.76 73.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.611 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 53' ' ' ASP . 15.0 mm100 -66.81 -49.95 64.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.113 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -69.27 -40.58 77.7 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.287 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 82.7 mt -70.37 -9.69 56.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 61.93 53.91 2.95 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.104 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.5 mtm -137.91 150.69 68.38 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.911 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.21 133.4 17.8 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.843 1.695 . . . . 0.0 111.147 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 tt -45.03 -36.3 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.241 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.99 -32.48 74.22 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.4 -34.72 28.2 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.637 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 82.7 t -67.43 -45.47 85.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.906 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -61.8 -37.25 77.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.873 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.9 ttmt -65.6 -61.54 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.19 -37.76 48.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.97 -42.68 76.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.13 97.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.665 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -57.18 -48.57 78.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.722 0.296 . . . . 0.0 111.112 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.79 -40.49 65.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.042 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.03 -42.4 65.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.777 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 42.7 t80 -63.31 -42.32 99.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.777 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -57.45 -54.45 46.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.84 -42.88 92.71 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.821 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 80' ' ' ARG . 52.9 mt -57.7 -52.34 65.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.781 0.324 . . . . 0.0 110.571 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.08 -38.19 7.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.364 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -63.07 -26.41 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' LEU . 30.6 mmm-85 -90.9 -30.86 16.66 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.4 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.422 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 14.7 m80 -116.02 27.45 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.483 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -49.91 -37.39 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.911 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.81 -45.11 95.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -72.08 -48.53 49.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.087 0.47 . . . . 0.0 110.506 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 87' ' ' LYS . 86.7 t -59.74 -51.84 68.04 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.328 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.8 t0 -50.19 -7.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 85' ' ' VAL . 24.6 mtpp -74.98 -11.47 60.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.02 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.71 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.89 -26.91 19.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.919 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 77.0 m-20 51.39 -14.32 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.858 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.71 ' H ' ' C ' ' A' ' 88' ' ' PHE . 21.4 p30 -162.51 139.62 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.995 0.426 . . . . 0.0 110.775 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.51 -35.79 0.77 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.5 m -64.61 -43.47 93.68 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.617 -0.433 . . . . 0.0 112.147 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.8 m -68.4 -29.42 68.1 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.1 tt -75.03 -59.47 2.73 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.693 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 128' ' ' ILE . 99.5 t -41.79 -43.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.081 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 96' ' ' MET . 18.3 tmm? -79.36 -18.79 51.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.317 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.32 1.18 57.26 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.356 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.9 mt -45.36 -87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.871 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 13.8 p-80 -42.31 -52.15 4.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.225 0.536 . . . . 0.0 110.765 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.521 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 73.1 m-20 -38.62 -103.35 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.489 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.6 m -77.21 -46.67 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.0 mt -54.16 -47.37 67.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -90.72 -7.79 51.59 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.455 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.04 -31.23 20.64 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' O ' HD23 ' A' ' 109' ' ' LEU . 48.0 tp10 -80.01 -37.69 33.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.162 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 102' ' ' ILE . 6.1 m -72.63 -24.12 21.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.394 . . . . 0.0 110.465 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 110' ' ' TYR . 28.8 t30 -71.52 -45.27 62.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.563 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -70.42 -25.12 63.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -49.85 -34.67 20.67 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.093 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.617 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 63.2 t80 -154.77 176.44 12.46 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.511 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.617 ' N ' ' CD2' ' A' ' 110' ' ' TYR . 32.3 m80 -57.75 -154.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.546 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 61.05 63.81 2.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.582 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.51 69.5 5.91 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.623 2.216 . . . . 0.0 112.063 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.5 t -168.95 121.73 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.437 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.9 mt -133.12 152.27 79.32 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 96.2 Cg_exo -37.01 159.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.694 2.263 . . . . 0.0 112.226 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -96.65 121.23 38.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.523 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.06 136.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.524 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -132.72 109.57 9.78 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.52 129.14 9.61 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -129.13 131.42 47.21 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.21 132.68 35.36 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.995 0.426 . . . . 0.0 110.569 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -110.84 155.69 41.94 Favored Pre-proline 0 N--CA 1.47 0.528 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.83 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.5 Cg_exo -41.62 168.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.955 1.77 . . . . 0.0 111.513 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.4 -126.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.192 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -133.53 55.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.558 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.05 148.35 49.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.681 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.415 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.0 mt -130.37 126.36 61.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.506 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.3 109.78 21.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.3 106.37 16.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.767 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -85.65 145.23 27.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -144.23 150.56 38.15 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.567 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 134' ' ' SER . 12.2 t -175.2 147.64 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.0 110.573 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER 167.43 154.09 0.11 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.156 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.63 -27.52 32.29 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.32 2.013 . . . . 0.0 111.828 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -72.39 -14.8 61.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.497 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 48.7 mtp85 55.14 -111.65 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.683 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 55.07 11.14 0.47 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.123 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.0 t -46.23 -32.12 2.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.81 -32.71 73.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.281 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.91 -37.45 84.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.55 83.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.98 -53.96 50.85 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.603 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.62 -41.03 80.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.1 mt -58.82 -45.24 90.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.787 0.327 . . . . 0.0 110.44 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.33 -40.25 93.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.229 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -70.26 -35.2 73.61 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.937 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.21 -40.15 93.39 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.24 -27.51 56.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.1 -53.09 42.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -62.58 -45.98 90.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.48 . . . . 0.0 110.12 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -44.04 -29.34 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.93 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -118.58 27.52 8.88 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.002 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 39.95 44.83 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.06 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -116.73 88.88 2.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.169 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -60.17 138.06 57.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.173 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.6 pt -147.94 167.46 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.98 142.65 50.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.646 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.27 129.39 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.147 0.499 . . . . 0.0 111.406 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.9 t -109.11 111.12 22.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.736 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.628 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 15.4 t-160 -112.79 84.86 2.06 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.826 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -92.96 -36.13 12.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 5.8 m -91.81 121.18 33.2 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.907 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 43.3 t -137.43 130.62 30.79 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 111.072 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 16.2 ttt -54.64 -30.6 55.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.924 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -58.89 -16.6 18.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.215 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.0 21.62 14.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.797 0.332 . . . . 0.0 110.742 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.15 -16.04 59.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.26 154.0 8.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 56.1 t0 -90.19 8.66 31.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.909 0.385 . . . . 0.0 110.477 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -171.13 -166.32 0.46 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.628 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 53.2 t -138.23 158.57 44.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.073 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.411 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 40.9 ttm -133.95 109.66 9.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.611 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 8.1 mp -115.75 113.46 23.48 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.9 mm -102.17 118.92 49.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.82 105.33 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.915 0.388 . . . . 0.0 110.883 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -86.19 130.3 34.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.841 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -94.81 127.61 40.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.419 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -78.04 137.49 38.29 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.454 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.2 p-10 -110.98 11.65 22.16 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.498 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.586 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.47 ' O2A' ' CG ' ' A' ' 116' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' O ' ' O ' ' A' ' 3' ' ' GLY . 34.3 ttpt -84.08 108.69 17.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.528 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.26 101.52 0.01 OUTLIER Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.564 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -83.24 -46.39 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.06 -42.62 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.008 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.71 -28.65 67.02 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.585 ' ND2' HH21 ' A' ' 80' ' ' ARG . 49.5 t-20 -64.28 -44.79 90.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.769 0.319 . . . . 0.0 111.107 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.9 t -72.24 -30.8 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.648 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.4 tp -69.61 -53.84 16.86 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.339 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.8 -32.43 1.55 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.021 0.438 . . . . 0.0 110.291 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.1 -29.3 63.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.147 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.589 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.88 -54.42 7.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.014 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.5 m -58.03 -44.29 86.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.574 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.524 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.3 t -53.33 -27.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.95 -16.65 40.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.232 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -96.5 -50.63 4.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.83 -15.64 4.84 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -177.9 17.85 Favored Glycine 0 N--CA 1.473 1.165 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -24.07 39.95 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.514 0.197 . . . . 0.0 111.196 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.78 -36.2 82.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.225 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.19 -40.22 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 110.135 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.448 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.5 t-105 -65.25 -42.56 93.16 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.129 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -74.1 -28.1 61.2 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.17 -63.36 1.08 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.954 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.036 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.41 -20.07 64.64 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.812 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.036 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.1 tp -73.66 -39.77 64.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.49 -32.99 60.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -73.36 -43.04 61.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.438 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 60.6 m-70 -89.6 3.02 53.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.718 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -143.33 148.78 45.6 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.29 -159.93 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.572 2.181 . . . . 0.0 111.887 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -57.3 -46.34 83.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.45 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' VAL . 91.9 m-20 -77.81 51.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.496 ' NH1' HD23 ' A' ' 26' ' ' LEU . 36.4 ptt85 -72.33 15.28 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.04 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 m -84.18 125.32 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.773 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -89.02 121.92 31.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -102.54 126.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.743 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 110' ' ' TYR . 23.2 p -63.88 -31.77 73.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.164 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.62 -38.54 80.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.355 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -84.29 -174.37 5.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.075 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' A' ' 44' ' ' GLU . 7.3 t -160.98 7.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.855 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -66.95 -38.92 87.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.593 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.09 19.27 2.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.726 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' A' ' 41' ' ' SER . 20.2 pt-20 -68.64 -36.96 79.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.687 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -65.05 -30.93 71.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -58.48 -27.9 64.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.754 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -57.21 -41.56 79.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.37 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -66.05 -49.21 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.493 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.6 t -56.76 -33.88 67.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.174 0.512 . . . . 0.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 25' ' ' LEU . 62.2 mt -74.78 -35.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.083 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 47' ' ' LEU . 38.8 t -70.02 -38.56 75.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.198 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -75.18 -38.72 60.7 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.998 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 41.2 t0 -71.28 -56.9 5.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.68 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.69 -31.29 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.564 -0.455 . . . . 0.0 109.873 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.71 -33.46 72.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.2 mm-40 -66.41 -51.11 60.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.026 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.7 ptm180 -68.29 -41.8 80.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.0 mt -68.91 -9.88 54.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.057 0.456 . . . . 0.0 109.791 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 60.41 59.87 2.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.329 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.2 mtt -143.6 151.05 52.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.148 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 133.33 16.18 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.85 1.7 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -45.97 -35.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.24 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.17 -31.81 73.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.735 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -83.54 -35.12 25.03 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.579 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 91.7 t -66.53 -44.6 90.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -62.23 -38.15 80.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' N ' HG13 ' A' ' 66' ' ' VAL . 23.9 ttmt -64.24 -61.32 2.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.3 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.69 -37.56 51.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.668 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -56.92 -43.66 81.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.827 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.49 -55.7 19.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -42.19 -47.04 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.1 t80 -74.75 -39.84 61.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.288 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.2 tp -53.12 -41.87 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.592 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.0 t80 -63.44 -45.5 90.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.03 -56.11 20.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.199 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.92 96.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.97 -56.76 17.59 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.777 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.05 -36.32 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.436 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 51.5 p -69.45 -21.89 63.69 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.81 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.585 HH21 ' ND2' ' A' ' 7' ' ' ASN . 49.0 mmt-85 -85.69 -34.02 21.39 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.211 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' CE1' HMC3 ' A' ' 182' ' ' HEM . 0.3 OUTLIER -128.39 35.98 4.33 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -42.84 -39.96 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.77 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.46 -40.15 77.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.53 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.3 -47.6 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.1 t -64.03 -51.63 66.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.581 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -46.01 -7.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.8 mtpp -80.02 -11.62 59.77 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.573 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.711 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -92.27 -28.43 16.99 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.699 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 25.0 t70 50.96 -13.82 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.877 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.711 ' H ' ' C ' ' A' ' 88' ' ' PHE . 61.9 m-20 -162.38 138.06 7.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.088 0.47 . . . . 0.0 110.683 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.9 t80 -40.49 -34.28 0.34 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -65.15 -42.28 93.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -70.5 -29.4 65.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.2 tt -75.64 -56.55 4.58 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.898 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG1' HG21 ' A' ' 128' ' ' ILE . 71.3 t -41.63 -43.7 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.904 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.5 ptm -79.45 -15.62 57.48 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.173 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.62 0.05 57.97 Favored Glycine 0 N--CA 1.473 1.109 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.009 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.35 -88.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.865 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -42.58 -50.36 5.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.305 0.574 . . . . 0.0 110.814 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -40.27 -100.73 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.548 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -77.84 -47.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.4 mt -54.56 -44.44 68.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.24 -9.86 43.67 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.718 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.19 -31.76 21.59 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.511 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -78.03 -47.21 18.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.686 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' TYR . 15.6 m -56.8 -36.9 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 110' ' ' TYR . 38.5 t30 -54.73 -45.76 74.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.836 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -72.09 -32.62 67.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 70.9 mt -83.39 -13.89 53.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 38' ' ' SER . 12.4 t80 -144.58 123.97 13.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 110' ' ' TYR . 56.4 m80 -57.88 -154.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.389 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 57.82 78.43 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.29 -166.9 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.387 2.058 . . . . 0.0 111.945 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 m 62.67 56.77 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.4 mt -69.49 152.79 96.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.316 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' A' ' 115' ' ' LEU . 65.6 Cg_exo -35.18 157.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.147 0 C-N-CA 122.696 2.264 . . . . 0.0 112.405 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -89.99 119.61 30.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.675 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -147.26 129.98 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.458 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -133.25 110.24 9.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.161 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.29 128.14 9.26 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -127.41 130.92 50.22 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.39 132.72 35.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.018 0.437 . . . . 0.0 110.75 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.7 OUTLIER -111.0 155.88 41.77 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.737 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.7 Cg_exo -41.88 168.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.02 1.813 . . . . 0.0 111.527 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 60.15 -126.28 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -133.48 55.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.611 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -126.21 147.9 49.57 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.41 HG21 ' CG1' ' A' ' 95' ' ' VAL . 56.2 mt -130.31 126.57 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -96.36 111.2 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 tp -107.91 109.35 20.84 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.573 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -87.42 144.98 26.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.036 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.525 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 7.5 t80 -139.36 150.2 45.05 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.501 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.429 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 1.9 p -165.96 138.69 4.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.408 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.493 ' O ' ' SD ' ' A' ' 165' ' ' MET . 1.4 t 171.48 150.72 0.19 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.47 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.93 -50.18 0.35 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.515 2.143 . . . . 0.0 112.041 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ttm105 -53.03 -22.06 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.411 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 60.26 -103.57 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.789 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 138' ' ' LEU . 87.7 mt 52.13 15.76 0.47 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.904 0.383 . . . . 0.0 110.524 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 6.1 m -46.28 -35.74 5.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.583 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.5 -30.61 3.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.222 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.3 t -75.27 -43.14 52.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.383 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.29 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.311 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.66 -48.24 82.43 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.284 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.38 -45.82 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.25 -45.23 76.06 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.4 mt -58.04 -41.95 84.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 151' ' ' GLN . 62.9 m-85 -71.35 -33.66 69.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.669 0.271 . . . . 0.0 111.138 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -73.24 -32.64 64.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.705 0.288 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.7 -50.97 62.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.894 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 147' ' ' PHE . 1.6 mp0 -62.46 -49.01 77.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.062 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -40.03 -28.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.84 37.05 3.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.794 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLN . 90.9 mt-30 36.97 44.63 0.38 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.257 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.456 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.9 tp60 -119.01 111.86 18.84 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.066 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -83.92 140.73 31.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.808 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.56 168.44 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.081 0.467 . . . . 0.0 111.244 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -131.83 143.43 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.344 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 47.6 mt -123.08 129.14 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.117 0.484 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -109.27 101.86 10.84 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.845 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.548 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.0 t-160 -104.79 82.35 1.87 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.614 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -90.44 -34.66 15.53 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.63 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.71 120.52 36.11 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.06 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 166' ' ' HIS . 25.9 p -144.44 124.2 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.644 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 134' ' ' SER . 22.9 ptm -50.3 -10.62 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 15.1 t-80 -71.64 -20.16 62.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.766 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.481 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -101.85 21.27 14.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.799 0.333 . . . . 0.0 110.794 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.48 -13.02 67.25 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.14 158.16 7.3 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.108 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.43 -2.27 57.33 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 110.401 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -160.02 -164.83 1.36 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.306 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 30.1 m -141.27 157.12 45.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.39 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 36.0 ttm -134.69 113.84 12.1 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.548 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.4 mp -117.24 111.87 20.01 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -101.25 118.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.83 105.61 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 120.825 0.345 . . . . 0.0 110.886 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -86.57 128.94 35.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.34 129.09 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -79.65 136.57 36.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.367 . . . . 0.0 110.403 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -110.11 11.83 23.67 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.571 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.481 ' CAC' HG11 ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' H ' ' A' ' 39' ' ' ALA . 7.1 mmt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 49.6 mtpt -141.85 63.77 1.41 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.741 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.12 99.1 0.01 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.8 tp -74.5 -44.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.294 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -60.6 -44.86 97.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.33 -29.22 68.72 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.432 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -66.16 -50.42 64.0 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.49 -30.44 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.367 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.1 tp -69.11 -53.32 20.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.293 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 14' ' ' VAL . 87.7 tt0 -44.41 -28.1 0.52 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.185 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -73.35 -34.74 65.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.501 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.7 mtt -71.14 -53.38 14.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.0 m -58.98 -45.56 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.232 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.1 t -51.81 -26.94 7.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.851 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.48 -16.36 39.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.379 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -95.08 -50.86 4.89 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.74 -15.11 4.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.72 17.71 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.596 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.23 -24.84 42.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.558 0.218 . . . . 0.0 111.181 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 19.6 t -61.99 -36.02 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.116 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.656 ' CG2' ' HE ' ' A' ' 57' ' ' ARG . 1.4 p -69.33 -39.33 78.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.043 0.449 . . . . 0.0 110.313 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.67 -34.86 79.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.273 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 3.2 m120 -82.26 -26.35 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.763 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -71.16 -63.47 1.1 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.024 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -65.87 -24.77 66.93 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.791 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.024 ' N ' HD13 ' A' ' 25' ' ' LEU . 58.8 tp -71.14 -38.51 72.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HE ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -74.05 -34.57 64.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.972 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -74.65 -43.96 52.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -83.89 2.08 40.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.559 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -132.12 147.27 65.13 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.539 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.0 -170.06 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.461 2.107 . . . . 0.0 112.09 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -59.73 -35.37 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' ARG . 81.2 m-20 -50.95 -55.67 16.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.403 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.539 ' HE ' ' CD ' ' A' ' 27' ' ' GLU . 69.0 ttt-85 40.74 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.861 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 37' ' ' VAL . 7.3 p -149.91 139.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.287 0.565 . . . . 0.0 110.942 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -117.24 91.8 3.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.375 179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.4 t -108.9 133.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.796 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.741 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.7 p -79.03 -34.8 43.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.595 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.43 ' H ' ' N ' ' A' ' 1' ' ' MET . . . -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.73 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 42' ' ' TYR . 4.0 mmmm -64.89 -54.56 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.517 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 m 57.46 5.94 0.35 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 40' ' ' LYS . 66.1 t80 -70.17 -33.8 72.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.385 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.97 -4.37 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.756 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -46.37 -31.06 2.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.415 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.3 p -58.34 -33.48 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 0.0 110.352 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -68.23 -24.9 64.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.609 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.19 -44.75 71.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.81 -51.58 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.727 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -54.54 -33.72 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 109.925 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.467 HG12 HD21 ' A' ' 25' ' ' LEU . 63.3 mt -74.74 -35.5 37.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.121 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.65 -39.06 77.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -74.7 -38.18 62.43 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.136 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.2 t70 -71.99 -56.81 5.0 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.776 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.76 -32.0 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.569 -0.453 . . . . 0.0 109.831 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.43 -33.88 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.635 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.69 -50.82 61.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.166 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.656 ' HE ' ' CG2' ' A' ' 21' ' ' VAL . 5.6 ptm85 -68.29 -42.23 79.8 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.284 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.6 -9.3 48.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.55 59.29 2.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.211 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.459 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.5 mtp -142.62 150.41 53.99 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.062 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.17 133.66 16.61 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.896 1.731 . . . . 0.0 111.038 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.2 tt -46.74 -35.6 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.197 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.12 -31.91 73.35 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -84.12 -34.71 24.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.642 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 92.4 t -66.42 -45.29 89.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -61.5 -38.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.009 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.7 ttmt -64.47 -60.8 2.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.498 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.34 -38.69 54.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.24 -42.32 77.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.805 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.47 -36.56 93.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.709 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.17 -48.17 82.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.635 -0.333 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.16 -41.34 64.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.035 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -49.68 -43.7 47.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.006 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.653 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.3 t80 -63.36 -42.97 98.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.05 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -56.6 -46.01 81.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.483 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.82 -45.13 35.37 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.824 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 80' ' ' ARG . 24.3 mt -56.33 -51.81 66.88 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.405 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.87 -39.22 11.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.322 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -66.16 -25.03 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 20.3 mmm180 -90.82 -32.8 15.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.534 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 1.9 m80 -119.19 31.16 6.76 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.482 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -49.32 -33.56 13.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.81 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.15 -45.61 87.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.2 t -71.14 -48.48 54.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.002 0.429 . . . . 0.0 110.627 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.58 -51.59 71.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.577 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.9 t0 -50.65 -9.19 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -72.08 -11.68 60.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.964 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.704 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.54 -27.24 19.29 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.016 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 86.1 m-20 51.83 -15.27 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.868 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.704 ' H ' ' C ' ' A' ' 88' ' ' PHE . 65.2 m-20 -160.94 138.86 9.51 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.01 0.433 . . . . 0.0 110.689 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -41.83 -37.51 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.6 m -63.61 -42.23 98.23 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.721 -0.391 . . . . 0.0 112.01 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.6 m -69.72 -27.75 65.24 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -76.68 -57.43 3.86 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.731 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 128' ' ' ILE . 92.2 t -40.55 -46.83 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.295 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -77.65 -16.01 58.81 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.538 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -100.12 -0.53 55.99 Favored Glycine 0 N--CA 1.474 1.229 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.029 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.1 mt -45.63 -87.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.994 0.397 . . . . 0.0 110.902 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -42.32 -52.32 4.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.332 0.587 . . . . 0.0 110.718 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -38.7 -102.54 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.537 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.555 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.16 -47.16 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.555 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.37 -50.65 63.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -88.85 -4.78 58.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.935 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -86.05 -29.86 23.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.035 0.445 . . . . 0.0 109.81 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -77.59 -41.35 39.06 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.973 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 107' ' ' ASN . 12.3 m -63.04 -40.13 87.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.961 0.41 . . . . 0.0 110.439 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' N ' HG23 ' A' ' 106' ' ' VAL . 49.9 t-20 -54.79 -41.5 70.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.954 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -71.92 -31.84 66.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.965 0.412 . . . . 0.0 110.39 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.58 -34.58 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 107' ' ' ASN . 16.2 m-85 -101.17 147.91 25.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -85.28 88.17 7.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 114' ' ' SER . 7.9 pt-20 -179.19 70.3 0.19 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' HD21 ' A' ' 107' ' ' ASN . 31.5 Cg_exo -57.21 68.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.949 2.433 . . . . 0.0 112.253 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 112' ' ' GLU . 2.0 t 171.97 122.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -133.42 150.86 76.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 115' ' ' LEU . 57.9 Cg_exo -37.5 169.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 123.081 2.521 . . . . 0.0 112.945 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -97.39 123.54 41.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.99 132.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.0 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -139.5 122.75 17.0 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 111.616 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.7 128.74 9.65 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -125.55 133.64 52.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.63 133.95 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 111.068 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.472 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.71 -177.79 0.47 Allowed Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.47 -0.786 . . . . 0.0 108.909 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.4 Cg_endo -89.23 168.48 5.23 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.25 1.967 . . . . 0.0 112.257 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 125' ' ' ASN . 1.4 m-20 67.9 24.53 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.8 OUTLIER 65.38 47.04 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.419 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -122.87 149.24 44.46 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 95' ' ' VAL . 48.4 mt -130.42 126.31 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.79 0.329 . . . . 0.0 110.833 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.82 109.91 22.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.77 110.17 20.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.13 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.2 ttt180 -86.82 143.82 27.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.552 ' CE1' HMA3 ' A' ' 182' ' ' HEM . 78.7 t80 -141.34 148.31 39.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.93 0.395 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 134' ' ' SER . 0.8 OUTLIER -159.87 134.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 132' ' ' TYR . 1.5 m -168.53 135.39 1.62 Allowed Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 -54.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.308 2.005 . . . . 0.0 112.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -82.33 -46.64 13.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.879 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.57 ' NH2' ' CGD' ' A' ' 182' ' ' HEM . 72.5 mtt-85 -73.14 149.41 43.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.053 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.2 mt -102.34 133.99 46.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.412 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 7.5 t -62.83 -24.18 67.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -32.91 69.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.279 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 18.2 t -69.04 -38.94 79.41 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' HB2' ' CMA' ' A' ' 182' ' ' HEM . . . -60.98 -37.24 81.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.52 -50.44 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.959 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.76 85.18 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.25 -44.86 80.07 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.822 0.344 . . . . 0.0 110.603 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.22 -40.59 94.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.425 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -71.67 -35.47 70.33 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 111.192 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.22 -41.59 98.31 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.78 -31.48 57.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.761 0.315 . . . . 0.0 110.873 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.05 -49.72 69.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.743 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.9 mt-30 -63.2 -48.03 80.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.021 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 17.3 t-80 -41.85 -28.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.559 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -116.01 32.88 5.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.887 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.0 tp60 39.52 42.06 0.83 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.4 tp60 -116.54 110.26 18.34 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -83.96 139.8 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 pt -147.93 168.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.943 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -131.11 141.21 50.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.557 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.2 mt -121.93 129.09 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 121.193 0.52 . . . . 0.0 111.428 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.7 t -111.46 114.22 27.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.79 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.714 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.6 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.753 0.787 . . . . 0.0 110.772 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -96.35 -27.96 14.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.067 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.5 m -103.31 121.01 41.85 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.472 ' C ' ' H ' ' A' ' 166' ' ' HIS . 5.4 p -142.0 123.83 15.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.639 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 134' ' ' SER . 5.8 ptp -52.58 -9.32 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 164' ' ' CYS . 60.8 m-70 -74.36 -18.36 60.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.456 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.6 m -103.09 21.14 16.3 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.803 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.55 69.8 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.912 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.23 158.21 20.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.169 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 27.1 p-10 -89.07 -9.78 49.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.926 0.393 . . . . 0.0 110.476 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.533 ' CG ' HH21 ' A' ' 131' ' ' ARG . 41.5 p-80 -154.8 -162.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.482 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 22.0 m -140.57 158.86 43.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.4 ttp -133.93 109.96 9.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.349 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.05 117.0 28.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.2 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.9 mm -104.46 119.62 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.8 108.98 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.864 0.364 . . . . 0.0 111.002 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -87.77 129.93 35.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.998 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.1 mt -95.52 127.61 41.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.31 137.94 35.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.82 0.343 . . . . 0.0 110.533 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -113.65 14.92 18.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.623 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.57 ' CGD' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' GLY . 35.7 mmtm -79.92 120.26 23.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.381 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.655 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.15 97.53 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.682 HD11 ' HD3' ' A' ' 80' ' ' ARG . 9.3 tp -74.61 -41.51 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.161 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.0 mm -63.44 -43.76 98.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.006 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -69.41 -28.69 66.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.524 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 91.3 m-20 -65.34 -44.96 86.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.08 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.9 t -70.4 -31.91 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.925 0.393 . . . . 0.0 110.342 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.6 tp -68.46 -53.47 23.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.222 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.3 -31.49 1.04 Allowed 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.232 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.8 -30.22 63.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.08 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.59 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.0 -53.68 8.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.73 -44.32 85.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' N ' HG23 ' A' ' 13' ' ' VAL . 38.2 t -53.5 -27.63 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.34 -17.01 38.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -96.8 -50.93 4.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.58 -16.62 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.45 176.67 19.82 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.432 ' HE2' ' OE2' ' A' ' 10' ' ' GLU . 3.3 ttt -74.24 -29.75 61.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.531 0.205 . . . . 0.0 111.172 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -54.67 -38.81 67.4 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.7 -35.9 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.7 t-105 -67.49 -42.49 82.83 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -75.38 -26.95 58.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -70.87 -62.42 1.4 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.75 -22.16 64.32 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.742 -179.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.7 tp -71.13 -41.27 70.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.67 -30.3 61.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -77.43 -43.14 33.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.802 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -91.16 -3.43 57.04 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -88.55 150.84 47.19 Favored Pre-proline 0 N--CA 1.47 0.575 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.659 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 30' ' ' ALA . 73.5 Cg_exo -47.72 -172.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.335 2.023 . . . . 0.0 112.071 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 13.5 ttmm -54.19 -53.28 55.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.656 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 32' ' ' LYS . 63.4 m-20 -160.89 77.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -127.64 162.62 26.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.436 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 36' ' ' TYR . 69.1 t -122.34 158.08 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.726 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' N ' HG12 ' A' ' 35' ' ' VAL . 3.3 p90 -81.14 136.21 35.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.337 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.66 127.33 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.655 ' N ' ' H ' ' A' ' 3' ' ' GLY . 86.7 p -67.56 -30.73 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.54 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.21 -41.81 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.763 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.5 mmmt -77.11 -67.84 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.404 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.428 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 61.5 m 50.24 10.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 40' ' ' LYS . 69.4 t80 -61.28 -34.76 75.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.568 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.65 43.25 1.1 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.1 pm0 -53.56 -25.5 17.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.57 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.5 t -54.19 -33.69 58.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -57.66 -37.7 73.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.8 tp -63.05 -41.91 99.59 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.532 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -65.95 -44.98 83.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.491 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.8 p -62.71 -35.05 78.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.043 0.449 . . . . 0.0 110.148 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG12 HD21 ' A' ' 25' ' ' LEU . 55.1 mt -73.95 -32.31 33.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.167 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LEU . 31.2 t -72.43 -38.92 61.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.329 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.06 -38.39 63.98 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.218 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.3 t70 -71.93 -57.1 4.6 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.788 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.6 p -47.18 -30.8 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.745 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.602 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -34.74 74.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.569 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.8 mt-30 -65.43 -51.17 62.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.124 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.3 ptm180 -68.47 -42.15 79.16 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.439 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -68.36 -9.73 50.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 60.89 59.55 2.06 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.252 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.2 mtp -143.33 150.97 53.64 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.117 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 132.53 14.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.911 1.741 . . . . 0.0 111.085 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -44.6 -35.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.206 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -64.87 -32.32 73.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.754 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 54.2 t0 -83.17 -34.53 25.97 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.614 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG21 ' CB ' ' A' ' 55' ' ' ALA . 99.0 t -67.5 -44.05 86.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.969 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.0 p -62.93 -37.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.835 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -65.64 -61.33 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.448 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.84 -39.44 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.29 -40.44 74.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.697 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.51 -51.26 43.69 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -46.55 -46.4 19.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 110.83 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.59 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.49 -40.7 61.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.204 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp -50.65 -40.94 54.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.555 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 28.2 t80 -65.32 -43.7 90.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.01 -56.3 21.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.264 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -42.56 98.5 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 28.1 mt -56.04 -54.17 48.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.831 0.348 . . . . 0.0 110.445 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.82 -39.83 12.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.48 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.0 t -67.26 -23.9 65.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.573 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.682 ' HD3' HD11 ' A' ' 4' ' ' ILE . 35.3 mtt85 -94.01 -32.23 13.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.56 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.95 30.12 7.34 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -47.05 -31.99 3.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -65.11 -46.91 79.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.74 -48.54 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 0.0 110.781 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.7 -51.17 76.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.738 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 47.8 t0 -50.37 -13.06 0.1 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -68.06 -11.95 59.94 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.058 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.707 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.24 -25.93 18.4 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.234 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.8 t70 51.12 -14.22 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.707 ' H ' ' C ' ' A' ' 88' ' ' PHE . 55.3 t0 -163.07 139.33 7.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.003 0.43 . . . . 0.0 110.809 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -41.94 -35.38 0.85 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -65.02 -43.41 92.55 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.957 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.7 t -69.02 -29.33 67.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.3 tt -74.26 -57.92 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.533 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 128' ' ' ILE . 97.9 t -38.86 -46.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.427 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.6 ptm -77.7 -16.81 58.22 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.693 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -99.69 -1.67 56.38 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.195 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -45.64 -87.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.909 0.355 . . . . 0.0 111.173 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD1' ' A' ' 100' ' ' ASP . 5.5 p80 -43.2 -50.7 6.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.312 0.577 . . . . 0.0 110.816 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD1' ' CE1' ' A' ' 99' ' ' HIS . 70.2 m-20 -40.52 -99.62 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.97 -48.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.9 -44.48 73.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -89.98 -9.97 46.73 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.55 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 tt -86.39 -30.97 21.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.294 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.532 ' O ' HD23 ' A' ' 109' ' ' LEU . 49.2 tp10 -78.66 -34.68 46.16 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 102' ' ' ILE . 12.1 m -72.01 -26.06 24.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.949 0.404 . . . . 0.0 110.385 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 111' ' ' HIS . 41.6 t-20 -71.87 -48.93 42.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.56 -23.03 65.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -49.85 -35.04 21.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.085 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 48.0 t80 -160.78 23.05 0.14 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.733 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 107' ' ' ASN . 74.7 m80 52.86 77.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.667 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 107' ' ' ASN . 79.3 mt-10 -78.54 150.01 75.77 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.419 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 114' ' ' SER . 59.0 Cg_endo -71.71 81.21 1.35 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.416 2.077 . . . . 0.0 112.112 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.43 ' O ' ' O ' ' A' ' 113' ' ' PRO . 37.6 p 56.09 159.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.737 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 116' ' ' PRO . 12.3 mt -134.57 152.48 77.87 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 115' ' ' LEU . 81.5 Cg_exo -36.89 160.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.582 2.188 . . . . 0.0 112.425 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -99.65 91.47 4.89 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.374 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 118' ' ' ILE . 15.9 mt -108.61 126.8 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 119' ' ' ASN . 0.4 OUTLIER -126.36 102.62 7.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.84 126.78 8.44 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -127.03 126.79 43.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.67 134.63 38.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.129 0.49 . . . . 0.0 111.047 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -113.3 158.43 38.3 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.331 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 123' ' ' LEU . 80.6 Cg_exo -41.96 -115.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.566 2.177 . . . . 0.0 111.923 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.798 ' O ' ' N ' ' A' ' 127' ' ' GLN . 81.9 m-20 -31.45 125.95 0.22 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 41.6 p-10 -21.93 66.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 124.043 0.839 . . . . 0.0 113.05 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.798 ' N ' ' O ' ' A' ' 125' ' ' ASN . 82.2 mt-30 -136.99 146.17 45.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.111 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.4 mt -131.21 126.24 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -94.71 111.13 22.92 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.76 109.91 20.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.152 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.9 ttt180 -87.62 145.17 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.144 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE1' ' SG ' ' A' ' 139' ' ' CYS . 34.4 t80 -140.28 143.65 36.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.839 0.352 . . . . 0.0 110.909 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 p -160.23 138.33 10.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.453 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.84 154.21 1.77 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.54 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 137' ' ' ARG . 60.4 Cg_endo -71.99 -54.95 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.661 2.241 . . . . 0.0 112.124 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.628 HH21 ' CGA' ' A' ' 182' ' ' HEM . 34.0 ttp180 -48.93 -11.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.491 ' H ' ' C ' ' A' ' 135' ' ' PRO . 58.8 ttp180 40.23 93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.5 tp -150.18 38.76 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.151 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.419 ' SG ' ' CE1' ' A' ' 132' ' ' TYR . 18.6 m -58.54 -31.51 68.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.949 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -54.47 -35.27 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.283 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.11 -39.56 82.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.97 -35.62 80.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.746 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -62.75 -55.31 27.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.5 -40.89 71.18 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 142' ' ' ALA . 31.1 mt -58.64 -43.65 89.8 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.75 0.31 . . . . 0.0 110.507 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 mt -62.01 -39.15 91.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.175 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.6 -34.64 67.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.711 0.291 . . . . 0.0 111.073 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.02 -43.24 99.16 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -71.12 -35.42 71.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.733 0.302 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.9 -51.69 60.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 154' ' ' GLN . 4.3 tt0 -59.48 -50.62 73.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -40.03 -28.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.769 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.6 m-85 -115.02 35.6 4.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.4 tt0 38.56 42.49 0.58 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.507 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.2 tp60 -118.27 111.41 18.75 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.145 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -83.52 140.96 31.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.14 168.31 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.269 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -131.5 145.49 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.287 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 50.4 mt -126.87 130.59 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.175 0.512 . . . . 0.0 111.547 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 38.4 t -109.62 108.03 18.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.832 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' A' ' 174' ' ' LEU . 18.6 t-160 -110.32 82.98 1.68 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.753 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -89.89 -35.19 15.76 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.548 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.54 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -95.99 118.87 33.46 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.967 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 24.8 t -139.73 125.56 19.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 ptm -50.47 -20.26 1.09 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.418 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -64.99 -18.91 65.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.095 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.31 22.21 12.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.98 -9.79 74.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.701 -0.559 . . . . 0.0 111.701 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.75 158.24 16.12 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.015 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 55.3 t0 -90.76 -2.37 57.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.425 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CG ' HH21 ' A' ' 131' ' ' ARG . 55.7 p-80 -160.8 -163.85 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.486 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.2 m -141.64 151.69 43.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.494 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.5 ttm -128.02 111.9 14.03 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.662 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.9 mp -117.28 114.14 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.029 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.5 mm -102.36 119.23 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.2 mp -100.8 108.93 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.867 0.365 . . . . 0.0 111.066 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -92.01 130.0 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.591 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 14.1 mt -91.09 128.56 36.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.479 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -85.59 144.33 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.528 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -115.02 16.77 17.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.557 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.623 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.628 ' CGA' HH21 ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' N ' ' OG ' ' A' ' 38' ' ' SER . 64.6 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' GLY . 9.1 mtmp? 56.61 65.06 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.534 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.666 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 38.33 98.49 0.01 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.501 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -72.93 -41.17 60.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.078 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -62.13 -48.36 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.469 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -66.46 -29.21 69.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -65.74 -48.98 70.08 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' ILE . 11.9 t -69.49 -29.62 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.403 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -69.19 -54.09 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.25 -28.26 0.5 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.086 0.469 . . . . 0.0 110.045 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -72.99 -33.63 65.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.503 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.426 ' N ' ' O ' ' A' ' 9' ' ' LEU . 23.1 mtt -71.88 -53.96 11.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.011 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG23 ' N ' ' A' ' 14' ' ' VAL . 33.9 m -57.83 -45.13 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.953 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.4 t -52.43 -27.65 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.9 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.88 -16.91 37.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.395 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -95.05 -50.95 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.72 -13.91 4.14 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 110.67 176.85 20.68 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ttm -74.67 -30.4 61.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.605 0.24 . . . . 0.0 111.104 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -38.71 64.14 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.619 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -69.2 -36.49 73.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -67.23 -41.18 86.12 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.091 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.9 m120 -76.28 -27.73 56.75 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.64 -63.35 1.09 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.017 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.24 -21.03 65.75 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.664 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.017 ' N ' HD13 ' A' ' 25' ' ' LEU . 39.8 tp -73.42 -38.74 65.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 30' ' ' ALA . 95.7 mt-10 -76.81 -32.99 57.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.274 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -73.97 -45.14 52.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.195 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -86.9 3.13 46.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.464 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -142.98 156.08 62.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.331 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' ALA . 85.0 Cg_exo -42.68 175.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.517 2.145 . . . . 0.0 112.423 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -46.2 -54.36 8.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.019 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -147.74 77.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.925 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 ttp-105 -86.44 149.81 24.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.981 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.1 t -113.36 136.82 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -97.04 135.32 39.2 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.341 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' CA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -123.76 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.666 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.3 p -70.67 -31.3 68.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.653 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -72.46 -37.55 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.21 -174.34 4.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.42 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 43' ' ' ALA . 21.6 t -151.51 -137.45 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.365 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' C ' ' N ' ' A' ' 44' ' ' GLU . 42.1 t80 61.39 -70.58 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.88 -17.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 42' ' ' TYR . 82.5 tt0 -49.94 -26.12 3.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.371 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.9 p -59.86 -26.24 65.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.678 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -71.47 -26.24 62.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.993 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 tp -54.98 -46.12 75.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.595 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -62.37 -47.75 82.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.65 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.1 p -57.62 -33.69 68.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 109.906 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 25' ' ' LEU . 66.2 mt -74.98 -31.96 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.24 -38.68 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.18 -37.95 63.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.218 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.9 t70 -71.93 -57.18 4.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.845 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.4 -31.32 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.847 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.584 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.97 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.661 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.1 mt-30 -66.29 -51.23 59.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.036 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.502 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.29 -41.82 80.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.1 mt -68.53 -10.29 54.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.781 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 60.89 59.51 2.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.312 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.5 mtt -143.39 150.93 53.29 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.64 131.83 13.96 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.845 1.696 . . . . 0.0 111.089 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.428 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 tt -44.05 -35.73 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.209 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.59 -31.37 72.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.747 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -83.39 -35.89 24.73 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.643 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.7 t -66.28 -46.54 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.75 -37.94 77.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.3 ttmt -64.33 -61.35 2.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.396 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.18 -37.27 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -57.09 -44.36 83.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.734 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.42 -36.08 92.74 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -61.0 -48.36 82.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.141 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.86 -39.94 66.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tp -50.65 -43.46 57.23 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.029 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.1 t80 -64.25 -43.6 94.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -55.2 -53.46 55.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.379 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.2 93.39 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.799 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -56.14 -53.87 51.96 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.48 -39.72 7.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -65.3 -26.29 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.812 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' LEU . 29.2 mmt180 -93.23 -32.01 14.52 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.465 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -117.88 31.26 6.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.2 m -49.82 -32.62 14.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -65.21 -45.97 82.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.17 -48.75 59.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.06 0.457 . . . . 0.0 110.699 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.8 -51.22 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.864 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 49.5 t0 -51.27 -12.46 0.14 Allowed 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -68.38 -12.26 60.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.193 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.706 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.5 -25.87 19.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.125 -178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 57.7 t0 50.94 -13.78 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.0 p30 -162.65 138.56 7.26 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.804 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -41.76 -36.19 0.95 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -65.32 -42.25 93.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.7 -0.4 . . . . 0.0 112.032 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.0 m -69.44 -29.06 66.68 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.0 tt -74.98 -59.47 2.72 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.678 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.432 ' N ' HD23 ' A' ' 94' ' ' LEU . 88.7 t -39.22 -46.06 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.705 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.427 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 21.8 ptm -79.56 -17.03 54.86 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.691 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.88 -2.48 57.19 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.12 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.9 mt -44.23 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.946 0.373 . . . . 0.0 111.076 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 46.0 p-80 -41.83 -52.5 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 110.948 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.579 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 70.0 m-20 -39.35 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.579 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.1 m -76.5 -47.84 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.579 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.01 -46.65 77.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -87.84 -10.68 50.08 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.694 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -84.22 -33.33 24.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.042 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -74.56 -55.06 6.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.455 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.4 m -51.63 -34.19 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.915 0.388 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 110' ' ' TYR . 51.9 t30 -55.52 -44.56 76.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.974 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -67.83 -29.46 68.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 110.366 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 110' ' ' TYR . 10.7 mp -71.61 -45.57 61.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.263 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 109' ' ' LEU . 81.7 m-85 -158.26 -161.49 1.01 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.559 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.591 ' NE2' HMD3 ' A' ' 182' ' ' HEM . 15.2 m-70 65.22 101.54 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.685 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 mt-10 -78.25 -35.85 1.23 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.389 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 91.7 Cg_endo -88.36 174.31 4.36 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 122.504 2.136 . . . . 0.0 112.12 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 p -65.04 150.94 47.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.573 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 116' ' ' PRO . 13.1 mt -91.08 152.54 44.27 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.382 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' CG ' ' O1A' ' A' ' 182' ' ' HEM . 85.1 Cg_exo -36.15 158.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 122.602 2.202 . . . . 0.0 112.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.39 130.68 36.45 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.487 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.888 HD12 ' N ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -153.91 125.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.888 ' N ' HD12 ' A' ' 118' ' ' ILE . 5.3 t-20 -129.39 100.25 5.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.94 129.1 9.55 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -129.21 130.56 46.47 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.09 133.46 36.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.09 0.472 . . . . 0.0 110.629 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.8 OUTLIER -111.1 156.42 40.98 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.702 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 123' ' ' LEU . 83.9 Cg_exo -42.02 169.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.069 1.846 . . . . 0.0 111.645 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 58.94 -125.68 1.34 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.243 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 178' ' ' LEU . 43.7 p-10 -133.64 55.36 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -126.29 148.2 49.56 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 64.3 mt -130.49 125.96 60.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.846 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.505 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -92.52 108.06 19.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 tt -107.85 110.24 21.97 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.014 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.659 HH21 ' CG ' ' A' ' 171' ' ' HIS . 62.6 ttt180 -92.23 144.91 24.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.347 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CG ' ' N ' ' A' ' 133' ' ' SER . 89.6 t80 -141.82 157.03 45.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.486 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.402 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 12.4 m -162.45 138.51 7.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.621 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 137' ' ' ARG . 7.8 p -171.87 135.54 0.89 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.269 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.0 -58.05 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.297 1.998 . . . . 0.0 113.153 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.784 HH22 HH21 ' A' ' 137' ' ' ARG . 35.6 ptt-85 -86.85 -37.69 17.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.784 HH21 HH22 ' A' ' 136' ' ' ARG . 32.3 mtt180 -71.68 148.54 46.36 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.759 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -102.73 135.72 43.86 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.272 0.558 . . . . 0.0 111.008 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.4 t -68.95 -30.79 69.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.361 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.55 -34.47 3.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.264 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.46 -43.56 55.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.147 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.7 68.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -58.92 -46.49 87.8 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.3 74.89 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.0 mt -57.28 -43.95 83.6 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.71 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.01 -41.1 91.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.481 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -73.28 -34.57 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 111.062 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.52 97.8 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -76.73 -31.25 57.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.92 -50.06 67.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.807 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 154' ' ' GLN . 86.7 mt-30 -63.02 -48.59 78.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.133 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.19 -27.98 0.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.931 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -115.9 34.09 5.15 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER 38.93 43.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.879 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.8 tp60 -120.01 107.54 13.21 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.106 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.571 ' NZ ' ' NE2' ' A' ' 179' ' ' GLN . 9.8 ptmm? -83.44 141.43 31.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.819 0.342 . . . . 0.0 110.695 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt -147.15 172.26 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.132 0.492 . . . . 0.0 111.259 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -131.89 144.15 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.264 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.1 mt -125.81 131.18 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.187 0.517 . . . . 0.0 111.496 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 t -109.75 109.39 20.08 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.84 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.596 ' CG ' HD11 ' A' ' 174' ' ' LEU . 13.5 t-160 -113.33 85.27 2.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.902 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -93.38 -32.18 14.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 4.2 m -101.58 125.57 48.26 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.212 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.1 t -146.5 146.24 30.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 13.6 tpp -60.8 -27.28 67.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.952 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.545 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.9 OUTLIER -63.93 -16.42 61.45 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.385 -179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.545 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -100.44 22.2 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.79 0.329 . . . . 0.0 110.704 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.15 -12.6 61.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.17 156.68 11.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.6 t0 -90.58 -2.12 57.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.86 0.362 . . . . 0.0 110.474 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.659 ' CG ' HH21 ' A' ' 131' ' ' ARG . 43.5 p-80 -160.87 -171.54 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.7 153.68 51.52 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.415 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.406 ' C ' HD12 ' A' ' 174' ' ' LEU . 50.4 ttp -129.24 108.9 10.69 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.72 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.8 mp -115.99 115.7 26.61 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.46 119.77 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mt -101.74 115.47 43.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.882 0.372 . . . . 0.0 111.047 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -96.04 130.21 43.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.021 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.521 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 17.9 mt -94.04 128.66 40.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.169 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.571 ' NE2' ' NZ ' ' A' ' 156' ' ' LYS . 38.2 mt-30 -90.83 150.65 21.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -43.0 -48.28 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.748 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 58.0 t0 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.599 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.591 HMD3 ' NE2' ' A' ' 111' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.2 pttt -155.27 142.56 19.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.745 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 41.46 101.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 5' ' ' ILE . 9.9 tp -80.38 -40.72 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.3 mm -69.37 -44.42 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -67.97 -30.02 69.21 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.956 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -64.49 -41.88 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 111.132 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.3 t -75.27 -28.6 20.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.9 tp -72.02 -54.39 10.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.666 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 14' ' ' VAL . 7.7 pt-20 -45.31 -32.14 1.88 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.152 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -72.03 -29.31 64.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.145 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.593 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.04 -54.04 7.85 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.145 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 14' ' ' VAL . 34.6 m -57.87 -43.32 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.497 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.86 -28.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.9 -16.99 39.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.343 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.32 -51.02 4.55 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.67 -15.83 4.36 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.13 177.29 20.0 Favored Glycine 0 N--CA 1.47 0.962 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.7 ttt -75.7 -27.61 58.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.567 0.222 . . . . 0.0 111.158 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -56.5 -38.59 71.98 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.682 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -69.3 -36.68 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 63.3 t-105 -67.24 -43.21 82.52 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.156 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -74.18 -28.3 61.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.854 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -68.92 -63.23 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.71 -20.79 64.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.834 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.018 ' N ' HD13 ' A' ' 25' ' ' LEU . 54.3 tp -73.68 -38.62 64.86 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 32' ' ' LYS . 63.2 mm-40 -75.43 -33.05 60.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.472 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -73.55 -41.05 63.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.965 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -91.19 2.58 56.25 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.625 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.5 154.23 73.26 Favored Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.63 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 30' ' ' ALA . 75.7 Cg_exo -45.49 -176.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.453 2.102 . . . . 0.0 112.564 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 15.5 ttmm -45.52 -51.37 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.001 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -155.55 74.5 0.89 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.029 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -90.79 147.16 23.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.149 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.71 144.61 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 120.872 0.368 . . . . 0.0 110.806 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -94.13 114.81 27.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.67 125.21 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.492 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.745 ' N ' ' H ' ' A' ' 3' ' ' GLY . 51.4 p -66.71 -32.57 73.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.5 -40.48 80.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.906 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -78.96 -174.69 4.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.371 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.8 m -158.99 79.68 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.509 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' C ' ' N ' ' A' ' 44' ' ' GLU . 98.6 m-85 -150.38 158.28 43.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 48.92 12.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.568 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 42' ' ' TYR . 87.1 tt0 -54.78 -31.62 59.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.435 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 m -53.65 -23.68 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -53.89 -27.06 28.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.539 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.7 tp -57.4 -41.05 79.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.224 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.22 -46.13 78.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -59.98 -32.97 71.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 25' ' ' LEU . 65.9 mt -76.03 -35.25 28.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.173 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.2 t -70.62 -38.19 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.278 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -74.93 -37.83 61.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.099 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 56' ' ' GLN . 26.6 t0 -72.06 -56.95 4.73 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.718 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.66 -31.02 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.09 -34.63 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.712 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.6 mt-30 -65.32 -50.94 63.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.532 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.5 ptm180 -68.54 -42.03 78.98 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.434 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.1 mt -68.5 -10.37 55.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.823 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 61.25 59.97 1.84 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.299 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -144.09 151.09 51.24 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.157 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.02 131.65 13.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.914 1.743 . . . . 0.0 111.088 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 tt -43.72 -36.56 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.315 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.46 -31.75 73.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.69 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.27 -35.98 24.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 84.3 t -66.06 -45.08 91.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.809 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -62.71 -37.28 78.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.809 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' N ' HG13 ' A' ' 66' ' ' VAL . 16.2 ttmt -64.09 -60.96 2.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.306 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.88 -38.78 62.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.5 -40.65 72.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.62 -60.66 6.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -39.13 -45.52 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.835 0.35 . . . . 0.0 110.813 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.593 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -74.33 -41.32 61.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.861 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -51.57 -40.59 60.03 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.182 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 32.7 t80 -62.56 -44.02 97.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.617 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -58.89 -56.93 15.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.528 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.88 -43.39 98.99 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.9 mt -51.75 -56.1 15.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.869 0.366 . . . . 0.0 110.453 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.18 4.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.9 t -69.9 -14.33 62.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.972 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -95.81 -30.64 13.57 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.493 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 p80 -128.49 36.09 4.3 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.04 -23.81 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 81' ' ' HIS . 23.5 t70 -71.95 -47.71 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.761 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -67.07 -49.17 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.975 0.417 . . . . 0.0 111.015 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -63.35 -48.46 87.21 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.43 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -40.35 -13.16 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 85' ' ' VAL . 28.4 mtpt -82.04 -2.15 50.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 0.0 110.012 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.676 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.89 57.34 0.69 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.475 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 54.6 p30 -52.86 -17.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.802 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 77.0 m-20 -145.52 151.6 38.41 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.353 0.597 . . . . 0.0 111.421 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -37.33 79.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.788 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 83.6 m -63.72 -43.19 97.27 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.722 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.8 m -65.28 -29.15 69.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.009 0.433 . . . . 0.0 110.483 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 94' ' ' LEU . 2.8 tt -70.95 -71.11 0.27 Allowed 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.3 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.509 ' CG1' HG21 ' A' ' 128' ' ' ILE . 47.4 t -34.03 -44.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.1 ptm -81.87 -18.21 44.62 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.795 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.06 -2.05 54.79 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.232 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.1 mt -45.41 -86.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.069 0.435 . . . . 0.0 110.605 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -42.92 -51.03 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.326 0.584 . . . . 0.0 110.759 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -38.9 -100.61 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 102' ' ' ILE . 1.7 m -78.06 -47.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.535 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.2 mp -54.43 -48.88 68.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -88.34 -8.68 54.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.852 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -82.56 -33.84 27.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.1 tp10 -74.72 -54.6 7.07 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.519 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 107' ' ' ASN . 17.0 m -44.7 -39.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.994 0.426 . . . . 0.0 110.002 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.491 ' N ' HG23 ' A' ' 106' ' ' VAL . 26.7 t-20 -57.33 -37.54 72.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 105' ' ' GLU . 91.1 mttt -74.45 -35.24 63.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 109' ' ' LEU . 4.6 mm? -55.57 -44.06 76.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.956 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 111' ' ' HIS . 9.6 p90 -166.38 175.64 8.04 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.785 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.623 ' CG ' ' N ' ' A' ' 112' ' ' GLU . 3.5 p80 39.21 -152.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.623 ' N ' ' CG ' ' A' ' 111' ' ' HIS . 2.7 mt-10 -170.61 -53.1 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 112' ' ' GLU . 86.6 Cg_endo -82.65 -161.37 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.327 2.018 . . . . 0.0 112.024 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p 64.84 18.14 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.856 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.99 104.68 41.38 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.12 169.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.453 2.102 . . . . 0.0 112.816 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -99.64 91.08 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.99 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -99.2 125.87 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.467 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -130.79 105.22 7.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -91.37 128.69 9.45 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -127.26 124.15 38.15 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.31 133.82 37.57 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.199 0.523 . . . . 0.0 111.529 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.34 -177.8 0.47 Allowed Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.814 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.4 Cg_endo -89.82 168.68 4.67 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.373 2.049 . . . . 0.0 112.267 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 68.35 25.16 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.084 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.75 46.16 3.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.304 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -122.25 146.88 46.86 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG21 ' CG1' ' A' ' 95' ' ' VAL . 59.9 mt -131.01 127.57 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -97.51 111.03 23.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.933 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -107.74 110.92 22.87 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.23 141.48 28.52 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -138.05 137.73 38.11 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.91 0.386 . . . . 0.0 110.963 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -149.91 135.46 18.32 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.345 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.19 156.62 2.45 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.413 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -38.88 7.15 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.616 2.211 . . . . 0.0 112.007 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.478 ' CZ ' ' O2A' ' A' ' 182' ' ' HEM . 54.7 mtm180 -64.09 -23.32 67.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.557 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 139' ' ' CYS . 67.7 mtm180 50.78 22.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.7 tp -75.6 34.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 110.35 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.465 ' H ' ' C ' ' A' ' 137' ' ' ARG . 19.3 m -49.91 -37.12 30.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.559 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -33.13 2.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.378 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 23.4 t -72.78 -41.15 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.632 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.93 -37.53 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.78 -52.37 64.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.009 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.17 83.64 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.2 mt -58.06 -44.27 87.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.802 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.1 mt -60.95 -39.05 88.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.189 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -73.16 -34.16 65.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.792 0.329 . . . . 0.0 111.02 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.89 -40.59 97.02 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.22 -30.67 43.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -64.81 -50.0 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.735 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.2 mt-30 -61.19 -47.74 84.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.121 0.486 . . . . 0.0 109.809 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -41.33 -28.29 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.829 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -115.52 31.71 6.53 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.125 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER 39.96 41.01 0.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.847 0.356 . . . . 0.0 110.697 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 30.2 tp60 -115.64 109.99 18.53 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -82.8 140.76 32.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -148.65 168.94 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -131.13 138.56 49.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.67 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -119.82 129.19 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.9 m -108.94 100.11 9.36 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.087 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.51 ' NE2' ' SG ' ' A' ' 164' ' ' CYS . 51.5 t60 -101.76 77.53 1.74 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.223 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.92 -37.74 15.03 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.678 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -90.52 124.84 35.33 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.808 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.51 ' SG ' ' NE2' ' A' ' 161' ' ' HIS . 5.5 t -144.76 128.32 17.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 111.08 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.8 ttt -51.96 -26.02 9.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.093 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -63.86 -18.07 63.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.347 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.06 23.86 10.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.697 0.284 . . . . 0.0 110.921 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.54 -16.74 57.16 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.22 159.29 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.047 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -92.39 6.94 45.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 110.413 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.3 p80 -171.43 -168.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.677 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 34.3 m -133.96 157.52 45.82 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.158 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 48.5 ttp -134.16 112.34 11.04 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD11 ' ND1' ' A' ' 161' ' ' HIS . 7.8 mp -115.23 112.3 22.26 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.1 mm -101.76 117.52 47.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 157' ' ' ILE . 2.5 mp -100.87 106.88 20.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.63 132.4 34.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.916 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.58 127.42 41.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -79.15 138.02 37.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.813 0.339 . . . . 0.0 110.462 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -108.18 14.78 24.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.464 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.589 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.492 ' CBC' ' CE1' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' GLY . 31.3 mmtm -79.77 140.42 36.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.397 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.719 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 34.68 99.58 0.01 OUTLIER Glycine 0 N--CA 1.467 0.713 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.15 -41.07 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.888 0.375 . . . . 0.0 110.277 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.7 mm -64.11 -46.32 94.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.475 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -67.15 -30.5 70.49 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -65.58 -49.16 69.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.734 0.302 . . . . 0.0 111.159 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 73' ' ' LEU . 15.6 t -67.63 -29.16 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.231 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.7 tp -69.36 -53.59 18.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.251 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.3 tt0 -43.91 -29.23 0.54 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -72.62 -33.86 66.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.56 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' LEU . 21.9 mtt -71.54 -53.55 13.42 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.6 m -57.85 -44.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.051 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.7 t -53.21 -27.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.781 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.51 -16.55 39.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -96.05 -50.47 4.83 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.99 -16.21 4.64 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.01 -177.19 17.21 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -26.68 39.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.572 0.225 . . . . 0.0 111.296 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.74 -36.07 77.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.202 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.08 -39.92 80.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.163 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.444 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.9 t-105 -65.42 -40.22 93.1 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.199 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.14 -28.19 57.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.795 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.08 -63.33 1.08 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.999 -178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.62 -20.93 65.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.714 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 37.1 tp -72.72 -39.3 67.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 110.111 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.22 -32.84 59.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.469 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 19.7 ttpp -75.04 -44.28 48.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.428 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.625 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 61.2 m-70 -86.86 1.99 50.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.522 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -138.32 154.58 73.87 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.462 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 87.1 Cg_exo -43.95 178.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.42 2.08 . . . . 0.0 112.404 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -42.83 -53.34 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 53.3 p30 -153.19 73.73 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.941 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -88.64 147.18 24.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.1 137.39 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.925 0.393 . . . . 0.0 110.832 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -90.66 114.92 27.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -97.33 133.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.803 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.719 ' N ' ' H ' ' A' ' 3' ' ' GLY . 78.8 p -75.29 -29.96 60.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.481 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.92 -38.03 69.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -78.87 -174.92 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.307 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 39.8 m -165.74 89.78 0.44 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.555 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' A' ' 41' ' ' SER . 91.4 m-85 -157.8 -46.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 -5.99 33.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.522 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -45.4 -32.99 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.584 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 t -58.94 -33.51 70.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.651 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -62.59 -28.07 69.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.57 -42.75 83.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.502 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -64.95 -45.68 84.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.645 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -61.32 -32.39 72.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 0.0 110.105 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.481 HG12 HD21 ' A' ' 25' ' ' LEU . 59.6 mt -75.76 -36.03 32.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.318 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.59 -38.21 76.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.225 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -74.91 -37.43 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.085 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' GLN . 14.9 t70 -72.14 -57.31 4.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.63 -31.41 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.863 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.592 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.77 -33.05 71.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.65 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.8 mm-40 -67.15 -51.12 57.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -68.17 -41.88 80.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.205 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.1 mt -68.5 -10.38 55.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.5 t30 61.13 59.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.225 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.456 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.3 mtt -143.21 150.8 53.48 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.063 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 130.17 12.08 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.935 1.757 . . . . 0.0 111.238 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.3 tt -42.53 -37.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.241 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' N ' HG23 ' A' ' 62' ' ' ILE . 5.5 pt20 -63.86 -31.52 72.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.765 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -83.65 -36.69 23.63 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.592 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.7 t -64.63 -46.7 91.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.773 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.4 p -60.77 -39.16 80.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.958 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 66' ' ' VAL . 17.4 ttmt -62.92 -60.48 3.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.448 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.29 -38.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -55.78 -41.13 73.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.65 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.13 -38.09 94.88 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.08 -50.05 74.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.91 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -69.85 -42.5 73.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.909 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -46.31 -44.48 16.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.805 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.8 t80 -61.37 -43.11 99.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 3.8 m-80 -58.03 -56.71 18.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.72 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.81 -44.67 95.85 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 80' ' ' ARG . 53.7 mt -54.36 -54.28 42.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.331 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.83 -36.17 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 p -70.22 -24.22 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 77' ' ' LEU . 33.2 mmt180 -96.86 -36.8 10.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.685 0.278 . . . . 0.0 110.728 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -113.66 33.8 4.96 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.189 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 m -48.46 -33.24 9.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.999 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -63.88 -47.94 78.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.258 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.4 t -70.42 -48.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.096 0.475 . . . . 0.0 110.532 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 87' ' ' LYS . 79.0 t -60.59 -52.31 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.306 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 23.4 t0 -39.54 -13.82 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.5 mtpp -81.59 -2.96 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.952 0.406 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.931 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.7 p90 -74.67 -7.1 52.21 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.887 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 88' ' ' PHE . 86.1 m-20 21.1 -59.62 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.21 0.944 . . . . 0.0 112.338 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.931 ' N ' ' O ' ' A' ' 88' ' ' PHE . 85.5 m-20 -132.85 147.03 52.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.944 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -51.66 -41.59 61.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.716 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 m -62.76 -37.74 87.83 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.564 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.7 p -69.73 -28.23 65.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.678 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -72.06 -71.23 0.29 Allowed 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.367 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.489 ' CG1' HG21 ' A' ' 128' ' ' ILE . 42.1 t -37.02 -42.56 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.6 -19.62 45.09 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.59 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.08 11.33 48.44 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.263 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.5 mt -54.21 -88.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.522 ' CE1' ' OD2' ' A' ' 100' ' ' ASP . 4.9 p80 -41.5 -47.96 3.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.364 0.602 . . . . 0.0 110.461 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.522 ' OD2' ' CE1' ' A' ' 99' ' ' HIS . 14.0 m-20 -39.24 -100.51 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.648 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -74.98 -49.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.616 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.49 -53.51 24.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -83.02 -10.19 58.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.125 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.6 -35.65 29.86 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -75.12 -59.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.84 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 107' ' ' ASN . 13.4 m -44.08 -37.07 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.449 ' N ' HG23 ' A' ' 106' ' ' VAL . 25.6 t30 -55.82 -46.3 78.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.868 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -66.01 -25.95 67.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.472 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 11.2 mp -77.34 -18.47 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.653 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 32.4 m-85 -142.96 77.32 1.56 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.784 0.326 . . . . 0.0 110.947 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 107' ' ' ASN . 76.8 m80 36.85 -121.16 0.17 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.192 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' CG ' HD21 ' A' ' 107' ' ' ASN . 30.2 tt0 -166.48 66.88 0.98 Allowed Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.21 33.79 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 112.157 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.0 t 57.69 100.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -78.82 154.06 78.08 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.195 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 160.12 4.26 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.528 2.152 . . . . 0.0 112.144 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -92.12 125.16 36.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.6 tt -153.12 127.59 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -133.89 118.37 17.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.45 130.35 10.21 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -126.38 137.29 53.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -86.03 133.18 33.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.2 0.524 . . . . 0.0 111.356 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -115.98 -177.64 0.46 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-N 115.377 -0.828 . . . . 0.0 108.872 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 63.1 Cg_endo -89.67 169.39 4.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.327 2.018 . . . . 0.0 112.486 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 66.95 25.06 9.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.34 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.9 OUTLIER 65.89 48.0 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.361 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -124.98 148.4 48.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG21 ' CG1' ' A' ' 95' ' ' VAL . 62.0 mt -130.29 126.24 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.7 112.94 24.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.923 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 tp -108.82 107.42 17.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttm-85 -90.05 144.98 25.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.871 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 133' ' ' SER . 46.9 t80 -141.72 158.05 44.3 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 110.645 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.611 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 3.5 p -170.65 141.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.663 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.5 m 161.95 132.63 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.183 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.26 -30.61 2.31 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.017 1.812 . . . . 0.0 112.139 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 138' ' ' LEU . 98.4 mtt180 -55.37 -25.22 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.804 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 37.38 25.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -84.99 20.8 1.76 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.943 0.401 . . . . 0.0 109.925 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 132' ' ' TYR . 10.9 m -43.93 -33.95 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.004 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.56 -34.91 59.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.352 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 10.8 t -66.31 -36.11 82.1 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.494 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -63.75 -33.53 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.921 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.05 -53.51 56.92 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.066 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.72 -40.83 81.12 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 142' ' ' ALA . 30.0 mt -58.52 -44.61 89.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.679 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -39.71 92.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.503 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.61 -33.87 66.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.755 0.312 . . . . 0.0 111.098 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -59.75 -41.72 97.68 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -78.77 -29.02 44.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.626 0.251 . . . . 0.0 111.036 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.22 -49.88 65.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.728 0.299 . . . . 0.0 110.974 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 154' ' ' GLN . 18.3 mm-40 -61.58 -49.29 77.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.983 0.421 . . . . 0.0 110.087 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.1 m-70 -42.09 -29.35 0.23 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.058 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -112.22 31.34 6.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.782 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 151' ' ' GLN . 34.5 tt0 39.35 42.04 0.76 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.9 tp60 -117.4 110.33 17.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.114 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -82.88 140.98 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 pt -148.62 168.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.012 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -131.1 143.83 50.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.55 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.0 mt -123.93 128.83 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.191 0.52 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.1 t -109.19 106.33 16.15 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.909 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.626 ' CD2' ' SG ' ' A' ' 172' ' ' CYS . 14.6 t-160 -107.13 83.13 1.78 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.448 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -91.09 -33.74 15.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.001 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.499 ' O ' ' SG ' ' A' ' 172' ' ' CYS . 4.9 m -94.63 119.05 32.66 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.118 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 164' ' ' CYS . 13.8 p -138.4 123.98 19.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.038 0.447 . . . . 0.0 110.632 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.59 ' HA ' ' HB3' ' A' ' 169' ' ' ALA . 73.7 mtm -52.41 -20.48 2.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.374 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -59.79 -18.42 43.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.913 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.503 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.9 m -104.14 24.43 11.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.864 0.364 . . . . 0.0 110.497 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.15 -11.2 72.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 165' ' ' MET . . . -56.83 154.3 9.5 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.106 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.5 t0 -92.67 -7.1 47.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.417 . . . . 0.0 110.059 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -156.09 -174.87 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.34 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.626 ' SG ' ' CD2' ' A' ' 161' ' ' HIS . 41.5 t -131.76 158.82 40.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.468 ' N ' ' SG ' ' A' ' 172' ' ' CYS . 38.7 ttm -134.17 112.01 10.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.635 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.579 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 7.8 mp -116.84 111.98 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.0 mm -100.8 119.27 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.03 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.2 108.14 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 110.894 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -87.65 131.78 34.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.069 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.64 124.96 38.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 181' ' ' ASP . 44.5 mt-30 -83.31 145.79 28.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 47.5 p-10 -39.99 -27.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.899 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 56.4 t0 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.54 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.416 ' O2A' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.6 mtmm -78.74 133.5 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.64 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 51.81 114.4 0.01 OUTLIER Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -87.6 -48.69 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.7 mm -66.59 -40.26 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.165 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -70.12 -27.36 64.51 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.365 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.94 -48.69 70.51 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.058 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.33 -29.36 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.664 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.7 tp -70.37 -53.88 14.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.377 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.564 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.6 -29.05 0.67 Allowed 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.133 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.5 -34.04 67.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 24.2 mtt -71.57 -53.82 12.52 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.928 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.1 m -57.99 -45.2 88.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.049 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.6 t -52.23 -27.19 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.917 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.6 -16.67 38.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.06 -50.78 4.93 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.8 -14.45 4.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.81 -176.63 17.32 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.77 -25.93 37.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.527 0.203 . . . . 0.0 111.259 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -60.98 -36.26 78.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.234 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.9 p -69.01 -39.48 79.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.113 0.483 . . . . 0.0 110.155 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.441 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.1 t-105 -65.78 -40.88 92.42 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.172 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -75.63 -28.13 58.69 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.82 -63.62 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.99 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.51 -20.39 65.44 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.766 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 40.1 tp -73.61 -39.56 64.49 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.15 -33.51 63.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.447 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -74.83 -42.31 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -89.85 1.77 55.78 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.895 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -141.95 147.52 45.06 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.29 -158.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.612 2.208 . . . . 0.0 111.683 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 34' ' ' ARG . 4.8 ttpm? -55.76 -29.47 59.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.592 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.02 39.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.513 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 32' ' ' LYS . 64.4 mtm180 -47.57 -22.0 0.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.99 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.92 137.14 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.035 0.445 . . . . 0.0 111.178 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -105.43 137.62 42.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 3.4 t -121.33 120.31 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.925 0.393 . . . . 0.0 110.672 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.6 p -61.94 -25.73 67.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.749 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.59 -40.82 33.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -79.19 -177.35 5.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.632 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -168.21 40.84 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.349 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -57.92 -40.35 80.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.815 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.9 69.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.731 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -62.81 -24.51 67.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.429 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 85.1 p -55.64 -21.88 20.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.734 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.51 -30.89 43.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.22 -47.59 83.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.551 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.78 -46.19 89.17 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.393 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.7 p -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.276 0.56 . . . . 0.0 109.609 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG12 HD21 ' A' ' 25' ' ' LEU . 55.4 mt -74.9 -29.84 23.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.932 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -74.96 -37.77 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.284 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -74.82 -38.31 62.09 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.06 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.3 t70 -71.52 -57.21 4.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.715 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.2 p -47.47 -31.02 2.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.549 -0.461 . . . . 0.0 109.79 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.07 71.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.558 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' ASP . 90.1 mm-40 -66.95 -50.67 61.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.995 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.71 -41.64 78.8 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.275 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.4 mt -69.06 -10.42 57.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.8 t30 60.92 60.24 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.349 0.595 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.464 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 mtp -143.75 151.43 53.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.053 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.95 132.7 14.44 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.862 1.708 . . . . 0.0 111.08 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.8 tt -44.96 -35.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.175 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.44 -31.66 72.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.718 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.43 -35.44 25.01 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.656 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 55' ' ' ALA . 72.8 t -66.64 -45.93 87.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.732 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 67' ' ' LYS . 9.0 p -61.57 -37.47 77.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.891 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.8 ttmt -64.25 -61.65 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.378 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.77 -36.94 49.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.711 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -56.58 -44.0 80.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.855 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.44 -44.76 92.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -51.07 -46.13 61.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.741 0.305 . . . . 0.0 110.922 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.61 -39.9 57.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.97 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -52.56 -43.01 64.96 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.932 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.5 t80 -64.42 -43.52 94.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.711 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.47 -51.92 65.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.525 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.1 -43.09 82.52 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.746 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 80' ' ' ARG . 30.9 mt -55.7 -53.24 58.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.365 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.25 -39.03 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.376 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 t -65.84 -26.94 67.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.728 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 77' ' ' LEU . 1.1 mmp_? -91.59 -31.95 15.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.467 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 6.6 m-70 -117.66 29.36 7.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.42 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -47.85 -31.43 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.821 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -66.13 -46.99 75.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.6 t -70.22 -48.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.067 0.46 . . . . 0.0 110.595 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.3 t -60.18 -52.16 64.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.608 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -49.39 -13.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -67.41 -12.02 59.21 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.001 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -91.55 -27.18 18.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.056 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.694 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 84.1 m-20 51.84 -14.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.773 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 64.7 m-20 -161.8 139.14 8.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.764 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -41.54 -36.94 1.0 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -64.07 -42.04 97.12 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.6 t -70.14 -27.97 64.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.7 tt -76.55 -57.02 4.1 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.719 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 128' ' ' ILE . 72.4 t -40.02 -48.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.132 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.455 ' C ' ' SD ' ' A' ' 96' ' ' MET . 0.0 OUTLIER -76.49 -15.79 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.546 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.13 1.32 54.62 Favored Glycine 0 N--CA 1.475 1.233 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.168 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 99' ' ' HIS . 96.6 mt -47.34 -89.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.98 0.39 . . . . 0.0 111.074 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 98' ' ' ILE . 59.7 t-80 -42.34 -50.08 5.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.337 0.589 . . . . 0.0 110.702 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -39.97 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.593 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.9 m -76.54 -48.45 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.617 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -53.87 -47.76 63.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -89.21 -7.25 55.94 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.783 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.65 -31.24 21.19 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.071 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 106' ' ' VAL . 4.6 tm-20 -75.86 -42.8 48.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.635 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.534 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m -62.74 -31.99 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 110.056 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -58.49 -41.65 85.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.583 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.65 -33.14 74.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.026 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.69 -35.79 81.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.081 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -103.33 -163.77 1.02 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.446 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.75 74.8 1.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.672 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -177.92 66.84 0.2 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.49 101.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.661 2.241 . . . . 0.0 112.121 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.6 t -177.35 38.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.593 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.7 147.32 89.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.274 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -38.72 155.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 122.403 2.069 . . . . 0.0 112.327 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -90.08 112.93 24.54 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.378 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 118' ' ' ILE . 12.4 mt -130.34 125.98 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.531 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.21 102.8 6.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.48 127.45 8.81 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -127.17 131.52 50.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.83 134.0 35.12 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.161 0.505 . . . . 0.0 111.068 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.498 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.82 -177.9 0.47 Allowed Pre-proline 0 N--CA 1.469 0.481 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.7 Cg_endo -89.75 166.6 4.97 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.251 1.967 . . . . 0.0 111.929 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.509 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 1.2 m-20 68.07 31.36 5.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.482 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 14.0 p30 58.14 44.52 18.98 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.075 0.464 . . . . 0.0 112.19 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.28 146.94 44.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.467 HG21 HG11 ' A' ' 95' ' ' VAL . 49.2 mt -128.88 128.7 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.806 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.498 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.96 111.09 23.59 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.87 110.35 21.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.673 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.438 HH21 ' CG ' ' A' ' 171' ' ' HIS . 52.3 ttt180 -87.09 142.42 27.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.826 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -136.74 139.82 42.16 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.872 0.368 . . . . 0.0 110.745 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -158.4 136.97 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.454 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.9 p -172.81 148.38 1.72 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.289 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.6 -32.3 15.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.299 1.999 . . . . 0.0 111.856 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.48 -10.67 59.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.591 ' NH1' ' SG ' ' A' ' 164' ' ' CYS . 32.0 ttt85 59.91 -96.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' O ' ' O1A' ' A' ' 182' ' ' HEM . 1.5 mm? 46.56 16.94 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 110.066 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.511 ' SG ' ' CZ ' ' A' ' 137' ' ' ARG . 20.3 p -50.66 -39.61 51.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.714 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.478 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -44.23 -31.67 1.06 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.362 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.97 -41.65 61.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.434 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 139' ' ' CYS . . . -54.54 -41.15 69.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.234 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -59.45 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.136 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.44 -48.72 63.5 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.28 -44.33 64.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.5 -40.57 83.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.438 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -74.24 -33.41 63.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.721 0.296 . . . . 0.0 111.141 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.1 99.43 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.91 -32.0 61.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.731 0.3 . . . . 0.0 110.981 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.34 -51.07 62.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 154' ' ' GLN . 87.5 mt-30 -62.86 -48.2 80.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.002 0.429 . . . . 0.0 110.266 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -41.94 -28.69 0.18 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.793 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.39 33.09 5.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.9 tt0 39.31 44.99 1.12 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.189 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.443 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 31.0 tp60 -119.1 112.67 19.83 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.97 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -85.03 140.25 31.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.024 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.5 pt -148.42 168.4 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.95 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -130.88 141.19 50.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.519 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 48.6 mt -121.54 128.12 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.176 0.512 . . . . 0.0 111.397 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 t -111.5 116.08 30.27 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.848 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.7 OUTLIER -115.63 93.79 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.712 0.767 . . . . 0.0 110.743 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -96.12 -31.67 12.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.6 m -99.63 120.67 40.06 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.591 ' SG ' ' NH1' ' A' ' 137' ' ' ARG . 16.8 t -139.19 123.87 18.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.732 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.3 ptp -52.9 -17.56 1.47 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.203 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 16.1 t-80 -69.03 -18.32 64.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.856 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -101.48 23.04 11.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.49 -10.25 74.49 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.01 156.4 21.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -89.48 -3.32 58.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.297 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.438 ' CG ' HH21 ' A' ' 131' ' ' ARG . 22.5 p80 -159.9 -166.02 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.416 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 60.4 m -140.01 159.61 41.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 39.0 ttm -135.13 112.21 10.33 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.693 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.1 mp -116.76 116.4 27.42 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.68 119.73 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 mp -101.38 105.65 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -86.0 130.13 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.904 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.18 124.6 36.38 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -85.0 146.36 27.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 0.0 110.634 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 181' ' ' ASP . 40.9 p-10 -41.08 -31.87 0.22 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.744 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 180' ' ' ASN . 90.8 m-20 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.482 ' CGA' HMA1 ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 3' ' ' GLY . 26.2 mtmm -79.2 107.32 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 47.38 114.16 0.01 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.0 tp -77.92 -44.42 28.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.4 mm -63.82 -40.73 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.15 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -70.4 -28.86 65.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.533 ' ND2' ' NH2' ' A' ' 80' ' ' ARG . 51.6 t-20 -64.97 -48.68 73.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.787 0.327 . . . . 0.0 111.206 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 73' ' ' LEU . 9.6 t -68.98 -30.26 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.5 tp -68.97 -53.52 20.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.201 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.94 -31.3 0.85 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.056 0.455 . . . . 0.0 110.296 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -72.19 -31.97 66.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.219 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.603 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 11.7 mmm -72.8 -54.65 8.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -57.87 -44.12 85.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.587 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.1 t -53.84 -26.86 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.655 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.09 -16.67 37.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.292 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -97.41 -50.75 4.41 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.28 -15.67 4.6 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.63 176.53 20.17 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.0 ttm -75.05 -28.19 60.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.524 0.202 . . . . 0.0 111.085 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -55.97 -38.73 70.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.716 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -69.62 -36.69 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 64.5 t-105 -67.11 -43.48 82.36 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.225 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.6 m120 -74.44 -27.04 60.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -70.55 -62.94 1.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.015 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.81 -20.83 64.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.86 -178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.015 ' N ' HD13 ' A' ' 25' ' ' LEU . 32.1 tp -72.9 -42.74 63.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.51 -29.68 65.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.662 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -77.67 -41.1 39.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.675 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -104.97 -3.42 23.31 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -44.37 158.22 0.28 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.642 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.96 -177.91 4.26 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.802 2.335 . . . . 0.0 111.876 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -65.54 -33.43 75.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.354 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -65.55 -23.47 66.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.587 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 71.74 0.86 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.988 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 m -140.43 162.77 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.895 0.378 . . . . 0.0 110.756 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -113.27 114.23 26.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.185 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 39' ' ' ALA . 4.5 t -111.97 132.74 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.522 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.0 p -72.94 -28.42 62.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.662 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -75.43 -36.73 60.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.053 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -80.6 -174.68 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.377 . . . . 0.0 110.58 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 43' ' ' ALA . 19.9 t -151.09 -144.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.0 t80 60.45 -72.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -55.61 -19.09 9.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.488 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -47.71 -24.53 0.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.4 p -56.95 -28.37 62.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.615 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -55.84 -26.97 49.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -56.3 -44.39 79.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.17 -48.12 77.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.613 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -58.24 -33.08 68.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.179 0.514 . . . . 0.0 109.992 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.504 HG12 HD21 ' A' ' 25' ' ' LEU . 55.5 mt -75.14 -35.88 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.189 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -69.37 -39.31 78.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.195 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.24 -38.07 63.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.192 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 56' ' ' GLN . 41.5 t0 -72.35 -56.87 4.77 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.788 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.91 -31.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.764 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.47 -34.2 74.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.655 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' N ' ' O ' ' A' ' 53' ' ' ASP . 88.7 mm-40 -66.18 -51.33 58.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.181 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.4 ptm180 -67.88 -42.1 81.76 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.279 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.7 mt -68.45 -9.69 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.409 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.3 OUTLIER 60.6 59.85 2.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 mtt -143.49 150.82 52.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.03 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 133.89 16.06 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.862 1.708 . . . . 0.0 111.079 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -46.65 -35.45 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.175 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.03 -32.06 73.6 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.767 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -83.92 -34.73 24.44 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.692 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 96.3 t -67.19 -45.02 87.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.31 -38.51 81.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.926 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.4 ttmt -64.15 -61.07 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.365 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.56 -38.67 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.02 -41.84 79.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.814 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.68 -39.54 95.39 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -58.48 -47.74 83.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.946 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.603 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.2 t80 -71.81 -42.86 66.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.3 tp -47.26 -42.45 20.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.936 0.398 . . . . 0.0 110.444 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.665 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 35.8 t80 -63.0 -47.6 82.44 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -53.27 -52.17 59.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.442 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.89 -41.31 93.5 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.751 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ARG . 16.8 mt -56.6 -52.04 66.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.714 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.69 -35.23 4.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.5 t -71.11 -23.18 62.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.9 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH2' ' ND2' ' A' ' 7' ' ' ASN . 32.8 mmt180 -90.43 -35.88 14.9 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.863 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.5 p-80 -125.08 41.55 3.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.127 0.489 . . . . 0.0 110.784 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 m -51.53 -40.47 59.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.985 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -57.29 -41.51 79.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.707 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.75 -47.93 60.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.415 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.544 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 53.0 t -63.57 -51.44 70.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.631 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 51.7 t0 -48.38 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.6 mtpp -79.03 -11.83 60.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.345 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.04 -27.43 17.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.697 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 19.3 t70 51.11 -14.02 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.855 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 59.9 m-20 -162.49 138.29 7.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.966 0.413 . . . . 0.0 110.694 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 95' ' ' VAL . 61.1 t80 -40.83 -35.05 0.45 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.3 m -65.49 -41.11 93.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.654 -0.418 . . . . 0.0 112.123 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.7 t -70.46 -29.45 66.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 97' ' ' GLY . 5.5 tt -75.09 -59.41 2.75 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.707 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG1' HG21 ' A' ' 128' ' ' ILE . 93.3 t -41.1 -41.42 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.99 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.9 tmt? -80.37 -18.9 47.66 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.239 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.7 7.28 55.47 Favored Glycine 0 N--CA 1.477 1.384 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.157 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.0 mt -51.51 -85.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.989 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -42.59 -50.22 5.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.421 0.629 . . . . 0.0 110.467 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -39.9 -100.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 113.511 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.4 m -77.59 -48.12 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -176.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.591 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.67 -47.4 73.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.404 ' O ' ' CD1' ' A' ' 115' ' ' LEU . 2.2 m170 -88.92 -9.82 50.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.37 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.74 -34.86 22.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -73.65 -50.3 21.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.377 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG11 ' CAC' ' A' ' 182' ' ' HEM . 10.8 m -54.59 -31.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 109.775 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 110' ' ' TYR . 9.4 t-20 -57.26 -43.08 82.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.654 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -69.39 -25.66 64.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 110.445 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 10.3 mp -75.41 -15.98 60.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.488 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 111' ' ' HIS . 13.0 m-85 -137.85 -176.37 4.4 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.457 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 75.6 m80 -160.83 -29.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -79.27 -36.21 1.09 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.612 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 90.2 Cg_endo -88.96 131.07 2.19 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.7 p -86.03 156.43 20.43 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.29 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' PRO . 17.2 mt -102.83 119.83 54.44 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.75 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 115' ' ' LEU . 91.2 Cg_exo -43.42 178.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.591 2.194 . . . . 0.0 112.8 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -101.73 121.7 42.55 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.92 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.5 tt -148.59 129.4 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.578 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -133.71 113.75 12.68 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.149 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -95.38 129.98 10.11 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -127.47 138.64 53.0 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.27 133.67 34.0 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.167 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.481 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -115.2 -177.92 0.47 Allowed Pre-proline 0 N--CA 1.471 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.5 Cg_endo -89.45 168.65 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.308 2.006 . . . . 0.0 112.199 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 68.34 24.82 7.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.5 OUTLIER 64.78 46.89 2.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.381 179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -122.86 149.71 43.84 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.7 mt -130.73 127.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.37 112.3 24.18 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -109.25 107.78 18.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.927 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -88.52 144.12 26.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.955 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CG ' ' N ' ' A' ' 133' ' ' SER . 75.5 t80 -141.93 156.59 45.48 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.816 0.341 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.424 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 1.9 p -168.92 140.85 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 m 169.11 154.32 0.16 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.52 -30.19 12.54 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.488 2.126 . . . . 0.0 111.986 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 138' ' ' LEU . 7.9 tpp85 -53.46 -17.78 2.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.377 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 40.97 21.26 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.828 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -86.58 22.91 1.77 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 0.0 110.185 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.7 p -48.32 -27.64 2.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.77 -34.01 69.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.426 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.6 t -67.44 -37.19 82.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.504 ' HB2' HMA1 ' A' ' 182' ' ' HEM . . . -62.01 -39.2 91.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.155 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -59.41 -53.37 58.95 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.572 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -41.47 82.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 142' ' ' ALA . 16.4 mt -56.98 -47.37 80.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.815 0.34 . . . . 0.0 110.692 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.0 mt -59.14 -40.84 86.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.043 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -69.67 -34.09 73.47 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.68 0.276 . . . . 0.0 110.861 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.18 96.19 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.665 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -75.3 -27.3 59.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.739 0.304 . . . . 0.0 110.525 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.34 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.76 -45.81 90.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.201 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -44.54 -31.55 1.15 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.805 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.3 m-85 -115.53 26.21 10.22 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.951 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 40.61 45.2 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.759 0.314 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -117.08 89.09 3.04 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.096 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.562 ' HZ1' HE22 ' A' ' 179' ' ' GLN . 5.3 mtpm? -59.84 138.6 57.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.7 pt -149.57 167.5 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.695 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -130.45 141.46 50.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.646 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.4 128.25 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.05 0.453 . . . . 0.0 111.439 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.1 t -109.33 106.84 16.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.815 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.572 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.2 t-160 -108.8 84.54 1.94 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -92.33 -33.65 14.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.529 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.3 m -99.37 124.48 44.52 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.176 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 8.4 t -146.91 141.4 26.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.999 0.428 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.47 -19.92 51.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.527 ' C ' ' ND1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -68.85 -19.01 64.24 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.384 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.521 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.6 m -99.95 22.87 10.56 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.852 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.0 -11.72 68.37 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.76 156.13 14.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.113 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 43.3 p30 -87.98 -7.15 57.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 110.374 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.513 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 5.8 p-80 -156.32 -169.29 2.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.461 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 11.1 m -136.14 156.53 48.56 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.268 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 53.6 ttp -133.83 113.1 11.89 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.85 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.572 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.8 mp -117.37 112.83 21.23 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.8 mm -101.43 119.57 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.045 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.19 104.3 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-O 120.869 0.366 . . . . 0.0 110.844 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.89 131.34 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.964 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.33 127.54 41.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.562 HE22 ' HZ1' ' A' ' 156' ' ' LYS . 42.6 mt-30 -79.5 138.44 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.48 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -113.17 18.5 17.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.512 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.534 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.51 ' CAC' HG11 ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OG ' ' A' ' 38' ' ' SER . 11.4 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' GLY . 80.2 tttt 60.3 60.11 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.657 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 37.27 100.96 0.01 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.6 tp -74.34 -41.13 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.202 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -64.01 -46.81 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.302 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -66.84 -28.65 68.52 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.727 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 2' ' ' LYS . 90.6 m-20 -64.51 -43.47 93.97 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 73' ' ' LEU . 21.2 t -72.19 -35.47 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.917 0.389 . . . . 0.0 110.494 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.6 tp -65.41 -53.99 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.315 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.34 -32.5 1.34 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.293 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.96 -29.74 64.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.248 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.579 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.16 -54.05 7.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.067 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.8 m -57.98 -44.3 86.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.454 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.2 t -53.35 -27.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.14 -16.68 39.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.326 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -97.16 -50.99 4.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.26 -16.78 4.4 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.18 174.22 19.47 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.5 ttm -71.88 -29.68 64.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.659 0.266 . . . . 0.0 111.118 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 m -54.74 -38.61 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.873 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.26 -35.37 62.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 65.0 t-105 -67.8 -49.03 64.54 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.275 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.6 m120 -68.99 -27.04 65.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.81 -62.32 1.43 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.098 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -73.43 -24.24 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.307 -178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.022 ' N ' HD13 ' A' ' 25' ' ' LEU . 63.1 tp -69.21 -45.0 70.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.906 0.384 . . . . 0.0 110.159 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -71.31 -25.79 62.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.493 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -80.28 -41.53 24.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.085 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -97.94 -5.21 34.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -87.89 146.64 39.19 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.6 -164.8 0.26 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.454 2.103 . . . . 0.0 111.971 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -62.86 -30.61 71.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' VAL . 54.3 t0 -45.9 -38.2 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.424 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 61.95 -69.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.03 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' ASP . 1.8 m -70.9 152.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.04 0.448 . . . . 0.0 110.912 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.16 113.98 26.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.538 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -102.85 136.12 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.867 0.365 . . . . 0.0 110.925 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.657 ' N ' ' H ' ' A' ' 3' ' ' GLY . 31.4 p -78.57 -34.44 46.93 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.71 -46.34 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -65.48 -39.41 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.35 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.419 ' OG ' ' OE2' ' A' ' 44' ' ' GLU . 14.8 t 53.11 34.17 16.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.607 ' CD2' ' N ' ' A' ' 43' ' ' ALA . 68.6 t80 -99.32 173.01 6.98 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' N ' ' CD2' ' A' ' 42' ' ' TYR . . . 55.18 5.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 42' ' ' TYR . 83.0 mt-10 -47.7 -25.68 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.793 0.33 . . . . 0.0 110.444 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.2 p -60.11 -30.42 69.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.706 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.83 -25.53 68.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.525 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.68 -43.08 68.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.045 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -63.07 -46.53 87.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.362 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -57.94 -34.09 69.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.173 0.511 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 25' ' ' LEU . 96.6 mt -74.46 -35.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.196 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.8 t -69.98 -38.91 76.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.408 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -74.36 -38.19 63.27 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.06 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' GLN . 10.9 t70 -71.58 -57.66 4.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.708 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.3 p -47.08 -31.27 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.867 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.74 -34.29 73.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.681 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' ASP . 91.8 mt-30 -65.88 -51.07 61.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.6 ptm180 -68.72 -42.11 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.43 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.3 mt -68.5 -9.69 50.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.2 t30 60.92 59.8 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.257 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.5 mtt -143.53 150.89 52.63 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.33 131.5 12.84 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.932 1.755 . . . . 0.0 111.073 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.5 tt -43.5 -36.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.309 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.47 -32.27 73.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.724 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.18 -34.8 25.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.648 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.601 HG21 ' CB ' ' A' ' 55' ' ' ALA . 63.7 t -67.42 -43.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.931 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.7 p -63.65 -37.1 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -65.46 -61.07 2.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.296 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.72 -39.29 61.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -54.78 -40.08 69.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.547 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -59.77 7.08 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -38.94 -45.11 1.15 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.842 0.354 . . . . 0.0 110.941 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.579 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -75.2 -44.68 45.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.923 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.1 tp -48.45 -40.41 26.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.099 0.476 . . . . 0.0 110.022 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 37.2 t80 -62.22 -45.59 92.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.712 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -58.98 -56.41 22.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.516 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.67 -43.66 98.96 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.837 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 80' ' ' ARG . 23.6 mt -52.97 -55.43 23.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.611 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -44.22 -36.98 2.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 p -68.43 -25.21 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 77' ' ' LEU . 18.3 mmm180 -93.34 -35.86 12.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.619 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.95 33.34 5.46 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 0.0 110.162 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.6 m -48.92 -36.53 17.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.089 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -61.85 -47.67 83.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.118 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.12 -47.31 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.099 0.476 . . . . 0.0 110.59 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 42.6 t -65.82 -46.83 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 12.6 t0 -45.04 -8.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.5 mtpp -83.69 -3.31 57.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.189 0.518 . . . . 0.0 110.146 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.75 56.24 0.88 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.21 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 44.4 p30 -49.07 -18.93 0.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.049 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 89' ' ' ASP . 74.7 m-20 -146.55 152.83 39.59 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.393 0.616 . . . . 0.0 111.785 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -59.95 -38.5 82.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.729 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.1 m -64.45 -45.69 86.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.8 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.7 m -62.59 -29.63 70.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 110.453 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -70.47 -71.63 0.24 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.103 -179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 128' ' ' ILE . 56.3 t -35.54 -42.87 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.2 tmt? -80.81 -19.75 44.02 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.697 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -105.66 8.86 43.93 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.474 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.8 mt -51.44 -88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 117.18 0.49 . . . . 0.0 110.636 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' N ' HG22 ' A' ' 98' ' ' ILE . 85.9 t60 -42.11 -47.95 4.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.343 0.592 . . . . 0.0 110.766 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -38.68 -101.04 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.032 -0.985 . . . . 0.0 113.587 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -75.73 -48.44 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.606 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.07 -53.45 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -83.18 -11.52 57.8 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.143 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.39 -34.76 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 108' ' ' LYS . 27.3 tp10 -74.67 -56.33 4.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.729 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -44.64 -32.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.052 0.453 . . . . 0.0 110.262 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -62.17 -42.43 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.442 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.475 ' C ' ' N ' ' A' ' 110' ' ' TYR . 26.9 mtmt -73.12 -33.41 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.35 -13.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.562 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 60.0 t80 -147.14 174.05 11.94 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.325 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.562 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 23.2 m-70 -44.09 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.755 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -155.44 77.9 4.71 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.29 138.83 8.96 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.707 2.271 . . . . 0.0 111.998 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.8 m -65.62 149.84 49.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.539 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.88 152.76 80.86 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.131 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.38 160.18 49.44 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.527 2.151 . . . . 0.0 112.094 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -87.64 123.56 32.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.4 tt -152.93 125.08 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.463 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -130.84 115.88 17.18 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.009 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.53 129.51 9.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -126.7 136.18 52.11 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 mp -86.35 133.15 33.82 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.245 0.545 . . . . 0.0 111.138 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.0 OUTLIER -110.6 171.14 4.59 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 123' ' ' LEU . 70.2 Cg_exo -52.1 -121.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.23 1.954 . . . . 0.0 111.141 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.766 ' O ' ' N ' ' A' ' 127' ' ' GLN . 79.3 m-20 -27.79 128.64 0.06 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.407 -0.219 . . . . 0.0 110.407 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -22.31 68.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.956 0.785 . . . . 0.0 112.849 -178.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.766 ' N ' ' O ' ' A' ' 125' ' ' ASN . 34.7 mt-30 -138.15 143.81 40.48 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.989 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.492 HG21 ' CG1' ' A' ' 95' ' ' VAL . 54.6 mt -130.53 126.62 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.502 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -94.09 111.29 23.0 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 109.33 20.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.786 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -86.59 144.61 27.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.968 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' CD2' ' SG ' ' A' ' 139' ' ' CYS . 70.8 t80 -141.34 150.29 42.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.718 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.5 p -165.79 138.47 4.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.437 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.498 ' O ' ' SD ' ' A' ' 165' ' ' MET . 4.1 m -178.37 151.78 0.77 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.492 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.49 -33.92 6.33 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.522 2.148 . . . . 0.0 112.028 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -63.99 -14.92 57.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.562 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mtm105 51.86 30.73 7.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.929 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.0 mt -82.62 14.19 3.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.385 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.481 ' SG ' ' CD2' ' A' ' 132' ' ' TYR . 10.1 t -44.43 -35.01 2.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.815 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -55.81 -34.1 65.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.243 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 37.4 t -66.57 -37.06 84.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' HB2' HMA1 ' A' ' 182' ' ' HEM . . . -61.24 -39.08 88.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.996 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -61.34 -54.48 43.31 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.991 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.65 -42.37 77.09 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 57.8 mt -57.42 -43.12 83.54 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.711 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 59.1 mt -63.56 -39.41 94.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.341 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -70.87 -36.46 72.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.747 0.308 . . . . 0.0 110.975 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.33 -37.62 74.62 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -80.08 -26.59 39.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 110.539 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.38 -55.5 17.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.179 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -59.55 -48.13 82.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.993 0.425 . . . . 0.0 110.248 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -40.38 -30.27 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.919 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 3.3 m-85 -120.63 31.77 6.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.477 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 38.6 38.09 0.23 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.772 0.32 . . . . 0.0 110.894 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -108.28 85.02 2.04 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.922 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.8 mtmm -60.96 135.65 57.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -143.59 167.98 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.771 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -131.12 140.58 50.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.751 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.6 mt -121.38 128.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.125 0.488 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.4 t -111.04 116.68 31.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.043 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.715 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -116.52 93.18 4.11 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.704 0.764 . . . . 0.0 110.647 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -95.29 -30.6 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.108 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 m -102.57 121.53 42.57 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 39.4 t -140.16 120.67 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.619 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 134' ' ' SER . 4.0 ptt? -50.77 -20.26 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -66.47 -18.13 65.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.101 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -102.07 24.81 9.54 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.751 0.31 . . . . 0.0 110.982 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.71 -11.81 70.52 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.08 159.91 16.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.982 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' OD1' ' ND1' ' A' ' 171' ' ' HIS . 39.5 p-10 -91.42 -8.49 47.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 110.342 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' ND1' ' OD1' ' A' ' 170' ' ' ASP . 12.5 p-80 -154.45 -162.88 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.499 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 35.6 m -142.57 158.64 43.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 52.2 ttp -134.73 109.93 8.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.38 114.46 25.13 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.28 119.46 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mp -101.19 106.7 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.773 0.321 . . . . 0.0 110.901 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.98 129.06 40.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.385 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -83.79 142.58 30.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -111.36 14.86 21.56 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.498 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 50.5 p30 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.556 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.586 HMA2 ' O1A' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 3' ' ' GLY . 52.2 mttm -80.22 111.47 16.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 39.23 106.22 0.01 OUTLIER Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.537 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -75.0 -45.08 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.059 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 4' ' ' ILE . 8.6 mm -60.62 -44.64 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.299 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -67.64 -28.95 68.15 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.716 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -64.17 -47.38 80.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.139 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -70.06 -29.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.55 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 12' ' ' MET . 10.2 tp -69.91 -53.95 15.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.303 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.1 tt0 -44.05 -30.08 0.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.225 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -71.6 -33.5 69.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.542 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.424 ' N ' ' O ' ' A' ' 9' ' ' LEU . 22.5 mtt -72.04 -53.76 11.93 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.4 m -58.08 -45.43 88.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 10' ' ' GLU . 43.7 t -51.6 -28.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.771 0.32 . . . . 0.0 110.882 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.68 -16.36 39.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.573 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -94.68 -50.25 5.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.24 -13.58 4.98 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.5 -175.89 16.49 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -26.91 33.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.625 0.25 . . . . 0.0 111.303 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -61.19 -34.63 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.478 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 2.7 p -68.91 -40.67 81.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.463 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.6 t-105 -65.23 -42.25 93.58 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.123 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -74.11 -28.29 61.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.926 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.94 -63.35 1.08 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.05 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.39 -19.96 64.65 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.865 -179.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.8 tp -73.97 -39.34 63.77 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.05 -32.5 61.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.651 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.2 ttmm -75.48 -42.17 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.623 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.52 ' NE2' ' OD2' ' A' ' 53' ' ' ASP . 63.0 m-70 -89.36 1.79 55.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -118.73 144.76 36.18 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.01 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.87 -157.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.627 2.218 . . . . 0.0 111.658 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -57.29 -42.86 82.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 110.294 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.44 79.92 9.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -81.92 12.04 4.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 ' H ' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -76.75 139.52 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.975 0.417 . . . . 0.0 110.6 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 1.2 p90 -113.95 116.11 28.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.472 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.8 t -107.7 137.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.0 p -80.26 -28.59 38.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.603 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.73 -34.04 62.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.967 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -81.15 -174.17 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 110.653 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.6 t -156.96 -142.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.408 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 61.23 -71.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.601 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -53.68 -15.0 1.02 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.359 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -47.4 -25.45 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.2 m -54.72 -31.26 57.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.343 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -57.49 -27.76 62.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.477 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.0 tp -57.28 -40.43 77.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.198 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -66.55 -48.06 70.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.43 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 t -57.93 -33.54 68.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.232 0.539 . . . . 0.0 109.978 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 66.5 mt -75.3 -36.27 35.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.155 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.6 t -70.13 -38.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.212 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -75.52 -38.5 59.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.981 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' OD2' ' NE2' ' A' ' 29' ' ' HIS . 39.3 t0 -71.0 -56.97 5.05 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.0 p -47.88 -31.06 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.814 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.594 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.08 -33.68 72.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.589 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 89.3 mm-40 -66.07 -51.07 61.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.011 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -68.39 -41.61 80.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.225 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CD1' HG22 ' A' ' 54' ' ' VAL . 72.9 mt -69.04 -10.39 57.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.838 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.85 60.17 1.93 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.286 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.7 mtp -144.08 151.29 51.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.173 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.61 132.34 14.53 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.934 1.756 . . . . 0.0 111.049 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.57 -35.72 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.331 -178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -65.54 -32.04 73.42 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.747 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 52.7 t0 -82.74 -35.58 26.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.601 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.594 HG21 ' CB ' ' A' ' 55' ' ' ALA . 90.3 t -66.35 -46.57 86.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 67' ' ' LYS . 10.7 p -61.09 -36.65 73.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.919 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' N ' HG13 ' A' ' 66' ' ' VAL . 9.7 ttmm -64.99 -62.14 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.27 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.6 -36.97 37.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.499 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -57.53 -43.14 84.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.636 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.85 -41.81 95.36 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.34 -47.78 72.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.749 0.309 . . . . 0.0 110.859 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -41.6 64.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.952 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tp -51.03 -43.03 60.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.047 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 31.5 t80 -63.87 -44.59 92.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.713 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -55.72 -53.42 56.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.72 92.49 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 80' ' ' ARG . 27.7 mt -54.57 -54.01 46.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.813 0.34 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.76 -38.59 7.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.483 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.7 t -66.86 -25.64 66.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.955 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' LEU . 3.1 mmp_? -91.73 -31.58 15.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.827 0.346 . . . . 0.0 110.633 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.488 ' HE2' HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -120.77 29.62 7.31 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.649 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -45.84 -30.9 1.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.784 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.87 -46.1 79.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.183 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.15 -49.28 56.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 0.0 110.622 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.64 -52.26 63.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.611 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -49.53 -12.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.61 -13.29 62.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.708 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -90.51 -26.49 19.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.051 -178.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.689 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 24.7 t70 51.49 -14.96 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.815 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.708 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.7 p30 -161.77 138.59 8.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 110.659 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -41.05 -37.67 0.88 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.0 m -63.09 -43.09 99.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -69.01 -27.49 65.73 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -77.07 -57.98 3.54 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.905 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 128' ' ' ILE . 95.7 t -39.77 -46.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.358 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.5 ppp? -78.09 -15.8 58.56 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.524 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -102.13 0.02 51.11 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.482 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.82 -89.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.169 0.485 . . . . 0.0 110.967 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.588 ' CG ' ' N ' ' A' ' 100' ' ' ASP . 32.3 p80 -41.69 -50.04 4.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.251 0.548 . . . . 0.0 110.768 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.588 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 57.4 t0 -40.7 -99.98 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' N ' ' A' ' 102' ' ' ILE . 3.0 m -76.45 -49.28 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.628 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -53.51 -44.78 57.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.435 ' ND1' HD11 ' A' ' 118' ' ' ILE . 17.4 m80 -89.61 -12.97 38.19 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.717 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -82.31 -33.23 29.08 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -74.42 -55.82 5.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.516 ' CG1' ' HAC' ' A' ' 182' ' ' HEM . 18.7 m -45.28 -38.91 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 106' ' ' VAL . 51.0 t-20 -56.04 -40.65 73.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -70.2 -31.46 68.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.386 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.488 HD22 ' HE2' ' A' ' 81' ' ' HIS . 10.7 mp -68.48 -39.4 81.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.472 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' ASN . 77.9 m-85 -135.07 140.2 45.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.613 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -56.32 137.43 52.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.586 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -164.14 129.69 2.11 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.9 -59.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.995 1.797 . . . . 0.0 112.189 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.2 t -146.22 122.76 11.08 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.656 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.97 152.85 63.05 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.36 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' CG ' ' O2A' ' A' ' 182' ' ' HEM . 91.8 Cg_exo -35.8 157.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.66 2.24 . . . . 0.0 112.448 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -86.55 125.96 34.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.435 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.6 OUTLIER -152.9 126.19 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.967 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.53 108.19 8.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.864 0.364 . . . . 0.0 111.395 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.85 127.14 8.7 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -126.36 129.5 48.92 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.24 133.67 35.26 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.064 0.459 . . . . 0.0 111.202 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.05 -177.86 0.47 Allowed Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.6 Cg_endo -89.53 165.27 5.28 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.297 1.998 . . . . 0.0 111.901 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 24.8 t-20 69.86 30.58 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.735 HD22 HD21 ' A' ' 180' ' ' ASN . 12.3 p30 59.03 41.78 20.27 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.456 0.472 . . . . 0.0 112.174 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -116.79 146.8 42.61 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.478 HG21 HG11 ' A' ' 95' ' ' VAL . 47.0 mt -129.39 130.3 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.883 0.373 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -100.81 112.7 25.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.983 0.421 . . . . 0.0 109.876 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 tp -109.81 112.77 25.01 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -88.4 143.32 27.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.996 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.517 ' CE1' ' OG ' ' A' ' 134' ' ' SER . 44.1 t80 -141.4 150.08 41.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 2.0 p -168.15 139.74 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.453 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 132' ' ' TYR . 1.7 p 173.1 152.59 0.24 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.361 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.33 -28.58 18.1 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.535 2.157 . . . . 0.0 112.191 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -61.42 -16.3 45.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.474 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 45.08 27.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.031 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.6 tp -83.93 16.56 2.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.548 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 8.9 t -44.74 -41.82 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.672 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.2 -33.3 3.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.547 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 28.6 t -70.17 -39.13 75.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.666 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.84 -36.1 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -61.96 -53.99 47.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.04 -40.61 83.14 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.2 mt -59.08 -45.13 91.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.84 0.352 . . . . 0.0 110.509 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.62 -39.75 92.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.325 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -70.93 -34.92 71.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.727 0.299 . . . . 0.0 110.95 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.97 -44.44 97.39 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.39 -35.62 73.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.775 0.321 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.04 -48.86 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.864 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 154' ' ' GLN . 90.9 mt-30 -62.93 -48.4 79.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.036 0.446 . . . . 0.0 110.024 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.507 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -41.55 -27.88 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.2 m-85 -116.22 33.97 5.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 151' ' ' GLN . 32.9 tt0 38.86 44.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.13 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.481 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.83 110.75 17.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.969 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.513 ' CD ' ' H ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.58 140.26 33.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.85 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 176' ' ' ILE . 11.3 pt -148.08 168.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -130.79 139.72 50.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.655 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.2 mt -120.65 127.14 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.106 0.479 . . . . 0.0 111.339 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 28.0 t -108.96 104.39 13.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.786 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.557 ' CG ' HD11 ' A' ' 174' ' ' LEU . 14.3 t-160 -105.99 83.12 1.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.624 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -91.3 -34.18 15.03 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.747 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.534 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.7 m -96.35 121.78 38.52 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.732 -0.387 . . . . 0.0 109.985 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 166' ' ' HIS . 24.5 p -144.8 128.05 16.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.835 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.9 ttp -52.28 -8.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.52 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 164' ' ' CYS . 21.8 m80 -75.89 -19.83 58.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.175 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.8 m -102.19 22.95 12.39 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.771 0.319 . . . . 0.0 110.933 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.27 -13.36 67.48 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.79 158.65 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.94 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -87.81 -9.08 54.94 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -156.54 -158.55 0.8 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 6.6 m -143.81 158.76 43.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.434 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.06 114.85 13.62 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.641 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.6 mp -117.63 111.33 19.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mm -99.25 118.08 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 157' ' ' ILE . 3.1 mp -100.11 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.887 0.375 . . . . 0.0 110.717 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -82.74 132.27 35.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.006 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 26.2 mt -94.13 127.15 39.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.211 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -80.09 136.44 36.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 110.68 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.735 HD21 HD22 ' A' ' 126' ' ' ASN . 82.4 m-20 -104.86 8.75 34.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.453 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 56.0 t0 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.593 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.516 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' H2 ' ' CB ' ' A' ' 38' ' ' SER . 71.9 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 3' ' ' GLY . 92.2 mttt 55.09 70.85 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.596 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.698 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 39.4 98.62 0.01 OUTLIER Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.1 tp -74.14 -48.15 38.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.054 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.8 mm -56.85 -44.34 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.86 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.72 -29.58 68.85 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.423 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.09 -48.76 72.56 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.074 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 73' ' ' LEU . 3.7 t -68.62 -32.34 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.46 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 12' ' ' MET . 7.9 tp -66.74 -53.66 30.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.152 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.651 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.1 tt0 -44.21 -29.06 0.58 Allowed 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.173 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -72.79 -33.82 66.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.489 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.6 mtt -71.66 -54.01 11.74 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.825 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.11 -45.35 88.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.029 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.1 t -51.91 -27.36 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.778 0.323 . . . . 0.0 110.846 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.15 -16.13 38.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.459 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -95.57 -50.01 5.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.77 -15.31 4.95 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 116.27 -176.01 16.14 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -25.64 34.55 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.509 0.195 . . . . 0.0 111.235 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -63.16 -33.44 75.48 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.428 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 2.7 p -69.86 -39.54 77.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.024 0.44 . . . . 0.0 110.368 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.452 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -65.71 -40.25 92.05 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.426 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.93 -27.41 54.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.819 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.44 -63.14 1.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.2 -23.17 64.8 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.868 -179.039 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.028 ' N ' HD13 ' A' ' 25' ' ' LEU . 41.0 tp -70.8 -38.97 73.37 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -75.33 -31.82 60.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -79.01 -42.48 26.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.037 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -87.74 -4.78 58.88 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -92.87 147.97 35.01 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.621 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.47 -169.84 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.517 2.144 . . . . 0.0 111.958 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -62.26 -40.36 95.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.618 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 34' ' ' ARG . 90.6 m-20 -61.32 -46.25 91.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.574 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 33' ' ' ASP . 56.4 ttp180 43.29 94.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 37' ' ' VAL . 7.9 p -160.84 140.6 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.118 0.485 . . . . 0.0 110.946 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -116.04 91.61 3.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.553 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 35' ' ' VAL . 3.5 t -110.87 129.5 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.698 ' N ' ' H ' ' A' ' 3' ' ' GLY . 59.5 p -70.75 -28.57 64.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.389 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -72.61 -41.21 65.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' TYR . 18.1 mmmt -77.96 -69.16 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.296 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.42 ' O ' ' OE2' ' A' ' 44' ' ' GLU . 19.7 m 45.65 15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.77 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 40' ' ' LYS . 67.9 t80 -67.43 -19.44 65.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.53 48.52 1.39 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.758 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 47.0 mp0 -56.73 -28.83 61.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 110.276 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 t -57.22 -34.62 68.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.97 -40.19 94.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.7 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 tp -57.71 -45.39 85.8 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.463 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.76 -47.36 81.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.459 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -57.88 -33.58 68.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.2 0.524 . . . . 0.0 110.043 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 25' ' ' LEU . 56.0 mt -75.33 -35.37 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.126 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.3 -38.16 73.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.288 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -75.12 -37.47 61.44 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.084 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.6 t70 -72.15 -57.09 4.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.702 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.63 -32.09 2.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.859 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.31 -33.23 72.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.726 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 53' ' ' ASP . 92.6 mt-30 -67.38 -50.34 60.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.132 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.3 ptm180 -68.55 -41.59 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.1 mt -69.2 -9.89 55.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.834 179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 61.38 57.55 2.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.275 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.458 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.0 mtt -140.76 150.8 61.18 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.028 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.18 130.65 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.855 1.703 . . . . 0.0 111.208 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.454 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.9 tt -43.07 -36.96 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.162 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' N ' HG23 ' A' ' 62' ' ' ILE . 6.7 pt20 -64.3 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 56.8 t0 -84.29 -37.08 22.12 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 97.1 t -64.12 -46.18 94.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 62' ' ' ILE . 6.8 p -60.19 -40.22 82.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.936 0.398 . . . . 0.0 110.041 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 66' ' ' VAL . 6.6 ttmm -62.96 -59.62 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.675 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.56 -38.5 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -56.39 -42.68 78.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.75 -33.94 88.58 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -63.06 -50.11 71.9 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.233 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.75 -41.49 75.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.007 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HG11 ' A' ' 8' ' ' VAL . 2.0 tp -47.34 -45.63 24.85 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.704 -0.399 . . . . 0.0 111.098 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 29.6 t80 -62.0 -42.95 99.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.086 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -56.86 -55.33 35.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.697 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -45.82 92.88 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.795 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' ARG . 48.0 mt -51.02 -53.65 31.58 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.501 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . -45.57 -36.46 4.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.791 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 t -68.83 -25.38 64.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.914 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' LEU . 31.4 mmt180 -96.22 -35.69 11.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.767 0.318 . . . . 0.0 110.703 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.97 37.01 3.62 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.089 0.471 . . . . 0.0 110.322 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 78' ' ' ALA . 1.3 m -51.78 -35.27 43.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.931 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.01 -48.55 78.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.156 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.0 -47.97 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.428 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.64 ' O ' ' N ' ' A' ' 87' ' ' LYS . 53.1 t -61.18 -51.7 70.04 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.342 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 21.1 t0 -39.82 -13.42 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 85' ' ' VAL . 22.1 mtpp -81.94 -2.93 53.08 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.983 0.42 . . . . 0.0 110.542 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.937 ' O ' ' N ' ' A' ' 90' ' ' ASP . 5.9 p90 -74.72 -6.33 48.25 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.825 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' PHE . 91.1 m-20 21.0 -59.09 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 O-C-N 124.264 0.978 . . . . 0.0 112.4 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.937 ' N ' ' O ' ' A' ' 88' ' ' PHE . 75.8 m-20 -133.49 148.29 51.69 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.043 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -52.47 -39.95 61.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.665 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -64.05 -38.34 90.73 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 m -69.55 -28.54 66.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.647 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.6 tt -71.12 -71.45 0.26 Allowed 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.446 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 128' ' ' ILE . 61.0 t -36.06 -42.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.1 tmt? -81.13 -19.36 43.69 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.607 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -104.01 5.49 46.31 Favored Glycine 0 N--CA 1.476 1.354 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 99' ' ' HIS . 95.9 mt -49.74 -88.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 117.142 0.471 . . . . 0.0 110.598 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.412 ' N ' HG22 ' A' ' 98' ' ' ILE . 47.5 t-80 -42.3 -47.96 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 0.0 110.741 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -40.13 -100.87 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.607 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.8 m -75.27 -48.77 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.607 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -54.47 -48.92 68.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.407 ' HD1' ' HA ' ' A' ' 99' ' ' HIS . 23.7 m80 -85.87 -10.17 55.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.878 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.48 -33.66 31.81 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.314 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -75.93 -54.67 6.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.691 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.0 m -48.3 -33.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 109.977 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 110' ' ' TYR . 65.2 t30 -60.65 -41.47 95.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.495 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -68.04 -30.01 69.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.225 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.74 -32.9 71.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 39' ' ' ALA . 83.8 t80 -128.12 123.57 34.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.554 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -62.97 -172.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 62.18 69.56 0.93 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.3 120.93 9.18 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.8 t -179.68 52.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.602 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 116' ' ' PRO . 25.4 mt -82.47 148.38 58.65 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 115' ' ' LEU . 84.7 Cg_exo -40.64 169.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.403 2.069 . . . . 0.0 112.235 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -100.72 113.56 26.55 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.72 124.11 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.245 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.08 103.04 6.52 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.01 128.97 9.62 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -126.77 132.72 51.0 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.94 133.81 34.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.209 0.528 . . . . 0.0 111.203 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -114.45 -177.95 0.48 Allowed Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 60.1 Cg_endo -89.53 165.52 5.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.266 1.977 . . . . 0.0 111.94 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.495 ' O ' ' CG ' ' A' ' 126' ' ' ASN . 7.0 m-20 69.57 30.88 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.378 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' O ' ' OD1' ' A' ' 126' ' ' ASN . 12.4 p30 58.95 42.62 19.14 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.433 0.458 . . . . 0.0 112.13 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -117.38 148.25 41.92 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 ' CG1' ' A' ' 95' ' ' VAL . 57.1 mt -130.17 128.46 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.51 112.57 24.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.061 0.458 . . . . 0.0 109.926 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -108.87 112.08 24.14 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.797 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -89.66 143.75 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.466 ' CZ ' ' OG ' ' A' ' 134' ' ' SER . 61.4 t80 -142.69 151.45 41.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.095 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 134' ' ' SER . 11.6 p -155.63 134.26 11.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.521 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.507 ' O ' ' SD ' ' A' ' 165' ' ' MET . 66.3 m -168.63 133.5 1.4 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.393 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.65 -52.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.231 1.954 . . . . 0.0 112.806 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -86.12 -38.36 17.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.17 160.27 28.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.13 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.8 mt -114.1 138.86 49.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.914 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.2 t -65.72 -25.02 67.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.616 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -30.65 67.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.479 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 30.8 t -71.22 -39.99 71.39 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.424 ' HB2' HMA3 ' A' ' 182' ' ' HEM . . . -63.01 -33.67 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.125 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.44 -47.87 82.57 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.95 -44.91 87.71 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.9 mt -55.89 -44.73 78.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.794 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.0 mt -58.53 -42.05 86.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.285 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -72.13 -32.78 67.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.35 96.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -79.29 -27.62 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -66.8 -54.52 21.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.659 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 154' ' ' GLN . 26.2 tt0 -57.63 -48.7 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.7 OUTLIER -42.55 -29.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.977 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -113.11 30.98 6.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.923 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 151' ' ' GLN . 33.8 tt0 39.07 43.7 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 29.6 tp60 -118.53 112.36 19.79 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.062 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -83.76 140.14 32.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 pt -148.26 167.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -130.62 142.61 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.558 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mt -122.61 127.23 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.253 0.549 . . . . 0.0 111.234 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 m -110.29 107.07 16.68 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.791 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.716 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -109.3 93.24 4.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.655 0.74 . . . . 0.0 110.655 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.43 -29.91 14.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.113 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.5 m -105.6 121.18 43.45 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' CD2' ' A' ' 166' ' ' HIS . 1.6 t -139.93 133.57 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.065 0.459 . . . . 0.0 110.588 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 134' ' ' SER . 7.7 ptt? -55.94 -27.73 53.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.082 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.56 ' CE1' ' OG1' ' A' ' 167' ' ' THR . 0.7 OUTLIER -64.39 -14.48 56.8 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.997 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m -99.95 21.46 12.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.823 0.344 . . . . 0.0 110.555 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.55 -9.32 76.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.03 152.98 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -86.97 -3.08 59.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.991 0.424 . . . . 0.0 110.082 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -159.24 -172.31 3.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 24.3 m -137.17 156.32 48.47 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.464 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 50.5 ttp -132.4 109.65 9.99 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.507 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -116.5 112.15 20.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.3 117.23 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.118 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.46 102.78 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.855 0.36 . . . . 0.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -83.51 132.24 34.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.017 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 30.5 mt -93.23 124.98 37.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -85.25 147.37 26.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.384 . . . . 0.0 110.727 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -43.7 -39.44 3.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.805 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.411 ' OD1' ' OXT' ' A' ' 181' ' ' ASP . 51.8 p30 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.666 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.512 ' CGA' ' CMA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 3' ' ' GLY . 54.3 mtpt -68.74 -67.96 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 40.43 100.08 0.01 OUTLIER Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -85.19 -47.64 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.4 mm -64.91 -42.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.499 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.616 ' CD2' ' CD2' ' A' ' 36' ' ' TYR . 66.0 m-85 -68.46 -31.07 70.1 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.269 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -64.42 -50.23 68.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 73' ' ' LEU . 10.1 t -68.7 -29.56 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.495 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -68.46 -53.87 20.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.2 tt0 -44.36 -28.38 0.54 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.072 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -73.75 -33.61 64.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.433 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' LEU . 20.9 mtt -71.63 -53.75 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.744 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -58.61 -45.07 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 37.3 t -52.43 -27.44 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 -16.68 38.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.363 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -95.38 -50.54 4.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.22 -15.54 4.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.51 -177.23 17.44 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.18 -26.16 39.4 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.506 0.193 . . . . 0.0 111.208 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' OE1' ' A' ' 24' ' ' GLU . 23.2 t -61.11 -36.28 79.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.339 -179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.9 p -68.98 -39.83 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.055 0.455 . . . . 0.0 110.177 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.5 t-105 -65.52 -39.94 92.4 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.173 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.457 HD21 ' CD ' ' A' ' 27' ' ' GLU . 1.3 t30 -76.51 -27.78 56.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.962 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -69.39 -63.37 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.995 -178.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.019 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.54 -20.51 65.42 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.73 -179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.019 ' N ' HD13 ' A' ' 25' ' ' LEU . 31.6 tp -73.5 -40.44 64.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CD ' HD21 ' A' ' 23' ' ' ASN . 96.0 mt-10 -74.81 -33.41 62.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.189 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 28' ' ' LYS . 10.8 ttmm -73.69 -43.62 58.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -88.54 2.23 53.38 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.571 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -148.55 149.37 31.08 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.775 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.61 -162.39 0.15 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.599 2.199 . . . . 0.0 112.022 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -59.32 -38.94 81.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' VAL . 94.6 m-20 -79.44 55.35 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.22 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.488 ' C ' ' NE ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -74.44 17.09 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.007 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.4 m -80.26 125.93 39.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.838 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.616 ' CD2' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -97.98 129.51 44.87 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 4.1 t -109.97 126.68 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.837 0.351 . . . . 0.0 110.707 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.6 p -65.57 -32.81 74.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.563 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 111' ' ' HIS . . . -69.02 -50.26 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.844 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 42' ' ' TYR . 13.8 mmmt -66.4 -53.77 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.32 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m 61.77 1.19 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.623 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' LYS . 72.6 t80 -63.23 -37.48 87.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.545 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.71 56.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.772 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -46.37 -30.91 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.523 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.4 p -57.78 -35.1 70.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.499 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -67.68 -25.61 65.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.587 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 tp -55.28 -42.91 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.445 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.591 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 t -58.21 -33.26 69.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.228 0.537 . . . . 0.0 110.038 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG12 HD21 ' A' ' 25' ' ' LEU . 67.0 mt -75.15 -35.62 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.24 -38.2 73.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.108 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.18 -38.42 60.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.979 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 56' ' ' GLN . 13.8 t70 -70.99 -57.16 4.82 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.7 p -47.89 -31.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.514 -0.474 . . . . 0.0 109.851 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.6 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.27 -33.13 72.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.664 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.0 mt-30 -67.08 -51.37 55.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.053 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.2 ptm180 -67.78 -41.71 82.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.264 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.444 ' CD1' HG22 ' A' ' 54' ' ' VAL . 74.2 mt -68.82 -10.2 55.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.0 t30 60.98 59.81 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 6.4 mtt -143.53 150.97 52.92 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.111 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.0 131.01 12.75 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.847 1.698 . . . . 0.0 111.189 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.4 tt -43.13 -36.65 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.236 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -64.46 -32.38 73.98 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.79 -35.74 26.22 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.685 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG21 ' CB ' ' A' ' 55' ' ' ALA . 80.3 t -65.87 -45.89 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.6 p -61.77 -38.08 79.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.03 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.11 -60.9 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.43 -38.63 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -54.6 -41.6 70.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.3 -48.07 78.15 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -49.61 -47.84 49.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.647 0.261 . . . . 0.0 110.943 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -72.69 -40.4 66.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.968 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp -50.72 -42.14 56.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.3 t80 -61.3 -45.24 95.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.792 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.553 ' ND2' ' NE2' ' A' ' 152' ' ' HIS . 4.4 m-80 -57.06 -57.09 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.825 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.16 -42.13 99.52 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.036 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 77' ' ' LEU . 28.3 mt -54.51 -55.17 31.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.357 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.21 -36.95 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.514 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.9 t -69.68 -24.36 63.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -94.51 -36.55 11.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.748 0.308 . . . . 0.0 110.714 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -114.4 32.81 5.69 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.187 0.518 . . . . 0.0 110.177 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -47.76 -36.1 11.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.184 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -61.23 -47.32 86.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -71.13 -47.03 63.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.09 0.472 . . . . 0.0 110.645 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.59 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 45.1 t -65.7 -46.32 89.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.795 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -44.94 -8.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.7 mtpp -85.72 -2.97 58.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.354 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -100.68 56.33 0.89 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.301 -179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -50.32 -19.64 0.87 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.037 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 54.0 t0 -144.86 150.96 38.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.404 0.621 . . . . 0.0 111.585 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 54.6 t80 -58.93 -40.12 83.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.981 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 m -62.58 -46.04 90.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.78 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.3 m -60.83 -29.72 69.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 110.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -71.82 -73.67 0.18 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.167 -179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.491 ' CG1' HG21 ' A' ' 128' ' ' ILE . 45.3 t -36.22 -41.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.428 ' SD ' HD13 ' A' ' 122' ' ' LEU . 15.8 ttt -81.87 -20.53 38.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.478 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.39 10.6 42.87 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.518 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.4 mt -52.18 -88.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 117.301 0.55 . . . . 0.0 110.519 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -41.86 -47.96 4.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.384 0.612 . . . . 0.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -39.03 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.69 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.6 m -73.91 -47.94 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.589 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.99 -53.37 34.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -83.42 -6.42 59.46 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.016 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.83 -36.49 21.58 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.26 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -73.49 -56.14 5.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.494 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 107' ' ' ASN . 10.7 m -48.24 -37.18 7.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.124 0.488 . . . . 0.0 110.003 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.68 HD21 ' CB ' ' A' ' 113' ' ' PRO . 6.7 t-20 -52.81 -44.19 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.679 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -66.69 -31.98 72.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 109' ' ' LEU . 11.0 mp -72.7 -30.92 64.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.178 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -93.77 171.07 9.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.376 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.677 ' H ' ' CD2' ' A' ' 111' ' ' HIS . 6.0 p80 -68.63 -108.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.566 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 82.0 mt-10 -69.44 150.35 97.03 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.68 ' CB ' HD21 ' A' ' 107' ' ' ASN . 73.7 Cg_endo -73.88 -97.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.414 2.076 . . . . 0.0 111.857 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.8 p 39.14 47.16 1.3 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.186 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.14 153.19 84.4 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.29 158.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.416 2.077 . . . . 0.0 112.053 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -92.77 116.92 29.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.679 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 118' ' ' ILE . 20.6 tt -148.31 128.3 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.115 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -134.52 118.26 17.11 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.78 0.324 . . . . 0.0 111.208 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.6 130.37 10.22 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -127.46 134.5 49.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.2 mp -84.81 132.52 34.41 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.236 0.541 . . . . 0.0 111.284 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -114.61 -177.55 0.45 Allowed Pre-proline 0 N--CA 1.469 0.522 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.922 179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.3 Cg_endo -89.32 168.5 5.15 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 m120 67.96 24.81 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.18 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.608 ' ND2' HD21 ' A' ' 180' ' ' ASN . 0.7 OUTLIER 64.78 47.26 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -123.01 148.49 45.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.491 HG21 ' CG1' ' A' ' 95' ' ' VAL . 51.0 mt -130.44 126.18 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.743 0.306 . . . . 0.0 110.704 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -95.14 111.07 22.94 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.29 106.57 16.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.851 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -87.14 144.33 26.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.75 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.597 ' CE1' HMA1 ' A' ' 182' ' ' HEM . 65.0 t80 -142.54 152.1 42.29 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.902 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.8 m -163.9 140.54 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.437 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.3 p -177.66 150.33 0.79 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.626 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 137' ' ' ARG . 59.2 Cg_endo -71.64 -50.28 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.404 2.069 . . . . 0.0 112.108 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 137' ' ' ARG . 20.6 ptp180 -49.22 -11.5 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.59 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 135' ' ' PRO . 55.1 ttp180 41.11 95.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.854 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.9 tp -154.55 29.12 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.466 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 9.8 t -50.85 -33.24 22.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.732 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -53.93 -33.26 56.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.386 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 27.4 t -67.59 -38.17 83.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.531 ' N ' ' O1A' ' A' ' 182' ' ' HEM . . . -62.2 -35.52 79.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.871 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.78 -54.29 44.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.135 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.57 -40.77 79.66 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 142' ' ' ALA . 32.6 mt -57.88 -44.21 86.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.644 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.5 mt -64.8 -38.24 90.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.56 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.68 -36.69 73.44 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.081 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.532 ' O ' ' CE1' ' A' ' 152' ' ' HIS . . . -57.14 -38.25 84.82 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' O ' ' CD2' ' A' ' 153' ' ' PHE . . . -78.7 -27.71 45.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.921 0.391 . . . . 0.0 110.649 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.43 -54.13 32.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.284 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -59.07 -49.2 78.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 110.253 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.553 ' NE2' ' ND2' ' A' ' 75' ' ' ASN . 2.3 m-70 -40.42 -29.39 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.24 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 2.8 m-85 -121.0 31.18 6.5 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.35 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 38.41 36.15 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.054 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -105.62 84.79 2.13 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.33 134.11 56.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.195 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.8 pt -144.55 167.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -131.49 140.92 49.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.96 128.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.077 0.465 . . . . 0.0 111.169 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 24.4 m -111.66 113.69 26.23 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.976 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.705 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -115.0 94.65 4.84 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.771 0.796 . . . . 0.0 110.661 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 3.8 p30 -96.56 -33.68 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.174 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.5 m -93.98 118.33 31.34 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 166' ' ' HIS . 32.4 t -139.39 119.73 13.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.558 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -51.95 -9.21 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.408 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.605 ' N ' ' SD ' ' A' ' 165' ' ' MET . 17.1 t-80 -71.73 -18.2 62.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.8 m -104.27 20.4 18.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.525 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.33 67.08 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.61 22.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.311 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CG ' ' A' ' 171' ' ' HIS . 92.2 m-20 -93.12 -4.51 52.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.421 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ASP . 89.9 m-70 -157.65 -168.98 2.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.693 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 2.5 m -133.09 158.2 43.36 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.289 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 41.8 ttm -136.1 105.4 6.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.47 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.09 119.79 39.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.76 119.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.4 mp -101.79 110.48 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.944 0.402 . . . . 0.0 110.905 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -90.64 133.31 35.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.237 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.12 125.97 41.02 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.305 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -79.34 135.69 36.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 110.499 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.608 HD21 ' ND2' ' A' ' 126' ' ' ASN . 86.2 m-20 -104.52 7.71 35.33 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.408 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.408 ' O ' ' O ' ' A' ' 180' ' ' ASN . 64.2 t0 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.597 HMA1 ' CE1' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 3' ' ' GLY . 93.0 mttt -78.8 -65.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 2' ' ' LYS . . . 37.11 104.04 0.01 OUTLIER Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 5' ' ' ILE . 8.7 tp -75.58 -45.34 39.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.338 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' N ' HG23 ' A' ' 4' ' ' ILE . 9.1 mm -62.43 -43.47 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.57 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -69.39 -28.52 66.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.74 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -66.59 -53.66 31.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.783 0.325 . . . . 0.0 111.344 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.78 -27.86 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.557 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -70.49 -53.55 15.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.358 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.3 tt0 -44.29 -28.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.166 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -72.92 -35.03 66.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.559 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtt -70.69 -53.69 14.72 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.9 m -58.56 -45.0 90.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.131 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 10' ' ' GLU . 34.4 t -52.17 -26.91 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.88 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.87 -16.67 37.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.35 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -94.99 -50.74 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -128.49 -14.73 4.66 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.94 -177.69 17.93 Favored Glycine 0 N--CA 1.474 1.172 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.575 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -24.75 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.58 0.229 . . . . 0.0 111.202 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.2 p -62.26 -35.98 80.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.188 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 22' ' ' TRP . 1.8 p -69.38 -40.9 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.455 . . . . 0.0 110.286 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.46 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 69.0 t-105 -64.59 -45.51 86.67 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.336 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.13 -27.76 63.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.95 -62.59 1.31 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.115 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -71.58 -19.99 62.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.979 -178.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.033 ' N ' HD13 ' A' ' 25' ' ' LEU . 42.9 tp -73.78 -45.3 52.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.748 0.308 . . . . 0.0 110.196 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -70.43 -28.62 65.19 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.43 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -78.39 -40.66 35.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.594 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -104.83 -2.95 24.08 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -47.86 157.1 0.64 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.56 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.53 179.06 6.68 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.743 2.295 . . . . 0.0 111.965 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -64.87 -33.31 75.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.162 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' VAL . 52.1 t0 -72.23 -11.86 60.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.459 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 62.4 -69.36 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' ASP . 2.0 m -64.62 151.28 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.078 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 2' ' ' LYS . 1.3 p90 -107.11 113.79 27.46 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.885 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 39' ' ' ALA . 3.4 t -106.96 133.11 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.779 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.6 p -74.85 -27.53 60.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.525 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -75.15 -36.99 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -80.24 -174.07 4.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.556 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 52.5 p -156.03 -136.27 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.388 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' N ' ' OG ' ' A' ' 41' ' ' SER . 35.3 m-85 59.96 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.601 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -57.55 -13.12 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.484 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -47.25 -21.33 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 m -58.24 -26.69 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.515 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.36 -29.8 64.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.698 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.6 tp -56.89 -43.02 80.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.575 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -65.15 -46.93 78.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.532 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -59.99 -32.72 71.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.082 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.502 HG12 HD21 ' A' ' 25' ' ' LEU . 57.1 mt -75.31 -36.17 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.186 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.3 -38.64 77.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.199 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -75.11 -38.21 61.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.088 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 56' ' ' GLN . 39.7 t0 -71.81 -56.74 5.2 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.738 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.5 p -47.87 -31.58 2.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 109.888 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.82 -33.03 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.669 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 53' ' ' ASP . 93.2 mt-30 -67.12 -50.87 59.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.9 ptm180 -68.31 -41.77 80.39 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.5 mt -69.17 -9.7 54.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.82 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 60.52 59.77 2.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.31 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.8 mtt -143.46 150.95 53.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.151 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.5 132.89 15.24 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.863 1.708 . . . . 0.0 111.067 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.426 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.7 -35.64 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.246 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -65.16 -31.47 72.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.728 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.83 -35.9 23.88 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.598 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 85.8 t -65.78 -45.94 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.759 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.2 p -61.16 -38.7 80.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.941 0.4 . . . . 0.0 109.951 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.1 ttmt -63.4 -60.9 2.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.485 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.12 -38.1 56.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.79 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -56.7 -44.63 81.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.28 -36.73 93.58 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.626 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.04 -47.36 86.18 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.726 -0.279 . . . . 0.0 111.084 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -42.1 62.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.938 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tp -49.23 -44.18 43.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 39.0 t80 -63.69 -44.83 92.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.27 -53.51 52.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.234 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.76 94.55 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.552 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.03 -56.79 15.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.911 0.386 . . . . 0.0 110.241 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.57 -36.88 4.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 t -62.68 -29.04 70.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.731 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -95.67 -28.41 14.82 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.407 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.592 ' CG ' HBC1 ' A' ' 182' ' ' HEM . 63.8 m-70 -112.66 27.1 9.92 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.434 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.1 m -51.1 -40.11 57.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.019 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.9 -48.02 82.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.27 -49.51 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.255 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 87' ' ' LYS . 70.9 t -60.96 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.24 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -48.43 -8.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' VAL . 24.0 mtpp -75.09 -10.6 59.62 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.994 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.705 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.08 -26.58 18.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.012 -178.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.696 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 26.0 t70 50.8 -12.9 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.946 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 88' ' ' PHE . 2.8 p30 -162.75 137.89 6.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -40.42 -35.26 0.42 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.48 ' O ' ' CE ' ' A' ' 96' ' ' MET . 61.7 m -64.92 -47.43 77.75 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.758 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.1 t -64.33 -28.93 70.04 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' GLY . 3.9 tt -78.18 -54.38 6.3 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.95 -178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 94' ' ' LEU . 37.8 t -37.03 -52.1 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.219 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 92' ' ' THR . 1.1 ptp -80.73 -12.0 59.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.394 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -93.97 -3.89 63.58 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 118' ' ' ILE . 96.5 mt -46.51 -86.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.611 0.243 . . . . 0.0 110.85 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -42.68 -51.21 5.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.373 0.606 . . . . 0.0 110.612 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -40.96 -100.34 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.566 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.0 m -76.75 -48.08 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.566 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.7 -46.21 79.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -88.21 -9.77 51.93 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.686 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tt -83.85 -35.33 24.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.236 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -75.83 -57.68 3.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.623 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 102' ' ' ILE . 13.1 m -45.51 -37.49 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.056 0.455 . . . . 0.0 110.062 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -55.67 -43.15 76.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.814 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -69.69 -25.34 63.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.643 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.15 -45.93 31.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.558 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 107' ' ' ASN . 26.0 m-85 -102.21 154.02 19.42 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -62.35 -30.81 71.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.492 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER -46.11 108.45 0.82 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HA ' HD21 ' A' ' 107' ' ' ASN . 72.6 Cg_endo -79.9 -61.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.115 1.877 . . . . 0.0 112.208 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m -79.34 145.45 33.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.483 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 11.8 mt -132.72 153.37 81.06 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 88.0 Cg_exo -36.25 162.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.896 2.398 . . . . 0.0 112.813 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -96.21 124.42 40.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' ILE . 19.1 tt -154.24 128.51 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.243 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -134.05 119.03 18.45 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.871 0.367 . . . . 0.0 111.375 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.58 129.05 9.76 Favored Glycine 0 N--CA 1.46 0.298 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -126.04 143.03 51.27 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.476 HD13 ' SD ' ' A' ' 96' ' ' MET . 1.1 tp -91.79 133.97 35.15 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.717 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -116.48 -177.98 0.49 Allowed Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.854 178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 64.2 Cg_endo -89.89 169.24 4.52 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.484 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 66.72 25.24 9.8 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.488 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.4 OUTLIER 66.2 47.64 1.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.247 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -123.86 148.56 46.68 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG21 HG11 ' A' ' 95' ' ' VAL . 26.7 mt -128.75 128.28 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.828 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.488 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.19 109.28 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 tp -107.03 109.36 21.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.525 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -88.23 144.83 26.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.189 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.563 ' HH ' ' CGA' ' A' ' 182' ' ' HEM . 83.4 t80 -142.78 158.4 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.419 ' N ' ' CG ' ' A' ' 132' ' ' TYR . 3.8 p -168.6 141.82 2.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 t 178.89 150.37 0.45 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.494 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -73.46 -40.13 1.7 Allowed 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.549 2.166 . . . . 0.0 112.149 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 137' ' ' ARG . 83.7 mtp180 -54.39 -13.07 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.62 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' ARG . 93.1 mtt180 35.17 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -153.75 24.5 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 110.571 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 59.5 m -41.52 -35.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.784 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.28 -33.53 5.7 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.294 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.0 t -75.1 -44.65 46.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.53 67.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.778 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.29 -49.15 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.63 -42.92 85.92 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.9 mt -58.04 -45.52 86.84 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.21 -40.69 91.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.076 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -70.28 -34.72 73.11 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.736 0.303 . . . . 0.0 110.98 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.73 96.34 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.01 -28.06 61.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 0.0 110.557 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.06 -52.88 36.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.09 -47.06 84.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.371 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -44.05 -31.34 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.97 27.38 9.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.991 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 39.83 44.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -115.7 88.68 2.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.958 0.408 . . . . 0.0 109.916 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -60.25 137.85 58.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.413 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 pt -149.0 167.56 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.679 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -129.82 140.37 51.04 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.616 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.6 mt -120.6 127.35 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.126 0.488 . . . . 0.0 111.497 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.4 t -109.14 106.31 16.14 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.698 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.539 ' NE2' ' O ' ' A' ' 163' ' ' THR . 20.5 t-160 -108.09 83.8 1.85 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.886 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.05 -35.39 14.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.539 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 2.9 m -95.43 119.45 33.96 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 30.5 t -139.54 128.4 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 0.0 110.977 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.9 ttt -51.78 -24.28 5.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -65.06 -18.96 65.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.315 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.96 23.35 9.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.786 0.327 . . . . 0.0 110.969 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.99 -14.16 62.73 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.35 155.18 12.19 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.068 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.05 -3.49 59.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 3.7 p80 -160.34 -168.69 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.295 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 16.2 m -136.98 156.78 48.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.397 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 51.0 ttp -134.64 112.83 11.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.748 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.472 HD11 ' CG ' ' A' ' 161' ' ' HIS . 8.0 mp -116.49 113.85 23.38 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -101.23 118.53 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.8 mp -100.25 103.14 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -82.23 130.32 35.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.81 125.61 39.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.229 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -76.29 145.62 39.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.723 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -37.46 -35.2 0.12 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.041 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.588 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.592 HBC1 ' CG ' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' N ' ' OG ' ' A' ' 38' ' ' SER . 72.3 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 3' ' ' GLY . 25.9 mtmm 56.3 49.72 14.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 36' ' ' TYR . . . 37.24 103.05 0.01 OUTLIER Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.3 tp -74.3 -43.49 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.192 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.9 mm -62.82 -43.63 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.264 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -68.43 -30.48 69.37 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.049 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.38 -44.09 97.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.79 0.329 . . . . 0.0 111.25 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 73' ' ' LEU . 11.3 t -72.55 -29.76 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.5 tp -70.1 -54.05 14.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.273 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 14' ' ' VAL . 85.9 tt0 -44.2 -33.46 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.018 0.437 . . . . 0.0 110.319 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.62 -29.18 64.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.094 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.584 ' SD ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -75.19 -54.06 7.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.114 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 14' ' ' VAL . 29.2 m -57.83 -44.28 85.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.535 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 13' ' ' VAL . 39.3 t -53.13 -28.23 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.65 -16.8 40.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.357 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -96.13 -50.66 4.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.84 -15.93 4.78 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.66 -177.93 17.75 Favored Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.06 -24.67 40.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.571 0.224 . . . . 0.0 111.22 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.0 p -62.32 -35.97 80.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.226 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.6 p -69.3 -40.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.061 0.458 . . . . 0.0 110.242 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.0 t-105 -65.05 -42.88 93.85 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.317 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' N ' HD22 ' A' ' 23' ' ' ASN . 2.7 m120 -73.88 -27.97 61.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -69.08 -63.31 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.991 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.031 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -68.91 -20.68 64.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.84 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.031 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.9 tp -73.66 -38.41 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.013 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 30' ' ' ALA . 66.1 mm-40 -76.13 -32.79 59.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.346 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -72.77 -42.25 64.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.801 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -89.18 3.71 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.417 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -142.19 147.87 45.73 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.503 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.83 169.65 17.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.483 2.122 . . . . 0.0 111.923 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -56.91 -42.59 80.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.6 39.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' CB ' ' HB1' ' A' ' 30' ' ' ALA . 3.3 ppt_? -81.13 138.77 35.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.39 144.82 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.911 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.2 p90 -110.36 107.46 17.19 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 2.6 t -106.07 138.26 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 1' ' ' MET . 52.0 p -81.26 -26.2 35.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.624 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.95 -30.51 50.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -86.39 -174.48 5.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.619 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 43' ' ' ALA . 7.2 t -153.46 -129.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.248 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.467 ' C ' ' N ' ' A' ' 44' ' ' GLU . 96.7 m-85 51.72 -84.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -46.52 -16.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.524 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 42' ' ' TYR . 83.4 tt0 -47.25 -26.5 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.458 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -55.27 -31.11 61.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.546 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -54.62 -26.72 34.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 51' ' ' VAL . 14.3 tp -57.28 -39.18 75.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.15 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CE2' HD13 ' A' ' 138' ' ' LEU . 28.4 m-85 -66.67 -50.38 63.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.357 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.6 p -56.71 -33.17 66.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.132 0.492 . . . . 0.0 110.11 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG12 HD21 ' A' ' 25' ' ' LEU . 62.8 mt -75.51 -35.66 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.09 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.0 t -69.64 -39.4 78.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.165 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.66 -37.45 62.7 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.125 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' GLN . 11.8 t70 -72.33 -57.09 4.48 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.694 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.2 p -47.51 -31.12 2.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.801 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.3 -33.05 71.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.663 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 53' ' ' ASP . 85.3 mm-40 -66.73 -51.08 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.093 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.49 -41.8 79.53 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.349 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG22 ' A' ' 54' ' ' VAL . 76.4 mt -68.69 -10.03 53.86 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 t30 60.39 60.35 2.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.286 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.468 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.96 150.97 51.37 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.065 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.42 133.26 15.77 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.878 1.719 . . . . 0.0 111.102 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 66' ' ' VAL . 16.7 tt -45.54 -35.37 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.316 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.83 -31.93 73.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.715 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 53.9 t0 -83.13 -35.51 25.53 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.587 HG21 ' CB ' ' A' ' 55' ' ' ALA . 88.8 t -65.91 -45.75 90.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.807 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.3 p -61.79 -37.59 78.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.884 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 66' ' ' VAL . 15.6 ttmt -64.4 -61.51 2.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -38.36 53.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -56.46 -40.82 75.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.63 -53.97 25.14 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -45.12 -45.96 11.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.584 ' CG ' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.02 -42.02 60.96 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.427 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.0 tp -49.92 -42.15 47.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.887 0.375 . . . . 0.0 110.428 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.682 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 34.9 t80 -63.46 -47.25 82.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.692 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -53.47 -54.6 34.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.01 -40.92 98.67 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.802 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 80' ' ' ARG . 15.2 mt -56.11 -51.75 66.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.644 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.27 -34.43 4.44 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.363 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.519 ' OG ' ' NH1' ' A' ' 80' ' ' ARG . 17.0 p -72.65 -20.81 61.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.519 ' NH1' ' OG ' ' A' ' 79' ' ' SER . 56.0 mmt-85 -92.33 -35.63 13.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' NE2' ' CG2' ' A' ' 85' ' ' VAL . 5.1 p-80 -125.85 42.72 3.23 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.057 0.456 . . . . 0.0 110.694 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -52.07 -40.75 61.63 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.143 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.31 -40.78 78.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.632 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.03 -47.7 60.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' CG2' ' NE2' ' A' ' 81' ' ' HIS . 55.0 t -64.73 -50.65 74.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.577 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 53.0 t0 -48.76 -5.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 85' ' ' VAL . 23.5 mtpp -80.15 -10.76 59.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.35 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.713 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -92.9 -26.73 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.691 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 76.5 m-20 50.45 -12.73 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.86 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 t0 -163.61 138.22 6.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.021 0.439 . . . . 0.0 110.85 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 95' ' ' VAL . 64.3 t80 -40.92 -34.32 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.8 m -65.37 -43.22 91.47 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.6 m -69.69 -29.29 66.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.6 tt -75.33 -56.61 4.54 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.852 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 128' ' ' ILE . 77.2 t -40.63 -45.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.951 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.4 ptm -78.91 -16.58 56.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.305 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.06 1.88 59.53 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.806 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 118' ' ' ILE . 97.0 mt -48.77 -85.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.803 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -42.83 -50.09 5.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 110.571 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -41.56 -100.28 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.729 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -76.85 -48.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.587 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.6 mt -55.31 -45.77 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -89.48 -7.91 54.02 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.483 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tt -86.96 -31.48 20.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.471 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -79.2 -35.55 41.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 102' ' ' ILE . 16.2 m -65.99 -34.43 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.0 110.228 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -62.65 -46.56 87.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.047 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -67.45 -30.72 70.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.861 0.362 . . . . 0.0 110.415 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 110' ' ' TYR . 6.8 mt -64.46 -8.93 15.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.017 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 2.4 t80 87.91 109.97 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.661 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 111' ' ' HIS . 2.9 t-80 -166.12 39.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.294 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 111' ' ' HIS . 73.5 mt-10 57.15 150.51 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.579 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.43 -163.39 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.492 2.128 . . . . 0.0 112.084 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.1 m 60.75 59.27 2.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.623 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.36 128.78 85.38 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.89 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -36.89 153.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.19 1.927 . . . . 0.0 112.355 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -94.64 125.83 39.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.419 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.2 tt -156.26 129.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.987 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 120' ' ' GLY . 0.4 OUTLIER -134.61 116.05 14.55 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.845 0.355 . . . . 0.0 111.375 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 119' ' ' ASN . . . -96.1 128.91 9.7 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -126.4 132.52 51.5 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.84 133.68 34.73 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.146 0.498 . . . . 0.0 111.257 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.47 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.04 -177.77 0.46 Allowed Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.905 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 59.8 Cg_endo -89.41 168.92 5.01 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.354 2.036 . . . . 0.0 112.159 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 67.68 25.08 8.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.107 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.6 OUTLIER 64.68 47.06 2.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.371 179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -122.91 149.27 44.45 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG21 HG11 ' A' ' 95' ' ' VAL . 51.6 mt -130.74 127.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.861 0.362 . . . . 0.0 110.86 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.47 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -98.1 111.8 23.99 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -109.34 111.34 22.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.721 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -91.51 143.99 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.024 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -141.28 154.25 45.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.568 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 134' ' ' SER . 3.9 p -163.96 140.56 6.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.604 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.3 t 166.17 151.61 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.421 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 137' ' ' ARG . 60.2 Cg_endo -72.17 -30.52 13.12 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.442 2.095 . . . . 0.0 112.063 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 138' ' ' LEU . 61.4 mtp180 -49.4 -15.05 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.661 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 135' ' ' PRO . 34.2 ptt180 37.33 24.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.12 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 136' ' ' ARG . 5.0 tp -84.89 21.7 1.53 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.124 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 6.7 p -45.38 -39.48 6.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.65 -32.72 3.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.296 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 40.6 t -73.14 -41.16 64.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.604 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.502 ' HB2' ' CMA' ' A' ' 182' ' ' HEM . . . -55.45 -41.37 72.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.047 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -60.57 -52.12 66.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.848 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.94 -41.47 84.5 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.65 -45.99 88.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.702 0.287 . . . . 0.0 110.677 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.4 mt -60.39 -39.56 87.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.89 -34.3 71.45 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.729 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.13 95.44 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -74.92 -27.44 60.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.803 0.335 . . . . 0.0 110.582 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.71 -53.68 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.46 -46.76 88.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -44.04 -29.75 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.903 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.1 m-85 -118.86 27.22 9.02 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.105 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 39.52 44.92 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.074 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -115.4 88.93 2.98 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 109.999 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -59.46 137.31 58.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.2 167.04 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.937 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -129.77 143.96 51.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.483 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.8 mt -124.3 128.16 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.163 0.506 . . . . 0.0 111.523 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.4 t -108.73 104.11 13.33 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.3 t-160 -106.55 84.97 2.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.065 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.94 -36.35 13.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.527 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 5.8 m -96.68 121.74 38.85 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.729 -0.388 . . . . 0.0 109.999 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . . . . . . . . . 15.1 t -142.0 133.7 27.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.001 0.429 . . . . 0.0 111.125 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 169' ' ' ALA . 6.0 tpt -54.91 -24.23 22.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.007 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -67.16 -19.07 65.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.371 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -100.11 22.74 10.91 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.749 0.309 . . . . 0.0 111.017 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.26 52.93 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -55.55 150.3 12.35 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.969 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 57.0 t0 -82.04 -0.26 43.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.364 . . . . 0.0 110.467 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -163.56 -167.74 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.1 m -140.05 156.02 46.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.407 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.2 ttm -134.68 112.12 10.54 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -116.74 111.6 20.0 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.84 118.26 46.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.154 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.5 102.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.813 0.339 . . . . 0.0 110.695 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -80.92 129.57 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.832 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.7 mt -95.53 128.75 42.65 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.474 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -82.75 138.43 34.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.538 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -112.14 13.95 20.62 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.53 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 47.9 p30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.627 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.548 HMC3 ' NE2' ' A' ' 81' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 3' ' ' GLY . 57.0 mmtt -79.66 141.01 36.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.456 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.713 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 35.06 99.94 0.01 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.2 tp -75.2 -40.12 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.4 mm -64.99 -47.11 89.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.263 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.38 -30.44 71.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.862 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -63.15 -44.21 96.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.81 0.338 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 73' ' ' LEU . 20.7 t -71.38 -34.41 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.553 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' MET . 9.0 tp -65.37 -54.02 34.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.133 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 14' ' ' VAL . 88.4 tt0 -43.88 -32.87 1.19 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.061 0.458 . . . . 0.0 110.244 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -71.74 -30.04 65.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.21 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.586 ' SD ' ' CD2' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -74.66 -53.67 8.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.053 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 14' ' ' VAL . 31.3 m -59.09 -45.06 92.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.54 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 10' ' ' GLU . 42.2 t -51.21 -28.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.555 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.5 -16.28 42.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.542 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -94.22 -50.62 5.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.77 -13.89 4.63 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 21' ' ' VAL . . . 115.39 -175.8 16.18 Favored Glycine 0 N--CA 1.471 1.028 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.83 -24.83 38.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.565 0.221 . . . . 0.0 111.265 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -63.07 -34.11 76.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.989 -0.285 . . . . 0.0 111.33 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' CG2' ' NH1' ' A' ' 57' ' ' ARG . 2.8 p -68.64 -41.12 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.145 0.497 . . . . 0.0 110.491 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.474 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 67.1 t-105 -64.81 -35.53 81.39 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.262 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 HD21 ' CD ' ' A' ' 27' ' ' GLU . 2.5 t30 -81.21 -27.4 35.32 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.674 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.9 -64.44 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.02 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -66.24 -21.62 66.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.6 -179.054 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.02 ' N ' HD13 ' A' ' 25' ' ' LEU . 34.2 tp -72.85 -39.88 66.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.825 0.345 . . . . 0.0 110.125 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' CD ' HD21 ' A' ' 23' ' ' ASN . 94.1 mt-10 -73.82 -34.18 64.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.197 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -73.92 -43.38 58.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -89.69 0.57 56.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.493 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -153.76 151.74 25.64 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.521 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 30' ' ' ALA . 74.6 Cg_exo -43.65 173.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.26 1.973 . . . . 0.0 112.122 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -75.64 -37.79 59.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -106.91 38.39 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.937 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.531 ' NH1' ' O ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -80.15 128.69 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.416 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' O ' ' NH1' ' A' ' 34' ' ' ARG . 2.5 m -125.49 127.34 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -86.3 113.88 22.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.818 179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 3' ' ' GLY . 7.3 t -98.61 132.38 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.637 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.713 ' N ' ' H ' ' A' ' 3' ' ' GLY . 87.0 p -68.62 -31.74 71.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.735 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -72.76 -38.73 67.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -80.54 -175.61 5.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.422 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.0 t -156.76 -141.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.503 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.445 ' C ' ' N ' ' A' ' 44' ' ' GLU . 18.6 m-85 62.02 -70.62 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.659 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -49.12 -14.82 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 42' ' ' TYR . 14.4 tm-20 -46.74 -27.32 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 84.8 p -53.3 -31.9 46.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.664 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.07 -27.06 68.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.636 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.96 -43.43 86.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.406 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.34 -47.93 77.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.464 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 m -57.9 -34.62 70.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.026 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.473 HG12 HD21 ' A' ' 25' ' ' LEU . 63.7 mt -74.24 -34.53 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.222 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.92 -40.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.236 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -73.4 -38.07 65.73 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.093 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.71 -58.29 3.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.73 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 58' ' ' LEU . 2.6 p -47.98 -31.2 2.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.974 0.416 . . . . 0.0 110.037 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.599 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.36 -37.81 74.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.766 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -62.37 -51.13 68.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.176 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG3' HH11 ' A' ' 57' ' ' ARG . 0.0 OUTLIER -69.03 -43.49 74.61 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.584 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.2 mt -66.3 -8.72 26.79 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.1 t30 61.52 57.75 2.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.364 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.444 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 15.2 mtp -142.44 149.86 52.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.069 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.6 131.54 13.72 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.865 1.71 . . . . 0.0 111.203 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 tt -43.73 -36.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.14 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -65.38 -31.38 72.47 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.46 -36.11 24.42 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.551 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' CB ' ' A' ' 55' ' ' ALA . 95.8 t -65.69 -45.53 91.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.706 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.5 p -62.11 -37.95 79.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.959 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttmt -64.08 -60.83 2.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.294 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.17 55.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -55.71 -41.26 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.39 -62.41 4.89 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 147' ' ' PHE . 28.1 mt-30 -37.74 -45.92 0.85 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' SD ' ' A' ' 12' ' ' MET . 2.0 t80 -74.12 -43.73 56.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.5 tp -50.72 -39.17 51.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.088 0.47 . . . . 0.0 110.043 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 47.8 t80 -63.25 -44.56 94.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.567 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -59.19 -55.05 39.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.452 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.72 -41.74 98.86 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.908 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 80' ' ' ARG . 26.2 mt -55.16 -54.82 38.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.265 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.87 4.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.1 t -69.41 -24.8 63.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . 12.8 mmm180 -94.61 -36.61 11.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.797 0.332 . . . . 0.0 110.613 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -114.22 34.19 4.83 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.068 0.461 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 m -49.17 -35.88 18.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.219 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -61.49 -47.07 87.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.095 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.81 -47.11 58.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.028 0.442 . . . . 0.0 110.727 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 58.7 t -66.63 -46.75 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -45.03 -9.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 85' ' ' VAL . 18.9 mtpp -83.62 -3.16 57.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.181 0.515 . . . . 0.0 110.103 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -100.27 56.01 0.92 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.258 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -50.9 -20.14 1.22 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.755 -178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 91' ' ' PHE . 53.3 t0 -145.22 150.8 37.34 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.324 0.583 . . . . 0.0 111.483 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 70.6 t80 -59.78 -38.04 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.005 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 85.5 m -63.38 -41.98 98.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.911 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.8 p -66.33 -28.51 68.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.04 0.448 . . . . 0.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.0 OUTLIER -72.3 -72.68 0.22 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.299 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.494 ' CG1' HG21 ' A' ' 128' ' ' ILE . 50.7 t -35.32 -43.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 96' ' ' MET . 1.3 tmt? -80.81 -19.48 44.62 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.652 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -106.24 10.94 43.75 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.478 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.96 -88.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.64 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -41.69 -47.15 3.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.342 0.592 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -39.61 -101.42 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.7 m -74.79 -48.68 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -176.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.599 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.7 mt -54.16 -52.88 33.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -83.51 -7.14 59.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.024 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -83.98 -35.84 23.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -74.47 -54.86 6.73 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.586 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 107' ' ' ASN . 11.5 m -48.63 -36.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.08 0.467 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 106' ' ' VAL . 32.5 t30 -54.26 -44.07 71.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.517 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -65.75 -31.44 72.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.057 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 109' ' ' LEU . 11.0 mp -73.17 -32.83 65.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.146 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -85.35 170.54 12.64 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.243 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -76.82 -29.22 55.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.869 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.63 153.12 29.94 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.432 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.86 -91.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.51 2.14 . . . . 0.0 112.033 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 60.7 m 43.92 30.1 0.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.692 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.86 147.29 88.67 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -39.53 160.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.452 2.101 . . . . 0.0 112.305 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -92.86 126.62 38.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.123 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 118' ' ' ILE . 18.8 tt -153.61 126.96 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.462 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.19 115.99 16.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.109 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -97.02 129.82 10.03 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.08 133.96 50.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.73 133.21 34.8 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.207 0.527 . . . . 0.0 111.443 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 129' ' ' ALA . 0.3 OUTLIER -115.45 -177.68 0.46 Allowed Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.945 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 123' ' ' LEU . 58.9 Cg_endo -89.25 167.74 5.32 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.374 2.049 . . . . 0.0 112.206 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.5 m120 69.28 24.35 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 126' ' ' ASN . 0.7 OUTLIER 65.01 45.78 3.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.345 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -121.43 149.4 43.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' CG1' ' A' ' 95' ' ' VAL . 55.6 mt -131.09 125.63 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.796 0.331 . . . . 0.0 110.72 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.473 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -93.68 111.71 23.45 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.51 106.88 16.8 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.736 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.615 ' NH2' ' CD2' ' A' ' 171' ' ' HIS . 32.9 ttt85 -88.58 145.31 25.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' CE2' ' OG ' ' A' ' 134' ' ' SER . 81.4 t80 -142.44 152.57 42.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.598 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' SER . 5.7 p -164.77 142.7 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.51 ' OG ' ' CE2' ' A' ' 132' ' ' TYR . 1.0 OUTLIER 166.35 153.78 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.164 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.89 -23.07 26.07 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.512 2.141 . . . . 0.0 111.897 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 138' ' ' LEU . 87.1 mtt180 -59.47 -20.66 56.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HE ' ' CE ' ' A' ' 165' ' ' MET . 94.7 mtt180 43.09 17.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 136' ' ' ARG . 3.4 mt -79.64 20.8 0.55 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.192 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 140' ' ' PHE . 19.7 p -45.01 -41.36 7.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.498 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.518 ' N ' ' SG ' ' A' ' 139' ' ' CYS . 0.1 OUTLIER -45.23 -31.55 1.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.213 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 12.2 t -72.53 -40.84 66.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.587 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.2 -36.66 68.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.868 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.43 -51.75 68.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.272 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.9 44.64 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 76.7 mt -52.03 -45.74 64.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.1 -40.73 81.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' HB3' HE21 ' A' ' 71' ' ' GLN . 54.9 m-85 -69.23 -33.58 73.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.083 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 152' ' ' HIS . . . -63.86 -44.75 95.67 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -68.76 -33.43 73.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.04 -44.26 96.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.76 -46.62 87.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.34 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -41.27 -35.37 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.911 -179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' O ' ' C ' ' A' ' 154' ' ' GLN . 28.6 m-85 -110.36 27.85 9.22 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.733 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' PHE . 46.1 tt0 39.57 44.83 1.26 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.062 0.458 . . . . 0.0 110.336 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -113.87 92.62 4.04 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.432 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -63.69 130.41 44.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.415 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 176' ' ' ILE . 12.0 pt -137.68 165.0 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.07 0.462 . . . . 0.0 111.115 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -129.1 138.98 52.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.422 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mt -118.63 126.39 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.057 0.456 . . . . 0.0 111.271 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.1 t -110.3 109.55 20.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.714 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.72 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.3 OUTLIER -111.26 93.08 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.805 0.812 . . . . 0.0 110.829 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -95.78 -29.3 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.051 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.8 m -104.59 122.43 45.6 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.543 ' HG ' ' HG1' ' A' ' 167' ' ' THR . 3.1 p -143.4 124.6 14.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 110.702 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 165' ' ' MET . 1.6 tmm? -51.79 -10.17 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.134 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 17.4 t-80 -76.56 -19.74 57.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.212 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.543 ' HG1' ' HG ' ' A' ' 164' ' ' CYS . 2.1 m -102.3 28.94 5.49 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.703 0.287 . . . . 0.0 110.982 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.97 -12.33 62.3 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 165' ' ' MET . . . -59.43 155.24 15.32 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.01 -5.35 58.56 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.615 ' CD2' ' NH2' ' A' ' 131' ' ' ARG . 42.8 p-80 -157.34 -167.73 2.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.443 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.66 156.4 46.85 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.395 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 46.5 ttp -135.09 111.03 9.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.6 mp -116.11 113.32 22.97 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 17.4 mm -100.85 120.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 157' ' ' ILE . 2.7 mp -102.95 106.84 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.938 0.399 . . . . 0.0 110.811 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -87.83 132.9 34.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.17 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 22.7 mt -95.03 125.91 40.02 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -76.08 139.83 41.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.94 17.48 19.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.551 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.465 ' O1D' ' NH1' ' A' ' 136' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLY . 68.5 mttm -80.52 138.05 36.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.592 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.726 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 41.19 100.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.7 tp -84.59 -47.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.032 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 ' N ' HG23 ' A' ' 4' ' ' ILE . 10.1 mm -62.7 -42.94 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.288 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -69.62 -26.96 64.68 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.058 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -66.37 -49.52 66.62 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.704 0.288 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 73' ' ' LEU . 4.5 t -68.87 -30.39 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 12' ' ' MET . 8.2 tp -69.2 -53.55 19.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.256 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 14' ' ' VAL . 86.6 tt0 -44.18 -28.7 0.54 Allowed 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.211 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.96 -33.74 66.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.525 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 9' ' ' LEU . 27.3 mtt -71.61 -54.09 11.54 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.944 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 14' ' ' VAL . 35.2 m -57.83 -45.07 87.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.994 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 10' ' ' GLU . 38.0 t -52.67 -27.31 11.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.879 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.71 -16.61 38.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.342 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -96.09 -50.63 4.76 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.9 -15.64 4.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.33 -177.35 17.59 Favored Glycine 0 N--CA 1.473 1.133 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -25.62 38.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.553 0.216 . . . . 0.0 111.222 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -61.4 -36.04 79.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.188 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.7 p -69.29 -39.96 79.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 110.086 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 68.4 t-105 -65.35 -43.6 90.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.18 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -28.38 62.79 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.68 -62.85 1.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.002 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.93 -19.81 63.37 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.953 -178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.034 ' N ' HD13 ' A' ' 25' ' ' LEU . 52.3 tp -73.73 -39.63 64.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -77.13 -31.35 55.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.663 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -76.61 -42.83 40.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.611 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -89.76 -0.27 57.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -128.74 148.47 68.68 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.796 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.4 -159.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.562 2.175 . . . . 0.0 112.019 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.47 -25.28 62.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 35' ' ' VAL . 57.5 t0 -45.49 -49.32 13.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.407 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 56.03 -75.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.421 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 33' ' ' ASP . 3.2 m -62.81 136.08 26.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 111.473 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -97.98 125.76 43.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.436 ' HA ' ' H ' ' A' ' 3' ' ' GLY . 6.2 t -103.33 121.46 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 110.611 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.726 ' N ' ' H ' ' A' ' 3' ' ' GLY . 80.7 p -59.72 -26.95 66.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.778 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' H ' HG12 ' A' ' 37' ' ' VAL . . . -78.92 -41.68 28.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -78.72 -178.07 5.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.956 0.407 . . . . 0.0 110.706 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.2 t -164.74 54.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.301 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -53.05 -40.72 64.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.704 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -170.84 90.82 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.602 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.16 -24.84 65.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.511 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.2 m -56.35 -27.7 56.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.624 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -49.29 -36.09 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 15.7 tp -58.36 -41.93 85.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.09 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -65.14 -47.72 76.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -57.63 -34.37 69.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 109.98 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.449 HG12 HD21 ' A' ' 25' ' ' LEU . 71.8 mt -75.69 -32.84 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.262 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' LEU . 40.3 t -73.26 -37.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -75.34 -38.0 60.41 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.088 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLN . 12.2 t70 -71.64 -57.06 4.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.649 0.262 . . . . 0.0 110.629 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 58' ' ' LEU . 3.8 p -47.68 -31.26 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.898 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.591 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -70.07 -33.49 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' ASP . 94.2 mt-30 -66.64 -50.94 61.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.016 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 8.0 ptm180 -68.34 -41.87 80.09 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.257 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' HG22 ' A' ' 54' ' ' VAL . 75.0 mt -68.91 -10.01 54.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 49.8 t30 60.69 59.86 2.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 4.5 mtt -143.52 151.04 53.17 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.105 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.51 133.2 15.57 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.851 1.701 . . . . 0.0 111.086 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.2 tt -45.88 -35.69 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.203 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.19 -31.33 72.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.748 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -83.98 -36.19 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.586 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 55' ' ' ALA . 94.3 t -65.45 -46.47 89.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.702 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 67' ' ' LYS . 7.1 p -60.4 -38.8 79.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 66' ' ' VAL . 18.2 ttmt -63.53 -60.99 2.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.404 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -51.47 -37.11 47.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.781 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -57.91 -43.06 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.35 -35.2 91.17 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -60.87 -48.93 79.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 111.023 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -71.27 -42.49 68.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.948 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HA ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp -48.79 -44.26 38.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.031 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 45.8 t80 -62.64 -45.29 93.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 0.0 110.822 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -55.79 -54.46 44.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.26 -44.47 95.5 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.732 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 80' ' ' ARG . 21.8 mt -54.06 -54.54 37.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.358 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -45.59 -39.16 7.3 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.382 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -67.92 -24.56 65.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.007 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' LEU . 71.8 mmt-85 -92.39 -34.57 14.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.544 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -116.57 28.37 8.61 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.225 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -44.47 -31.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.007 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.46 -46.99 80.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.72 -48.33 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.675 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 87' ' ' LYS . 85.2 t -62.8 -52.15 63.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.842 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -45.72 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 85' ' ' VAL . 21.3 mtpp -82.05 -6.71 59.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.057 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.688 ' C ' ' H ' ' A' ' 90' ' ' ASP . 0.4 OUTLIER -90.79 -34.06 15.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.138 -178.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.687 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 81.7 m-20 52.91 -16.31 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.742 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.688 ' H ' ' C ' ' A' ' 88' ' ' PHE . 52.1 p30 -161.76 144.92 12.16 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.194 0.521 . . . . 0.0 111.223 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -49.77 -36.09 24.77 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.5 m -63.31 -47.33 82.71 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.2 p -65.67 -24.89 67.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.754 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLY . 4.5 tt -74.9 -67.4 0.65 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.671 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG1' HG21 ' A' ' 128' ' ' ILE . 64.3 t -36.21 -43.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.4 ppp? -81.38 -18.46 45.46 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.576 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -101.43 0.23 53.49 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.469 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 95.3 mt -45.32 -89.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.115 0.458 . . . . 0.0 110.989 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 100' ' ' ASP . 19.1 p-80 -42.02 -50.48 4.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.278 0.561 . . . . 0.0 110.866 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 99' ' ' HIS . 71.7 m-20 -40.18 -100.63 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.3 m -77.52 -48.33 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -176.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.59 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.3 mt -54.25 -43.94 63.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -92.13 -8.52 45.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.722 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tt -85.65 -31.28 22.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.407 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -79.12 -52.55 8.03 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.676 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 107' ' ' ASN . 15.2 m -50.17 -40.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.984 0.421 . . . . 0.0 110.247 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' N ' HG23 ' A' ' 106' ' ' VAL . 17.8 t-20 -55.91 -43.94 77.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.834 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -72.85 -29.79 63.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 0.0 110.61 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.96 -12.92 60.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 107' ' ' ASN . 71.0 m-85 -147.97 -157.22 0.79 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.511 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -90.81 -103.63 0.1 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.565 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 31.2 mm-40 54.8 72.95 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.744 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.95 -30.08 23.08 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.767 2.311 . . . . 0.0 112.071 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -153.33 110.84 3.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.456 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 116' ' ' PRO . 14.6 mt -82.97 152.02 64.84 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.376 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 115' ' ' LEU . 98.9 Cg_exo -38.25 164.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.619 2.213 . . . . 0.0 112.41 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -94.27 117.67 30.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.715 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.9 mt -136.2 123.86 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.57 102.87 6.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.878 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.7 127.31 8.67 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -126.74 118.45 24.73 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 133.54 46.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 129' ' ' ALA . 16.6 mt -107.47 159.32 30.67 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' A' ' 123' ' ' LEU . 72.3 Cg_exo -47.75 -172.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.814 1.676 . . . . 0.0 111.526 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.711 HD22 ' H ' ' A' ' 126' ' ' ASN . 6.2 p-10 42.48 -123.1 0.66 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.264 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.711 ' H ' HD22 ' A' ' 125' ' ' ASN . 24.8 m-20 -134.26 56.49 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.947 0.404 . . . . 0.0 110.741 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.552 ' CG ' HD21 ' A' ' 125' ' ' ASN . 30.2 mt-30 -127.31 149.98 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.657 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.493 HG21 ' CG1' ' A' ' 95' ' ' VAL . 58.2 mt -133.72 129.33 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.726 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 123' ' ' LEU . . . -98.79 111.55 23.9 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.1 111.61 23.34 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.839 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 171' ' ' HIS . 58.6 ttt180 -87.62 140.77 29.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -138.41 150.47 46.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.744 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.4 m -158.32 134.76 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.462 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.8 p -169.14 132.55 1.2 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.224 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -77.61 -57.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.287 1.991 . . . . 0.0 113.0 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 137' ' ' ARG . 35.3 ptt-85 -80.89 -43.65 19.54 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.828 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 136' ' ' ARG . 6.8 tpt180 -71.24 154.51 41.6 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.946 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.1 mt -108.83 135.83 49.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.904 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 15.3 p -64.42 -31.72 73.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.463 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.88 -32.43 3.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.382 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 17.0 t -75.48 -43.93 46.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.337 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.08 69.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.082 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -59.56 -47.97 83.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.224 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -54.37 -42.81 75.58 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.57 -44.21 80.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.72 0.295 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 67.3 mt -61.62 -40.41 94.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.424 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.06 -35.03 69.17 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.148 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.47 -40.33 92.07 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -77.4 -26.11 51.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 0.0 110.518 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.84 -55.31 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.972 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.54 -47.67 84.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.347 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.445 ' O ' ' ND1' ' A' ' 152' ' ' HIS . 0.8 OUTLIER -42.08 -30.64 0.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.012 -179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.7 m-85 -120.13 30.77 6.82 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.16 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 38.28 43.09 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.453 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -113.2 86.04 2.3 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.002 0.43 . . . . 0.0 109.964 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -59.27 138.45 57.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.257 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.2 pt -149.12 167.53 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.722 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -130.14 144.64 51.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.677 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -126.51 129.27 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.135 0.493 . . . . 0.0 111.487 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 t -108.93 109.1 20.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.727 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 0.1 OUTLIER -110.19 90.01 3.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.447 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -99.29 -32.96 10.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -102.83 128.94 49.38 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.397 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 167' ' ' THR . 1.8 p -150.52 141.71 23.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 ttt -59.76 -21.78 61.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.472 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -66.65 -19.5 65.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 164' ' ' CYS . 1.7 m -100.87 24.57 9.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.748 0.309 . . . . 0.0 110.959 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 -16.63 54.92 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -57.48 159.43 4.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.95 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -91.82 3.76 54.41 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.912 0.387 . . . . 0.0 110.373 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.407 ' CG ' HH21 ' A' ' 131' ' ' ARG . 52.5 p-80 -167.66 -165.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 4.0 m -138.51 158.87 43.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.531 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 44.5 ttm -134.43 110.88 9.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.676 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.1 114.19 23.37 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 20.0 mm -102.73 119.07 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.46 107.25 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-O 120.896 0.379 . . . . 0.0 110.822 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -89.2 130.9 35.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.828 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.8 mt -94.43 129.03 41.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.416 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -78.76 137.44 37.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.682 HD21 ' ND2' ' A' ' 126' ' ' ASN . 80.0 m-20 -110.72 8.03 22.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.481 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 61.4 t0 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.518 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.515 HMA3 ' CGA' ' A' ' 182' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' N ' ' OG ' ' A' ' 38' ' ' SER . 74.3 mmm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -174.53 51.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.707 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.699 ' H ' ' N ' ' A' ' 38' ' ' SER . . . 36.32 99.5 0.01 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 5' ' ' ILE . 10.5 tp -72.14 -43.06 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.396 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 4' ' ' ILE . 7.3 mm -61.2 -46.44 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.05 -30.53 70.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.555 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -63.9 -47.26 81.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.95 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.57 -30.02 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.279 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.28 -52.12 30.67 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.911 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 14' ' ' VAL . 81.8 tt0 -49.68 -26.13 3.47 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.349 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.36 -39.11 62.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -47.31 35.88 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.864 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 14' ' ' VAL . 27.7 m -56.21 -44.19 78.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.107 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 10' ' ' GLU . 30.6 t -52.51 -29.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.571 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.28 -17.16 46.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.28 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -93.41 -50.88 5.24 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.78 -12.69 4.26 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.77 -176.96 18.05 Favored Glycine 0 N--CA 1.474 1.214 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -28.07 39.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.1 t -58.73 -36.16 73.86 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.102 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.519 ' CG2' ' NE ' ' A' ' 57' ' ' ARG . 1.4 p -69.04 -41.92 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 0.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.461 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 73.3 t-105 -64.17 -45.02 90.25 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.187 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -71.18 -28.78 64.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -68.15 -63.87 0.97 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.035 HD13 ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -69.31 -20.22 63.88 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.98 -178.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.035 ' N ' HD13 ' A' ' 25' ' ' LEU . 38.5 tp -72.22 -41.55 66.75 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.249 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.8 -30.58 62.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.712 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -76.36 -41.24 48.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -92.73 -0.77 57.23 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' LEU . . . -93.69 150.94 39.56 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.792 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 30' ' ' ALA . 55.4 Cg_exo -48.38 -171.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.274 1.983 . . . . 0.0 112.212 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -57.02 -53.64 55.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -161.6 77.93 0.54 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.672 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -127.38 169.33 13.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.439 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.14 162.37 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.758 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -95.35 115.53 27.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.192 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 3' ' ' GLY . 12.1 t -114.67 131.75 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.737 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.699 ' N ' ' H ' ' A' ' 3' ' ' GLY . 60.2 p -65.79 -33.58 76.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.533 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.517 ' O ' ' CE1' ' A' ' 110' ' ' TYR . . . -70.71 -49.11 50.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.698 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -69.56 -169.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.19 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 43' ' ' ALA . 44.1 t -52.17 138.23 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.272 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -71.11 12.14 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 41' ' ' SER . . . 40.15 44.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' ' NH2' ' A' ' 136' ' ' ARG . 79.9 tt0 -58.12 -28.66 64.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 m -63.13 -37.5 87.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.368 . . . . 0.0 110.642 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 46' ' ' GLU . 40.3 mp0 -80.97 -33.55 33.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -57.78 -43.89 85.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.583 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.28 -46.96 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -59.18 -33.19 70.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.128 0.489 . . . . 0.0 110.099 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.48 HG12 HD21 ' A' ' 25' ' ' LEU . 56.8 mt -75.5 -35.05 31.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.119 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.38 -38.1 72.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.321 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -75.42 -37.91 60.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.215 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 56' ' ' GLN . 9.2 t70 -72.49 -56.12 5.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.713 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 58' ' ' LEU . 4.1 p -47.64 -31.58 2.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.823 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.586 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -69.94 -33.21 71.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.661 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ASP . 95.6 mt-30 -66.8 -50.72 61.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.001 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' NE ' ' CG2' ' A' ' 21' ' ' VAL . 7.8 ptm180 -68.46 -41.47 80.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.336 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' HG22 ' A' ' 54' ' ' VAL . 73.2 mt -69.49 -10.16 56.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.769 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.2 t30 60.58 60.26 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.48 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 17.1 mtp -143.76 151.12 52.48 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.127 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.49 133.68 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.84 1.694 . . . . 0.0 110.914 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 66' ' ' VAL . 15.5 tt -45.86 -34.62 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.26 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -66.3 -32.27 73.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.643 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 50.6 t0 -82.66 -33.53 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.581 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 55' ' ' ALA . 86.8 t -69.38 -44.45 80.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 62' ' ' ILE . 7.3 p -62.68 -35.62 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.73 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -67.34 -63.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.203 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.46 -34.58 25.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.511 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.86 -43.78 86.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.672 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.61 -35.86 92.45 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.604 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -58.88 -51.3 70.59 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.64 -0.33 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.14 -43.22 68.01 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.937 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tp -48.19 -42.73 30.67 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.897 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 149' ' ' ALA . 33.1 t80 -62.97 -44.52 95.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' ND1' ' A' ' 152' ' ' HIS . 32.3 m-80 -56.32 -49.9 73.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.449 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.35 -42.85 81.26 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.861 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 80' ' ' ARG . 20.7 mt -57.38 -53.92 52.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' THR . . . -46.79 -40.22 13.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.4 m -68.01 -22.53 64.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.2 mmm180 -93.22 -33.97 13.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 110.556 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.515 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 8.1 m170 -116.46 25.26 10.74 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.017 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 78' ' ' ALA . 1.4 m -42.31 -30.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.062 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -65.26 -44.6 87.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.98 -48.45 55.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 87' ' ' LYS . 61.9 t -62.48 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.812 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 27.3 t0 -45.79 -6.49 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 85' ' ' VAL . 26.9 mtpt -81.32 -6.31 58.76 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.709 ' CD1' ' N ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER -94.32 -33.01 13.37 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -178.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.709 ' N ' ' CD1' ' A' ' 88' ' ' PHE . 95.6 m-20 52.21 -14.1 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.789 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 88' ' ' PHE . 3.4 p30 -160.45 137.81 9.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.073 0.463 . . . . 0.0 111.065 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -42.76 -36.08 1.35 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.4 m -63.28 -44.62 94.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 88' ' ' PHE . 77.8 p -69.37 -27.55 65.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 97' ' ' GLY . 6.0 tt -74.23 -59.32 2.78 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.529 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 128' ' ' ILE . 89.9 t -39.19 -47.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.216 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 96' ' ' MET . 3.9 ppp? -77.49 -16.99 58.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.56 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -98.16 -1.47 58.22 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.985 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.6 mt -45.71 -86.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.046 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -43.22 -51.28 6.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.349 0.595 . . . . 0.0 110.721 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -40.33 -101.74 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 102' ' ' ILE . 2.2 m -76.29 -47.1 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.568 ' N ' HG23 ' A' ' 101' ' ' VAL . 2.5 mt -55.8 -45.7 79.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.511 ' HB3' HD12 ' A' ' 115' ' ' LEU . 11.2 m170 -91.06 -6.22 54.14 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.631 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.71 -29.05 22.72 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.025 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.515 ' OE2' ' CE1' ' A' ' 81' ' ' HIS . 3.3 tm-20 -81.15 -34.36 32.5 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG1' ' HAC' ' A' ' 182' ' ' HEM . 10.7 m -70.96 -28.86 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.924 0.392 . . . . 0.0 110.478 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.553 HD21 ' CD ' ' A' ' 112' ' ' GLU . 8.3 t30 -68.32 -47.66 66.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -66.83 -25.1 66.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.749 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -52.31 45.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.216 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.568 ' CG ' ' N ' ' A' ' 111' ' ' HIS . 54.4 t80 -96.33 -106.6 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.566 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.568 ' N ' ' CG ' ' A' ' 110' ' ' TYR . 73.3 m80 -159.54 57.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.655 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.553 ' CD ' HD21 ' A' ' 107' ' ' ASN . 13.2 tp10 58.91 65.53 2.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.692 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.73 -91.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.676 2.25 . . . . 0.0 112.078 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.48 ' C ' HD22 ' A' ' 115' ' ' LEU . 33.8 t -143.11 108.13 4.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' HIS . 4.3 mm? -114.71 101.11 54.23 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.202 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.34 175.51 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.33 2.02 . . . . 0.0 112.216 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -103.83 113.25 26.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.499 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.43 126.39 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.452 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 100.3 5.78 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.528 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.54 127.79 8.78 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -128.28 119.46 25.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.51 134.7 43.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.005 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 124' ' ' PRO . 1.5 mt -111.09 155.11 43.08 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.669 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 123' ' ' LEU . 85.1 Cg_exo -42.21 168.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.988 1.792 . . . . 0.0 111.452 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 m120 61.03 -126.19 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.283 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -133.67 54.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.712 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -126.16 148.69 49.36 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 95' ' ' VAL . 59.1 mt -132.32 128.4 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.972 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.436 ' CB ' HD21 ' A' ' 123' ' ' LEU . . . -97.44 112.62 24.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 tp -110.25 112.13 23.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.83 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.695 HH21 ' CG ' ' A' ' 171' ' ' HIS . 67.6 ttt180 -92.01 145.49 24.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.131 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -140.42 146.55 38.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 134' ' ' SER . 4.8 p -158.32 139.45 13.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 133' ' ' SER . 1.0 OUTLIER 167.47 152.98 0.11 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.444 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.42 -31.8 16.97 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.533 2.155 . . . . 0.0 111.986 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 138' ' ' LEU . 34.3 mtp180 -52.13 -18.03 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.456 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 42.97 17.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 136' ' ' ARG . 4.7 tp -80.36 16.0 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.562 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.1 p -44.34 -30.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -56.55 -35.5 68.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.367 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 36.3 t -65.01 -35.14 80.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -61.9 -36.3 80.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.876 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -61.68 -55.25 32.43 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.735 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.8 -41.04 82.45 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 142' ' ' ALA . 20.6 mt -57.95 -45.55 86.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 110.525 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.98 -40.76 94.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.269 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.41 -34.37 72.44 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.08 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.19 -43.98 98.36 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 74' ' ' PHE . . . -70.92 -34.96 72.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.757 0.313 . . . . 0.0 110.97 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 155' ' ' GLN . . . -65.85 -50.47 64.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.021 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 154' ' ' GLN . 89.6 mt-30 -62.1 -49.92 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.904 0.383 . . . . 0.0 110.275 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.431 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 4.3 t60 -40.59 -28.92 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.685 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 149' ' ' ALA . 1.5 m-85 -115.12 35.14 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 151' ' ' GLN . 5.6 tt0 38.57 44.51 0.78 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.253 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.504 ' O ' ' HB1' ' A' ' 150' ' ' ALA . 28.8 tp60 -118.8 110.63 17.45 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.026 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -82.81 140.87 32.71 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.026 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 pt -149.07 168.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -131.36 142.41 50.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.611 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 39.3 mt -123.64 128.8 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 121.147 0.498 . . . . 0.0 111.526 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.9 t -108.85 103.94 13.1 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.563 ' CG ' HD11 ' A' ' 174' ' ' LEU . 15.8 t-160 -106.22 83.49 1.9 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.864 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.05 -34.41 15.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.53 ' O ' ' NE2' ' A' ' 161' ' ' HIS . 3.2 m -97.1 118.85 34.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' CYS . . . . . 0.427 ' C ' ' N ' ' A' ' 166' ' ' HIS . 13.6 t -141.02 129.26 22.24 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.965 0.412 . . . . 0.0 110.828 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 37.5 ttm -52.83 -12.55 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 166' ' ' HIS . 18.1 t-80 -74.3 -20.31 60.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.054 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -99.85 23.91 9.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.691 0.281 . . . . 0.0 110.793 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.94 -10.93 72.24 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.35 155.68 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.178 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' O ' ' ND1' ' A' ' 171' ' ' HIS . 50.7 t0 -88.27 -8.64 54.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.287 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.695 ' CG ' HH21 ' A' ' 131' ' ' ARG . 47.4 m-70 -153.36 -168.12 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.249 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 31.6 m -138.72 156.47 47.36 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.527 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.17 112.84 11.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.736 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 161' ' ' HIS . 7.7 mp -117.48 111.69 19.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.018 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.8 mm -99.47 118.38 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.08 104.23 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 110.914 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -86.03 129.64 34.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.737 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.7 mt -93.76 130.43 39.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -79.58 134.87 36.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -108.72 9.05 27.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.525 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HEM . . . . . 0.494 ' HAC' ' CG1' ' A' ' 106' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_